share your experience by using the - mca scientific events€¦ · share your experience by using...

33

Share your experience by using the hashtag #jenscongress on:

HOW TO DOWNLOAD THE CONGRESS APP

1. Connect to the Wi-Finetwork: Convention Center

password: venezia2017

2. Enter your store:

3. Search and download the “MCA EVENTS” app

/JENS.CONGRESS

@JENS_Congress

/jens_congress

/groups/8519337/profile

You can now interact with speakers using Q&A on MCA app. Ask questions to the speakers directly via app and engage the discussion at the end of the sessions.

44

ORGANISING INSTITUTIONS

SUPPORTED BY

european foundation for the care of newborn infants

www.uenps.euThe mission of UENPS is to improve healthcare in the neonatal and perinatal medicine in the European countries. Main goals of UENPS are to improve quality in perinatal and neonatal care by integrating, coor-dinating and adding national and scientific societies’ efforts, to promote the knowledge of the perinatal indicators and to develop recommendations, guidelines, training of the healthcare providers and any other tool to achieve the best healthcare for every newborn and surveillance of neonatal rights wherever they are born.

www.espr.infoThe European Society for Paediatric Research (ESPR) aims to promote paediatric research and post-gra-duate training in Europe. The Society aims to encourage collaboration between the various specialized fields of paediatrics, with the goal of maintaining paediatrics as a unified, scientifically orientated discipli-ne. It has involved into a dynamic and vibrant society which takes up wider societal responsabilities and has a succesful Journal in “Pediatric Research”. Within ESPR, the European Society of Neonatology (ESN) is responsible for education and training in Neonatology in Europe. In the past year a transition from ESN to a new Board of Neonatology (EBN) was realised to improve the representation of all European countries in the neonatal educational activities of ESPR.

www.efcni.orgThe European Foundation for the Care of Newborn Infants (EFCNI) is the first pan-European organisation and network to represent the interests of preterm and newborn infants and their families.It gathers together parents, healthcare experts from different disciplines, and scientists with the common goal of improving long-term health of preterm and newborn children. Our vision and activities are to ensu-re the best start in life for every baby with best possible treatments and care.

55

Dear Colleagues, Dear Friends,

The European Society for Paediatric Research (ESPR), the European Society for Neo-natology (ESN), the Union of European Neonatal and Perinatal Societies (UENPS) and the European Foundation for the Care of Newborn Infants (EFCNI) have combined their efforts for the 2nd Congress of joint European Neonatal Societies (jENS 2017). The congress promises yet again to be a unique event in the field of neonatology.

The congress will highlight best scientific research and clinical care programmes avai-lable nowadays. You will also have access to sessions where world-leading experts will cover a wide range of topics in neonatology, ranging from state-of-the-art basic and clinical research to patient-centred care and clinical guidelines.

A panel of more than 130 leading international experts who have personally contri-buted to the state of the art will review cutting-edge developments in the areas of neonatal care and research, which are particularly active today.

Networking and interactivity between renowned expert’s participants, Key Opinion Leaders, industry and the Organising Societies - will be the keywords of this congress. Innovative and interactive tools such as specially designed apps, jENS TV, interacti-ve e-posters, interactive communications between speakers and the audience and much more will make this congress a truly pioneering experience.

The 2nd edition of the congress comes to the most famous Italian city. Venice, with its combining spectacular buildings, incredible charm, and a true touch of romance was ranked the most beautiful city in the world. It certainly deserves a visit and will without a doubt become one of the congress locations that live on in memory.

The Organising Societies and Scientific Committee of jENS warmly welcome all par-ticipants in this 2nd edition and thanks all presenters and supporters for their great commitment. We wish you fruitful discussions with leading experts in the field of neonatology and are convinced that together, we will make the 2nd jENS an unfor-gettable experience.

Enjoy the Congress!

Professor Luc Zimmermann President ESPR

Doctor Morten Breindahl President ESN

Professor Manuel Sanchez Luna President UENPS

Silke Mader Chairwoman EFCNI

66

EXECUTIVE COMMITTEE

LUC ZIMMERMANNPresident of ESPR

MANUEL SÁNCHEZ-LUNAPresident of UENPS

SILKE MADERChairwoman of the

Executive Board and Co-Founder of EFCNI


MORTEN BREINDAHLPresident of the European Society for Neonatology

(ESN)

77

SCIENTIFIC COMMITTEE

MANON BENDERS VIRGILIO P. CARNIELLICongress President Chair

PIERRE GRESSENSPast Scientific President

AGNES VAN DEN HOOGEN

PETRA HÜPPI NEIL MARLOW

OLA D. SAUGSTAD UMBERTO SIMEONI

99

09:00 - 17:30 ESN COURSE 1 | CAPRI ROOM (PALAZZO DEL CINEMA)

NEONATAL INFECTIONS 09:00 - 09:15 Introduction/welcome Sinno Simons (The Netherlands)

09:15 - 10:15 Basics of infectious diseases in neonatology René Kornelisse (The Netherlands)

10:15 - 11:00 Early onset sepsis NICE guideline Mark Turner (United Kingdom)

11:00 - 11:30 COFFEE BREAK

11:30 - 12:30 Adequate antibiotic dosing/TDM Karel Allegaert (Belgium)

12:30 - 13:00 Time for questions

13:00 - 14:00 LUNCH BREAK

14:00 - 15:00 Infection prevention Agnes van den Hoogen (The Netherlands)

15:00 - 15:45 Emerging resistance patterns of microbial pathogens and how these relate to the choice of antibiotics Christoph Bührer (Germany)


16:00 - 17:00 Heart rate variability and physiologic monitoring of neonatal sepsis / probiotics in necrotizing enterocolitis Irwin Reiss (The Netherlands)

17:00 - 17:30 Discussion

30th October, 2017

1010

Visit SenTec booth No 17 and inform yourselves about the OxiVenTTM Sensor – a new generation of transcutaneous monitoring of ventilation and oxygenation.

Intraoperative use of transcutaneous CO2 measuring in paediatric and neonatal anaesthesia Michael BrackhahnConsultant AnaesthetistDepartment of Anaesthesia, PICU and EmergencyAuf der Bult, Kinder- und JugendkrankenhausHannover

Validation of novel combined transcutaneous sensor – virtually drift free tcPO2 sensing technologyIrwin Reiss Professor of Neonatology, Department of Paediatrics Head Division of NeonatologyErasmus MCRotterdam

Strategies and modern technologies of continuous noninvasive blood gas monitoringMosaici 2, November 1st, 12.30 pm – 1.30 pm

jENS 2017Congress of joint European Neonatal SocietiesOctober 31st – November 4th

Join our Symposium

1111

Visit SenTec booth No 17 and inform yourselves about the OxiVenTTM Sensor – a new generation of transcutaneous monitoring of ventilation and oxygenation.

Intraoperative use of transcutaneous CO2 measuring in paediatric and neonatal anaesthesia Michael BrackhahnConsultant AnaesthetistDepartment of Anaesthesia, PICU and EmergencyAuf der Bult, Kinder- und JugendkrankenhausHannover

Validation of novel combined transcutaneous sensor – virtually drift free tcPO2 sensing technologyIrwin Reiss Professor of Neonatology, Department of Paediatrics Head Division of NeonatologyErasmus MCRotterdam

Strategies and modern technologies of continuous noninvasive blood gas monitoringMosaici 2, November 1st, 12.30 pm – 1.30 pm

jENS 2017Congress of joint European Neonatal SocietiesOctober 31st – November 4th

Join our Symposium09:00 – 17:00 PRE-CONGRESS COURSE 1 VENTILATORY SUPPORT- MATCHING PHYSIOLOGY? | COMO ROOM (PALAZZO DEL CINEMA)

Industry Supported session - please see page 125 09:00 – 11:00 New insights in pathophysiology of neonatal lung disease Robin Steinhorn (United States)

11:00 – 11:30 COFFEE BREAK

11:30 – 13:00 News in NIV 1: Understanding the controversy of HFNC early in life Anna Lavizzari (Italy)

13:00 – 14:00 LUNCH BREAK

14:00 – 15:30 News in NIV 2: nasal HFOV Daniele De Luca (France)

15:30 – 17:00 News in NIV 3: Synchronised NIPPV Camilla Gizzi (Italy)

31st October, 2017

1212

09:00 - 17:00 PRE-CONGRESS COURSE 2 | VENEZIA ROOM MULTIMODAL NEURO-IMAGING AND NEURO-MONITORING IN NEONATES

09:00 - 09:45 The early development of brain white matter Jessica Dubois (France)

09:45 - 10:15 Quality assurance of MR images: why is it important and what does an MR physicist do anyway? Zoltan Nagy (Hungary)

10:15 - 11:00 How to measure brain prefusion in the newborn Thomas Alderliesten (The Netherlands)


11:30 - 12:15 How to diagnose cerebral venous thrombosis in the newborn Luca Ramenghi (Italy)

12:15 - 13:00 fMRI in the newborn-what do we learn? Petra Hüppi (Switzerland)


14:00 - 15:00 Connectomics and development Martijn Van De Heuvel (The Netherlands)

15:00 - 16:00 Strength and pitfalls of (a)EEG Laura Weeke (The Netherlands)

16:00 - 17:00 How to detect seizures in the newborn Geraldine Boylan (Ireland)

31st October, 2017

1313

09:00 - 17:00 PRE-CONGRESS COURSE 3 | ROMA ROOM UNMET NEEDS: IMPROVING THE QUALITY OF NEONATAL CARE - APPROACHES AND STRATEGIES

09:00 - 11:00 Meeting the patients needs Jos Latour (United Kingdom)


11:30 - 13:00 Parent-infant closeness - developmentally supportive environment Liisa Lehtonen (Finland)


14:00 - 16:00 Treatment of pain in the NICU – Do we treat our patients with respect of their needs? Marsha Campbell-Yeo (Canada)

16:00 - 17:00 Becoming parent of a preterm baby - what does that mean…

in Sweden Karl Rombo (Sweden)

in Romania Diana Gamulescu (Romania)

31st October, 2017

1414

09:00 - 17:00 ESN COURSE 2 | CAPRI ROOM (PALAZZO DEL CINEMA)

NEONATAL HAEMODYNAMICS Industry Supported session - please see page 125

09:00 - 09:10 Welcome and introduction Willem de Boode (The Netherlands)

09:10 - 09:50 Cardiovascular physiology Shahab Noori (United States)

09:50 - 10:30 Advanced haemodynamic monitoring Willem de Boode (The Netherlands)


11:00 - 11:40 Echocardiography on the NICU Afif El-Khuffash (Ireland)

11:40 - 12:20 Advanced echocardiographic technologies Eirik Nestaas (Norway)

12:20 - 13:00 Assessment and management of the PDA Patrick McNamara (Canada)

13:00 - 13:40 LUNCH

13:40 - 14:20 Assessment and management of PPHN Nim Subhedar (United Kingdom)

14:20 - 15:00 Assessment and management of shock Colm Breatnach (Ireland)

15:00 - 15:40 Longterm outcome of circulatory failure Mayka Bravo (Spain)


16:00 - 16:40 Case histories faculty

16:40 - 17:00 Plenary discussion, summary and close Willem de Boode (The Netherlands)

31st October, 2017

1515

09:00 - 13:00 PRE-CONGRESS COURSE 4 | FIRENZE ROOM CONTROVERSY IN PHARMACOLOGY

09:00 - 09:30 Introduction: what would you like to learn? Sinno Simons (The Netherlands)

09:30 - 10:15 Basics in neonatal pharmacology: what the clinician needs to know! Karel Allegaert (Belgium)

10:15 - 11:00 PK-PD modeling: what is it, and how can we use it? Catherijne Knibbe (The Netherlands)


11:30 - 12:15 Pharmacology in neonatal research: anything new? Sinno Simons (The Netherlands)

12:15 - 13:00 Inotropes in newborn care: an update Eugene Dempsey (Ireland)


14:00 – 17:00 PRE-CONGRESS COURSE 5 | FIRENZE ROOM NEONATAL GASTROENTEROLOGY, SURGERY AND NUTRITION

14:00 – 15:00 Feeding strategies and the risk of NEC: an overview Jon Dorling (United Kingdom)

15:00 – 16:00 Nutritional assessment in surgical neonates Mark Johnson (United Kingdom)

16:00 – 17:00 Nutritional management of an infant with ileostomy: practical aspects Alexandre Lapillonne (France)

31st October, 2017

1616

17:30 - 18:30 PLENARY SESSION 1 | DARSENA ROOM OPENING CEREMONY Chairs: Luc Zimmermann (The Netherlands); Silke Mader (Germany); Manuel Sanchez Luna (Spain); Morten Breindahl (Sweden)

17:30 - 17:50 Roundtable – The next step to fulfill the unmet needs in neonatology

Moderator: Michael Kary (Germany); Silke Mader (Germany); Discussants: Luc Zimmermann (The Netherlands); Manuel Sanchez Luna (Spain); Morten Breindahl (Sweden); Agnes van den Hoogen (The Netherlands)

17:50 - 18:10 Extreme Everest: lessons learnt from high altitude Daniel Martin (United Kingdom)

18:10 - 18:30 Learning from our mistakes Martin Elliott (United Kingdom)

31st October, 2017

1717

08:00 - 09:00 POSTER WALK | GROUND FLOOR Epidemiology & Networks Chairs: Niels Bjerregaard Matthiesen (Denmark) Cathrine Carlsen Bach (Denmark)

ID 004 AN EVALUATION OF DOCTORS AND MEDICAL STUDENTS KNOWLEDGE OF PAEDIATRIC VACCINATIONS IN PAKISTAN N. Nadeem (United Kingdom)

ID 005 AN EVALUATION OF DOCTORS AND MEDICAL STUDENTS ATTITUDES AND BELIEFS OF PAEDIATRIC VACCINATIONS IN PAKISTAN N. Nadeem (United Kingdom)

ID 115 MORTALITY; MORBIDITY AND SHORT-TERM RETINOPATHY OF PREMATURITY OUTCOMES IN EXTREME PRETERM NEONATES: A 5 YEAR STUDY H. Jarvis; M. Sdobnikovs; J. William; F. Dean; P. Satodia (United Kingdom)

ID 138 NEONATAL MORTALITY AND MORBIDITY IN FIVE PROVINCIAL HOSPITALS IN THE PEOPLE’S DEMOCRATIC REPUBLIC OF LAOS AFTER IMPLEMENTATION OF A TEACHING PROGRAM FOR NEONATAL CARE S. Schmidt 1; B. Saysanasongkham 2; T. Hoehn 1 (1. Germany; 2. Laos) ID 212 DOWN’S SYNDROME – PREVALENCE AND PRENATAL DIAGNOSIS IN LATVIA I. Zile; I. Gavare; I. Grinfelde; I. Malniece; Z. Baltane; A. Maurina (Latvia)

ID 294 THE CHANGING OF LATE FETAL DEATH IN LATVIA BETWEEN 2000 AND 2014 I. Zile; I. Ebela; V. Folkmanis; I. Rumba-Rozenfelde (Latvia)

ID 312 HOW “BABY FRIENDLY” CAN A “BABY-FRIENDLY HOSPITAL” BE? – EXPERIENCE IN A ROMANIAN NEONATAL CLINIC M. Simon; R. Sánta; Zs. Gáll; L. Suciu; R. Marian; M. Rusneac; C. Gliga; M. Cucerea (Romania)

ID 369 THE EFFECTIVENESS OF PRENATAL ULTRASOUND DIAGNOSIS IN RECOGNITION OF MUSCULOSCELETAL MALFORMATIONS A. Beke; Z.S. Tidrenczel; F.R. Eros (Hungary)

ID 409 PREVALENCE OF LATE PRETERM INFANTS IN THE UNIVERSITY HOSPITAL OF THE SOUTH REGION OF BRAZIL: INCREASED NEONATAL MORBIDITY RISK COMPARED WITH TERM INFANTS P.J.H. Nader; S.S. Nader; L. Acosta; A. Sangalli (Brazil)

ID 434 THE INFLUENCE OF TWO DIFFERENT FAT EMULSIONS USED FOR PARENTERAL NUTRITION ON THE INCIDENCE OF SELECTED COMPLICATIONS OF PREMATURITY Z. Owsiańska; G. Matusiak; K. Mielnik; T. Szczapa; J. Gadzinowski (Poland)

1st November, 2017

1818

ID 440 RIGHT PLACE - RIGHT TIME ? PLACE OF BIRTH AND TRANSFERS OF EXTREME PRETERM NEONATES WITHIN TWO ADJACENT NEONATAL OPERATIONAL DELIVERY NETWORKS D. Vieten; M. Sutcliffe; S.V. Rasiah; A. Philpott (United Kingdom)

ID 490 PHENOTYPIC SPECTRUM OF GOLDENHAR SYNDROME: A DESCRIPTIVE STUDY N. Kasdallah; M.T. Lamouchi; M. Sallemi; W. Barbaria; Kasraoui; H. Ben Salem; H. Kbaier; S. Blibech; M. Douagi (Tunisia)

ID 521 RETURN TO WORK TRAINING REQUIREMENTS FOR NEONATAL NURSES: A NETWORK SURVEY C. Hiatt; R. Blake; J. Furness; K. Dewitt; N. Shankle; V. McFadden; P. Nath; P. Satodia (United Kingdom) ID 560 TRENDS IN MAJOR MORBIDITY RATES AT THE LIMIT OF VIABILITY IN THE LAST DECADE S. Zeballos Sarrato; A. Rodriguez Sánchez de la Blanca; S. Villar Castro; C. Ramos Navarro; G. Zeballos Sarrato; M. Sánchez Luna (Spain)

ID 830 PAEDIATRIC HEAD TRAUMA IN THE EMERGENCY DEPARTMENT E. Ryan; T. Bolger; I. Okafor; M. Barrett; E.J. Molloy (Ireland)

Ethics Chairs: Charles C. Roehr (United Kingdom)

ID 657 INGEBORG SYLLM-RAPOPORT (1912-2017) – AN EXEMPLARY LIFE FOR CHILDREN AND PAEDIATRICS H. Sallmon 1; R.R. Wauer 1; C.C. Roehr 1;2 (1. Germany; 2. United Kingdom)

Neonatal GI Physiology & NEC Chairs: Jon Dorling (United Kingdom)

ID 204 CORRELATION BETWEEN CALPROTECTIN LEVELS IN MECONIUM AND VITAMIN D STATUS IN CORD BLOOD: ASSOCIATION WITH INTESTINAL DISTRESS DURING NEONATAL PERIOD S.H. Park; W.H. Kim; Y.M. Lee (Korea)

ID 244 COMPARISON OF FECAL CALPROTECTIN LEVELS ACCORDING TO FEEDING KINDS IN VERY PRETERM INFANTS J.H. Park; N.H. Lee; S.Y. Shin; C.S. Kim; S.L. Lee; W.M. Lee (Korea)

1st November, 2017

1919

ID 289 NEONATAL MORBIDITY OF EXTREME PRETERM INFANTS BEFORE AND AFTER THE INTRODUCTION OF A DONOR HUMAN MILK BANK AT THE PERINATAL CENTER GROßHADERN V. Lieftüchter; M. Kujawa; A. Schuze; A.W. Flemmer; S. Herber-Jonat (Germany)

ID 320 OPTICAL PROPERTIES OF EARLY STOOL FROM PRETERM INFANTS: IMPORTANT TO CONSIDER FOR ABDOMINAL OXIMETRY BASED ON NEAR-INFRARED SPECTROSCOPY H. Isler; D. Schenk; J. Bernhard; F. Scholkmann; S. Kleiser; D. Ostojic; D. Bassler; M. Wolf; T. Karen (Switzerland)

ID 407 REFERENCE VALUES OF ZONULIN IN TERM NEONATES A. Tarko; A. Suchojad; A. Jarosz-Lesz; M. Majcherczyk; M. Michalec; I. Maruniak-Chudek (Poland)

ID 472 DETERMINANTS OF THE NEED FOR TREATMENT IN PREMATURE INFANTS WITH SUSPECTED NECROTISING ENTEROCOLITIS N. Bussmann; A. El-Khuffash; D. Corcoran (Ireland)

ID 589 NEWBORNS WITH ULTRASOUND FINDING OF GAS IN HEPATIC PORTAL VENOUS SYSTEM: ANALYSIS OF RISK FACTORS; CLINICAL AND LABORATORY FINDINGS AND DEVELOPMENT OF ALLERGY J. Lozar Krivec; A. Nyasha Zimani; N. Zupančič; D. Paro-Panjan (Slovenia)

ID 621 NEONATAL FECAL BIOMARKERS OF NECROTIZING ENTEROCOLITIS I. Tofé; M.V. Rodriguez-Benitez; C. Hernandez-Chirlaque; M. Gil-Campos; M.D. Ruiz-Gonzalez; A. Martinez (Spain)

ID 664 THE PRETERM INFANT GASTRIC EMPTYING RATE IS DEPENDENT ON THE FEED VOLUME AND NOT POSTNATAL AGE C.H. Ferreira 1; F.E. Martinez 1; G.C. Crott 1; J. Belik 2 (1. Brazil; 2. Canada)

ID 675 NECROTIZING ENTEROCOLITIS IN A NEONATAL INTENSIVE CARE UNIT M. Branco; I. Falcão; T. Lopes; E. Proença; A. Almeida; C. Carvalho; L. Pinho (Portugal)

ID 678 SPONTANEOUS INTESTINAL PERFORATION: A DIAGNOSTIC CHALLENGE IN THE NEWBORN M. Branco; T. Lopes; I. Falcão; L. Pinho; C. Enes; A. Almeida; C. Carvalho; E. Proença (Portugal)

ID 806 NECROTIZING ENTEROCOLITIS: WHAT ASPECTS IN 2017? H. Ben Salem; I. Kasraoui; M.T. Lamouchi; E.D. Bouaicha; N. Kasdallah; S. Blibech; M. Doagi (Tunisia)

1st November, 2017

2020

ID 853 MATERNAL RISK FACTORS FOR NEC IN PREMATURES INFANTS WITH GA UNDER 28 WEEKS L. Olariu; G. Olariu; L. Olariu; S. Olariu (Romania)

Neonatal Pulmonology, Neonatal Respiratory Support, Resuscitation Chairs: Kajsa Bohlin (Sweden); Daniele De Luca (France)

ID 031 TIMING OF KEY EVENTS IN NEONATAL RESUSCITATION A. Heathcote; J. Jones; P; Clarke (United Kigdom)

ID 051 COMPARING NON-INVASIVE VENTILATION METHODS IN RESPIRATORY SUPPORT OF PRETRM NEONATES WITH RESPIRATORY DISEASS A. Shah Farhat; A. Mohammadzadeh; G. Ali Mamuri; R. Saeidi; S. Noorizadeh (Iran)

ID 062 NEONATAL NON-INVASIVE RESPIRATORY SUPPORT APPROACH: A TWO COUNTRIES COMPARISON I. Bresesti 1; S. Zivanovic 2; G. Lista 1; C.C. Roehr 2,3 (1. Italy; 2. United Kingdom; 3. Germany)

ID 064 PREDICTORS OF EARLY CPAP FAILURE IN VERY LOW BIRTH WEIGHT PRE TERM INFANTS W.A. Gonçalves-Ferri; F.P. Martins-Celini; G.H. Seribeli; E. Sacramento; C. Calixto; M. Bertoldi; D.C. Aragon (Brazil)

ID 069 LENGTH OF MECHANICAL VENTILATION AND CLINICAL FEATURES AT BIRTH IN PREMATURE INFANTS A.M. Nakato; R.P.G.V.C. Silva; N. Rosario Filho (Brazil)

ID 071 MATERNAL MUTATIONS OF FOXF1 CAUSE ALVEOLAR CAPILLARY DYSPLASIA DESPITE NOT BEING IMPRINTED M. Alsina; A. Monteagudo-Sánchez; L. Rodriguez Guerineau; C. Rovira Zurriaga; D. Monk; J. Moreno Hernando (Spain)

ID 073 CONGENITAL LOBAR EMPHYSEMA MISDIAGNOSED AS PNEUMOTHORAX I. Bakalli; E. Kola; R. LLuka; E. Celaj; D. Sala; I. Gjeta; S. Sallabanda (Albania)

ID 137 A CLINICAL CASE OF A CHILD WITH CCHS IN THE EARLY NEONATAL PERIOD R. Maslarska; M. Kalaydzhieva; S. Deneva; V. Konstantinova; S. Kontilska; I. Ilieva; J. Ivanova; V. Ivanova; E. Kerinova; R. Georgieva; T. Todorov (Bulgaria)

1st November, 2017

2121

ID 148 TRANSPORT OF HIGH-RISK NEONATES WITH RESPIRATORY FAILURE: A SINGLE CENTER COHORT ANALYSIS BASED ON THE TRANSPORT RISK INDEX OF PHYSIOLOGIC STABILITY VERSION II (TRIPS-II) M. Klemme 1; A. Staffler 2; K. M. Förster 1; A. Schulze 1; S. Herber-Jonat 1; J. Kappeler 1; A. W. Flemmer 1 (1. Germany; 2. Italy)

ID 193 FACTORS ASSOCIATED WITH EXTUBATION FAILURE IN VERY LOW BIRTH WEIGHT INFANTS A. Menshykova; D. Dobryanskyy (Ukraine)

ID 197 A COST IMPROVEMENT PROJECT: REVIEW OF THE USE OF INHALED NITRIC OXIDE (INO) IN A NEONATAL INTENSIVE CARE B. Zanetti; R. Roy (United Kingdom)

ID 200 IMPROVED SURVIVAL AND DECREASED INCIDENCE OF BRONCOPULMONARY DYPLASIA IN INFANTS LESS THAN 27 WEEKS GESTATION AFTER A RESPIRATORY CARE BUNDLE J. Soliz; A. Soliz (United States)

ID 233 LUNG FUNCTION AND IGE RESPONSE ARE REDUCED IN 9 TO 10 YEARS OLD ASTHMATIC CHILDREN WITH PRETERM BIRTH L.C. Fang; J.Y. Wang; S.D. Shyur; S.H. Chu; Y.H. Kao; W.T. Lei (Taiwan)

ID 249 PRETERM BIRTH REDUCES ATOPIC SENSITIZATION IN PRESCHOOL CHILDREN WITH ALLERGIC DISEASE J.Y. Wang; L.C. Fang (Taiwan)

ID 261 LOSS OF SURFACTEN® DURING BOLUS ADMINISTRATION USING A FEEDING CATHETER K. Fujioka; J. Kuroda; K. Yamana; M. Ashina; T. Ikuta; S. Fukushima; S. Ohyama; S. Okubo; K. Iijima; I. Morioka (Japan)

ID 278 EXPRESSION OF THE HYALURONAN RECEPTOR RHAMM IN BRONCHIOLAR EPITHELIUM OF NEONATES NEGATIVELY CORRELATES WITH AIR CONTENT IN THE LUNG L. Markasz 1; G. Sedin 1; R. C. Savani 2; R. Sindelar 1 (1. Sweden; 2. United States)

ID 298 BIPAP REDUCES EXTUBATION FAILURE IN THE FIRST WEEK COMPARED TO CPAP IN NEONATES < 30 WK OF GA WITHOUT INCREASED RISK OF PNEUMOTHORAX L. Capasso; A.C. Borrelli; M.A. Caiazzo; C. Parrella; R. Albachiara; F. Raimondi (Italy)

1st November, 2017

2222

ID 326 THE EFFECT OF SUSTAINED LUNG INFLATION ON EARLY RESPIRATORY OUTCOMES IN TERM INFANTS M. Cetinkaya; D. Kilic; S. Yılmaz Semerci; B. Cebeci; O. Saglam (Turkey)

ID 332 PROLONGED AIR RETRIEVAL OF A NEWBORN INFANT WITH TOTAL ANOMALOUS PULMONARY VENOUS DRAINAGE R. Pal; B. Carter; K. McDonald; J. Tan; D. Wagh; J. Davis (Australia)

ID 340 PERINATAL FACTORS ASSOCIATED TO THE FAILURE OF EARLY NASAL CONTINUOUS POSITIVE PRESSURE IN VERY LOW BIRTH WEIGHT INFANTS T.S. Souza; A.A.Vieira; C. Morcelli-Tovar (Brazil)

ID 357 IMPACT OF THE USE OF HIGH POSITIVE END EXPIRATORY PRESSURE ON EXTUBATION OF PREMATURE INFANTS WITH SEVERE BRONCHOPULMONARY DYSPLASIA W. Assad Gonçalves-Ferri; F. Pereira Martins-Celini; D. Cristina Troiano; D. Casale Aragon (Brazil)

ID 361 THE USE OF DEXAMETHASONE IN PRETERM INFANTS FOR LUNG DISEASE IN A TERTIARY NICU K.M. Sun; H. Gowda (United Kingdom)

ID 366 CONSULTANT PRESENCE AT DELIVERY: A RETROSPECTIVE AUDIT OF DEMOGRAPHICS AND OUTCOMES IN A TERTIARY UK CENTRE L. Mahoney; T. Hunt; H. Rabe; P. Amess; N. Aiton; N. Bhat; R. Bomont; N. Drenchev; C. Garland; C. Lawn; B. Reulecke; R. Watkins; R. Fernandez (United Kingdom)

ID 379 COMPARISON BETWEEN OUTCOMES OF MINIMALLY INVASIVE TECHNIQUE AND INTUBATION SURFACTANT EXTUBATION IN PRETERM INFANTS LESS THAN 1500 GRAMS IN A DEVELOPING COUNTRY W.A. Gonçalves-Ferri; P. Paiva; L. Scalioni; E. Sacramento; C. Calixto; A.C. Hallak; D.C. Aragon (Brazil)

ID 381 PREMATURE INFANTS WITH VERY LOW WEIGHT WITH APNEA HAVE POOR RESULTS DESPITE TREATMENT A.B. Gonçalves; M.M. Lourenço; L. Scacioli; E. Sacramento; C. Calixto; D.C. Aragon; W.A. Gonçalves-Ferri (Brazil)

ID 388 EARLY HIGH FREQUENCY VENTILATION – A PROMISE OF PROTECTIVE VENTILATION? W.A. Gonçalves-Ferri; M. Bertoldi; A.B. Gonçalves; E. Sacramento; C. Calixto; D.C. Aragon (Brazil)

1st November, 2017

2323

ID 395 INHALED NITRIC OXIDE AND PRETERMS: DOOM; GLOOM OR RIGHT? 11 YEARS’ EXPERIENCE AT TERTIARY CENTRE E. Syrimi; H. Warwick; P. Satodia; P. Nath (United Kingdom)

ID 405 CURRENT PRACTICE OF NEUTRALLY ADJUSTED VENTILATOR ASSIST IN THE NEONATAL INTENSIVE CARE UNIT: A TAIWAN SURVEY C.E. Chiang; Y.L. Chen; L.Y. Tsai; Y.H. Chien; S.C. Mu; K.Y. Chao (Taiwan)

ID 439 THE EFFECT OF HYDROCHLOROTHIAZIDE WITH SPIRONOLACTONE TREATMENT ON BRONCHOPULMONARY DYSPLASIA DEVELOPMENT IN VERY-LOW-BIRTH-WEIGHT INFANTS M. Buyuktiryaki; E. Alyamac Dizdar; N. Uras; N. Okur; O. Ertekin; S.S. Oguz (Turkey)

ID 443 NONINVASIVE RESPIRATORY SUPPORT VIA NASAL CANNULA IN PREMATURE INFANTS: IS IT REALLY SAFE? M. Buyuktiryaki; N. Okur; G. Kadioglu Simsek; H.G.Kanmaz; F.E. Canpolat (Turkey)

ID 453 BOCHDALEK HERNIA WITH INTRATHORACIC KIDNEY ASSOCIATED WITH AORTIC COARCTATION B. Skenderi Mustafa; H. Ismaili; F. Kajtazi; G. Hazbahta; F. Krasniqi (Kosovo)

ID 462 THE LARYNGEAL MASK AIRWAY AND ITS USE IN NEONATAL RESUSCITATION - A CRITICAL REVIEW OF WHERE WE ARE IN 2017 S.C. Bansal 1; S. Caoci 2; D. Trevisanuto 2; C.C. Roehr 1; E.M. Dempsey 3 (1. United Kingdom; 2. Italy; 3. Ireland)

ID 467 RETROSPECTIVE AUDIT OF POSTNATAL OUTCOME OF ANTENATALLY DIAGNOSED RENAL PELVIS DILATATION S. Vora; N. Kavalloor; T.L. Yap; PC Khoo; V. Rajadurai (Singapore)

ID 511 OUTCOMES OF POSTNATAL DEXAMETHASONE USE IN EXTREME PRETERM NEONATES IN A TERTIARY NEONATAL UNIT A. Holt; L. Osborne; P. Satodia (United Kingdom)

ID 516 VALIDATION OF A TRANSCUTANEOUS TCPO2/TCPCO2 SENSOR WITH AN OPTICAL OXYGEN MEASUREMENT IN PRETERM NEONATES W. van Weteringen; T.G. Goos; T. van Essen; N.H. Gangaram-Panday; R.C.J. de Jonge; I.K.M. Reiss (The Netherlands)

ID 524 SUCCESSFUL VENTILATION VIA ACCIDENTAL OESOPHAGEAL INTUBATION IN A CASE OF FLOYD TYPE III/FARO TYPE B TRACHEAL AGENESIS IN A DISCORDANT MONOZYGOTIC TWIN M. Noureldein; A. Olariu; J. Egyepong (United Kingdom)

1st November, 2017

2424

ID 528 WHAT IS THE IDEAL TARGET PRETERM POPULATION THAT MIGHT BENEFIT FROM THE EXPENSIVE PALIVIZUMAB PROPHYLAXIS? S. Tsilika; D. Batra (United Kingdom)

ID 538 INCIDENCE AND OUTCOME OF PNEUMOTHORACES IN A TERTIARY NEONATAL INTENSIVE CARE UNIT R.C. Ramaswamy; M.K. Brom; S.V. Rasiah (United Kingdom)

ID 546 CLINICAL IMPACT OF THE RESPIRATORY SYNCYTIAL VIRUS INFECTION IN INFANTS WITH A HISTORY OF PREMATURITY BETWEEN 32-34 WEEKS N. Ramos; C.M. Martín; G. Uclés; R.C Raynero; I. Pérez; M. González-Valcárcel; M.D Sánchez-Redondo; A. Pantoja; J. Cobas; A. Escobar; A. Martínez (Spain)

ID 554 LATE PRETERM INFANTS: WHAT IS THEIR REAL RESPIRATORY MORBIDITY? A.M. Gil Fenoy; F.J. Pacheco Sánchez La Fuente; P. Miranda Romera; L. Serrano López; E. Martín Álvarez; J.A. Hurtado Suazo (Spain)

ID 565 REVIEW OF OUTCOMES IN PRETERM NEONATES FOLLOWING CHANGE OF VENTILATORY PRACTICE TO VOLUME-TARGETED VENTILATION IN A NEONATAL INTENSIVE CARE UNIT I. Fernando; H. McDermott; A. Singh; S. Rasiah (United Kingdom)

ID 569 THYROID STATUS MONITORING DURING FIRST YEAR OF LIFE IN INFANTS WITH CONGENITAL HYPOTHYROIDISM DETECTED BY NEWBORN SCREENING N. Zdraveska; V. Anastasovska; A. Kostovski Mirjana Kocova (Macedonia)

ID 601 DIURETICS FOR EVOLVING CHRONIC LUNG DISEASE OF PREMATURITY: WHO ARE WE TREATING? A.K. Linklater; R. Cuzzilla; S.E. Jacobs (Australia)

ID 629 CAN TcCO2 MONITORIZATION IN THE DELIVERY ROOM BE HELPFUL FOR DIFFERENTIATING TERM NEWBORNS IN NEED OF HOSPITALIZATION FOR RESPIRATORY MORBIDITIES? I. Mungan Akin; E. Bocu; M. Uygun; S. Sevuk Ozumut; D. Buyukkayhan; S. Arslanoglu; F. Ovali (Turkey)

ID 635 MANAGEMENT OF PNEUMOTHORAX IN NEWBORNS: NEONATAL INTENSIVE CARE UNIT EXPERIENCE IN TUNISIA K. Ben Ameur; T. Khemis; A. Ben Salem; H. Ben Hamida; F.Z. Chioukh; K. Monastiri (Tunisia)

ID 642 MALIGNANT PERTUSSIS. IS IT TIME FOR EXCHANGE TRANSFUSSION? R. Roldán; M. Huescar; M.G. Espinosa; A. Morales; E. Salguero (Spain)

1st November, 2017

2525

ID 660 PERI-OPERATIVE MANAGEMENT OF NEONATES WITH OESOPHAGEAL ATRESIA IN LOW- INCOME COUNTRIES: EXPERIENCE OF TUNISIA F.Z.Chioukh; K. Ben Ameur; T. Khemis; A. Ksia; A. Ben Salem; H. Ben Hamida; K. Monastiri (Tunisia)

ID 662 LESS INVASIVE SURFACTANT ADMINISTRATION IN PRETERM INFANTS. REVIEW AFTER 4 YEARS OF IMPLEMENTATION C. Ramos-Navarro; S. Zeballos-Sarrato; N. Gonzalez-Pacheco; A. Rodriguez- De la Blanca; M. Arriaga-Redondo; S. Villar-Castro; I. Pescador-Chamorro; N. Navarro-Patiño (Spain)

ID 693 VERY LOW BIRTH WEIGHT PRETERM BABY PRESENT HIGH INCIDENCE OF RETINOPATHY OF PREMATURITY AND BRONCHOPULMONARY DYSPLASIA DESPITE DRUG TREATMENT A.B. Gonçalves; M.M. Lourenço; L. Scacioli; A. Borges; A.C. Hallak; M. Bertoldi; D. Testoni; G.H. Seribelli; B.B. Lima; E. Sacramento; C. Calixto; D.C. Aragon; W.A. Gonçalves-Ferri (Brazil)

ID 697 AN UNUSUAL CAUSE OF RESPIRATORY DISTRESS IN NEONATES: CONGENITAL PULMONARY LYMPHANGIECTASIS (TWO CASE REPORTS) S. Nouri Merchaoui; N. Mahdhaoui; H. Ayache; M. Bellalah; I. Kacem; H. Barbouche; A. Ghith; M.T.Yacoubi; J. Methlouthi; H. Seboui (Tunisia)

ID 711 APGAR SCORE OF 5 MINUTES LESS THAN 5 IS NOT RELATED TO POOR OUTCOMES IN VERY LOW BIRTH WEIGHT PRETERM INFANTS W.A. Gonçalves-Ferri; P. Paiva; A. Borges; E. Sacramento; C. Calixto; D.C. Aragon (Brazil)

ID 714 ETIOLOGICAL AND PATHOLOGICAL CORRELATIONS IN PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN M.L. Ognean; R. Dumitra; O. Boantă; C. Zgârcea; E. Olariu; S. Kovacs (Romania)

ID 717 BRONCHOPULMONARY DYSPLASIA - ARE THERE NEW RISK FACTORS IN VERY PRETERM INFANTS? M.L. Ognean; O. Boantă; E. Olariu; S. Kovacs; C. Zgârcea; R. Dumitra; D. Andreicuţ (Romania)

ID 729 OUTCOMES OF PRETERM INFANTS LESS THAN 26 WEEKS GESTATION AT BIRTH WHO RECEIVED CHEST COMPRESSION OR ADRENALINE DURING RESUSCITATION AT BIRTH H. Shing; H. Gowda (United Kingdom)

1st November, 2017

2626

ID 741 LUNG ULTRASOUND (LUS) TO ASSESS PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (PPHN) ETIOLOGY B. del Rey Hurtado de Mendoza; J. Moreno Hernando; J. Sánchez-de-Toledo; J. Rodríguez-Fanjul (Spain)

ID 745 NEURALLY ADJUSTED VENTILATION IN PATIENTS WITH CONGENITAL DIAPHRAGMATIC HERNIA A.M. Sanchez-Torres; H. Peinado; R. Madero; M.D. Elorza (Spain)

ID 746 NON-INVASIVE NEURALLY ADJUSTED VENTILATION (NIV-NAVA) IN THE NEWBORN H. Peinado; H. Sánchez-Torres; R. Madero; M.D. Elorza (Spain)

ID 748 THE NON INVASIVE RESPIRATORY SUPPORT FAILURES IN PRETERM INFANTS. RISK FACTORS AND OUTCOMES C. Ramos-Navarro; I. Marsinyach Ross; G. Zeballos-Sarrato; P. Chimenti-Camacho; A. Perez-Perez; R. Gregorio-Hernández; M. Sánchez-Luna (Spain)

ID 749 SELECTIVE LUNG VENTILATION: A THERAPEUTIC STRATEGY FOR ACQUIRED LUNG COLLAPSE IN A TERM INFANT H. Gowda; S. Bhayat (Spain)

ID 759 INCIDENCE OF RESPIRATORY MORBIDITY IN LATE PRETERM AND TERM INFANTS IN RESPECT TO DELIVERY MODE J. Gromann; T. Burkhardt; R. Arlettaz; S. Wellmann (Switzerland)

ID 788 RISK FACTORS ASSOCIATED TO SURVIVAL FREE BRONCHOPULMONARY DYSPLASIA ACCORDING TO GESTATIONAL AGE C. Ramos-Navarro; G. Zeballos-Sarrato; E. Sanz-Lopez; E. Maderuelo-Rodriguez; N. Gonzalez-Pacheco; M. Sánchez-Gómez de Orgaz; M. Sánchez-Luna (Spain)

ID 792 OUTCOME OF INFANTS BORN AFTER MID-TRIMESTER RUPTURE OF MEMBRANES T. Hurley 1; J. Miletin 1, 2; A. Martin 1; C. Fitzpatrick 1; J. Semberova 1, 2 (1. Ireland; 2. Czech Republic)

ID 793 NEURALLY ADJUSTED MECHANICAL VENTILATION (MV-NAVA) IN THE NEWBORN A.M. Sánchez Torres; H. Peinado; R. Madero; M.D. Elorza (Spain)

ID 803 CHYLOTHORAX: CASE SERIES OF 20 YEARS M. Rosário; A. Reis e Melo; S. Pissarra; G. Rocha; H. Guimarães (Portugal)

1st November, 2017

2727

ID 804 NEONATAL CHYLOTHORAX: 20 YEARS EXPERIENCE IN A TERTIARY NEONATAL UNIT H. Sharp; C. Kortsalioudaki; M. Sellwood; G. Kendall (United Kingdom)

ID 832 PREDICTIVE AND RISK FACTORS FOR EARLY NON-INVASIVE RESPIRATORY SUPPORT FAILURE IN A COHORT OF PRETERM INFANTS: A RETROSPECTIVE STUDY I. Bresesti; F. Viaroli; F. Castoldi; F. Scopesi; B. Roviglione; L. Ramenghi; F. Cerritelli; G. Lista (Italy)

ID 854 HOW SAFE IS NASAL CANNULAE OXYGEN THERAPY DURING NEONATAL TRANSPORT? A. Brunton; J. O’Shea; A. Jackson (United Kingdom)

ID 855 THE INCIDENCE OF RESPIRATORY MORBIDITY IN LATE PRETERM INFANT G. Olariu; S. Olariu; M. Tunescu (Romania)

ID 860 MATERNAL SMOKING IN PREGNANCY INCREASES THE DURATION OF HOME OXYGEN THERAPY IN INFANTS WITH BRONCHOPULMONARY DYSPLASIA A. Prayle; A. Davies; A. Silverman; S. Spencer; M. Hurley; J. Bhatt (United Kingdom)

ID 862 CONTROLLED VENTILATION WITH A LARYNGEAL MASK AIRWAY FOR 48 HOURS IN A NEWBORN WITH TRACHEAL AGENESIS R.H. Mupanemunda; R.F. Danha (United Kingdom)

ID 863 ASSESSMENT OF A NEONATAL INTUBATION SCORING INSTRUMENT: A PROSPECTIVE OBSERVATIONAL STUDY R. Bouwmeester; M. Binkhorst; N. Yamada; R. Geurtzen; A. van Heijst; L. Halamek; M. Hogeveen (United States)

Perinatal Pharmacology and Anethesia Chairs: Sinno Simons (The Netherlands)

ID 027 UNDERSTANDING THE RELATIONSHIP BETWEEN DOPAMINE CONCENTRATION AND BLOOD PRESSURE IN NEONATES: INCUBATORS VERSUS COT K. Kirupakaran; H. Rabe; B. Patel (United Kingdom)

ID 104 EFFECT OF CHRONIC EXPOSURE OF LOSARTAN IN MOUSE PRENATAL ALCOHOL EXPOSURE (PAE) MODEL A. Takyi (United Kingdom)

1st November, 2017

2828

ID 187 EFFECT OF POSTNATAL CORTICOSTEROID ON BROWN ADIPOSE TISSUE THERMOGENESIS IN NEONATAL RAT Y-S. Chang; C.H. Lin; Y.S. Tsai (Taiwan)

ID 492 VENO-ARTERIAL EXTRACORPOREAL MEMBRANE OXYGENATION IMPAIRS ACETYLCHOLINE-INDUCED CONTRACTION IN NEONATAL PORCINE CORONARY ARTERIES L. Provitera 1; G. Cavallaro 1; G. Raffaeli 1; I. Amodeo 1; S. Gulden 1; G. Zuanetti 1; V. Gentilino 2; F. Macchini 2; E. Villamor 1; F. Mosca 1 (1. Italy; 2. The Netherlands)

ID 875 POINT-OF-CARE ANALYSIS OF BETA-HYDROXYBUTYRATE CONCENTRATIONS IN BABIES IS A USEFUL ALTERNATIVE TO LABORATORY TESTING D.L. Harris; P.J. Weston; J.E. Harding (New Zealand)

1st November, 2017

2929

09:00 – 11:00 PARALLEL SESSION 1 (BRAIN 1)|DARSENA ROOM NEURODEVELOPMENTAL OUTCOME AND CONGENITAL HEART DISEASE Chairs: Bea Latal (Switzerland); Nathalie Claessens (The Netherlands)

09:00 – 09:20 Brain health in neonates with CHD: timing is everything Steven Miller (Canada)

09:20 – 09:40 Neurodevelopmental outcome and congenital heart disease Bea Latal (Switzerland)

09:40 – 10:10 Neonatal surgery and brain injury Petra Lemmers (The Netherlands)

10:10 – 10:25 Cognitive stability in children with congenital heart disease N. Naef; C. Schaefer; V. Rousson; R. Liamlahi; S. Polentarutti; I. Beck; V. Bernet, D. Hitendu; W. Knirsch; B. Latal (Switzerland)

10:25 – 10:40 Congenital heart defects and academic performance in a nationwide cohort of 458,318 Danish children N.B. Matthiesen; S.H. Larsen; T.B. Henriksen; C.C. Bach; J.R. Østergaard; V. Hjortdal (Denmark)

10:40 – 10:55 Early postoperative amplitude-integrated electroence phalography: biomarker of new brain injury in neonates with congenital heart disease N.H.P. Claessens; L. Noorlag; L. Weeke; M. Toet; J.M.P.J. Breur; M.J.N.L. Benders; F. Groenendaal; N.J.G. Jansen; L.S. de Vries (The Netherlands)

09.00 – 11.00 PARALLEL SESSION 2 (RESUSCITATION) |VENEZIA ROOM Chairs: Hans Fuchs (Germany); Klaus Klingenberg (Norway)

09:00 - 09:20 New techniques for optimising newborn resuscitation Peter Davis (Australia)

09:20 - 09:40 Unravelling the physiology of haemodynamic transition at birth Stuart Hooper (Australia)

09:40 - 09:55 Delayed cord clamping during resuscitation - a randomized trial O. Andersson; A. KC; N. Rana; U. Ewald; M. Målqvist (Sweden)1st November, 2017

3030

09:55 - 10:10 Sustained versus standard inflations during neonatal resuscitation to reduce mortality and improve respiratory outcomes: a systematic review and meta-analysis M. Bruschettini 1; C.P.F. O’Donnell 2; P.G. Davis 3; C.J. Morley 4; L. Moja 4; M.G. Calevo 4; S. Zappettini 4 (1. Sweden; 2. Ireland; 3. Australia; 4. Italy)

10:10 - 10:25 nCPAP pressure at initiation: is higher pressure better? S. Bhisikar; S. Goel; S. Manerkar; J. Mondkar (India)

10:25 - 10:40 Bradyprem study: is heart rate the most vital of all vital signs during preterm resuscitation? V. Kapadia 1; J. Oei 2; O.D. Saugstad 3; Y. Rabi 4; N. Finer 1; I. Wright 2; W. Tarnow-Mordi 2; W. Rich 1; D. Rook 5; J. Smyth 2; K. Lui 2; S. Brown 1; M. Vento Torres 6 (1. United States; 2. Australia; 3. Norway; 4. Canada; 5. The Netherlands; 6. Spain)

10:40 - 10:55 Predicting developmental outcomes in extremely low birth weight infants: a statistical learning approach C. Keogh; B. Arthurs; S. Atikah; P. Carr; N. Grayson; E. Horgan; E. Moran; S. O’Regan; E.J. Molloy (Ireland)

09.00 – 11.00 PARALLEL SESSION 3 (EFCNI 1) |ROMA ROOM PAIN REDUCTION – DOES A PARTNERSHIP WITH PARENTS REDUCE PAIN IN NEWBORNS? Chairs: Mats Eriksson (Sweden); Agnes van den Hoogen (The Netherlands)

09:00 - 09:30 The power of parents to reduce newborn pain Marsha Campbell-Yeo (Canada)

09:30 - 10:00 Facilitators and barriers for parents’ involvement in pain management Anna Axelin (Finland)

10:00 - 10:30 Working with parents to build better pain management for newborn infants Mats Eriksson (Sweden)

10:30 - 10:45 A user centered design approach to evaluate a alidated infant pain measure e- learning module B. Stevens; S. Gibbins; M. Campbell-Yeo; C. McNair; J. Yamada; K. Dionne; Sarah Dinsdale; C. Johnston; A. Taddio (Canada)

1st November, 2017

3131

10:45 - 11:00 Valid pain assessment in extreme prematures: a long way to go? N. Meesters; S.H.P. Simons; J. van Rosmalen; L. Holsti; Irwin Reiss; M. van Dijk

09.00 – 11.00 PARALLEL SESSION 4 |FIRENZE ROOM WHAT CAN WE LEARN FROM NEONATAL NETWORKS Chairs: Neena Modi (United Kingdom); Dominique Haumont (Belgium)

09:00 – 09:10 eNewborn, the journey thus far Dominique Haumont (Belgium)

09:10 – 09:20 Population data sharing: the UK experience Neena Modi (United Kingdom)

09:20 – 09:50 Big data opportunities for European Neonatology Mark Turner (United Kingdom); Lisa Lehtonen (Finland); Ola D. Saugstad (Norway); Maximo Vento Torres (Spain); Charles C. Roehr (United Kingdom)

09:40 - 09:51 Predicting bleeding risk in thrombocytopenic preterm neonates: the MONET study S.F. Fustolo-Gunnink; K. Fijnvandraat; I.M. Ree; C. Caram-Deelder; P. Andriessen; E.J. d’Haens; C.V. Hulzebos; W. Onland; A.A. Kroon; D.C. Vijlbrief; H. Putter; E. Lopriore; J.G. van der Bom (Netherlands)

09:51 - 10:02 A pilot study: implementing a structured amplitude integrated electroencephalography (AEEG) education programme in an irish neonatal intensive care unit (NICU) setting A. Jenkinson; M. Boyle; D. Sweetman (Ireland)

10:02 - 10:13 Fetal heart defects and disrupted cerebral growth: a cohort study in 63,371 fetuses M.H. Lauridsen; O.B. Petersen; E.M. Vestergaard; N. Uldbjerg; T.B. Henriksen; J.R. Østergaard; N.B. Matthiesen; V.E. Hjortdal (Denmark)

10:13 - 10:24 Characterisation and burden of 1-year chronic respiratory morbidity among extremely preterm infants: a retrospective claims analysis M. Mowitz; A. Mangili; L. von Krusenstiern; R. Ayyagari; W. Gao; J. Wang; J. Zhao; S. Sarda (United States)

1st November, 2017

3232

10:24 - 10:35 STOP (Septum Trauma Occurrence Prevention) in babies on nasal CPAP-A quality improvement project R. Mc Coy; K. Singh; V. Kairamkonda (United Kingdom)

10:35 - 10:46 Predictive value of early EEG for seizures during hypothermia in neonates with hypoxic ischemic encephalopathy M.C. Cornet; A. Pasupuleti; A. Fang; H.C. Glass; M.R. Cilio (United States)

09.00 – 11.00 PARALLEL SESSION 5 (NUTRITION 1) |SORRENTO ROOM NUTRITION AND THE BRAIN Chairs: Colin Morgan (United Kingdom); Elsa Kermorvant (France)

09:00 - 09:20 Neuroimaging, a new tool for investigating the effects of early diet on cognitive and brain development Helle Pfeiffer (Norway)

09:20 - 09:40 Improving neurological outcomes of preterm infant: update on the role of early nutrition Sissel Moltu (Norway)

09:40 - 09:55 Early parenteral use of a lipid emulsion containing fish oil results in improved longitudinal growth in extremely preterm infants – a randomized controlled trial S. Najm; C. Löfqvist; G. Hellgren; E. Engström; A.K. Nilsson; M.X. Andersson; K. Sävman; A. Hellström (Sweden)

09:55 - 10:10 Growth and body composition up to 4 months of age in preterm infants and term controls (PeaPod study) A. Chmielewska; A. Farooqi; M. Domellöf; I. Ohlund (Sweden)

10:10 - 10:25 Personalised prediction of weight changes in the first week of life S. Kasser; M. Wilbaux; J. Gromann; I. Mancino; T. Coscia; O. Lapaire; J.N. van den Anker; M. Pfister; S. Wellmann (Switzerland)

10:25 - 10:40 Z-score differences based on cross-sectional growth charts do not reflect weight gain in preterm infants: an adjusted Z-score for longitudinal assessment of growth N. Rochow 1; E. Landau-Crangle 1; A. Alkhoraidly 2; A. Bhatia 1; G. Fusch 1; P. Muppidi 1; W. Göpel 3; C. Fusch 1, 3 (1. Canada; 2. Saudi Arabia; 3. Germany)

1st November, 2017

3333

10:40 - 10:55 The maternal-fetal gradient of free and esterified phytoste rols at the time of delivery in humans A. Correani; S. Visentin; E. Cosmi; E. Ponchia; S. D’Aronco; M. Simonato; L. Vedovelli; P. Cogo; V.P. Carnielli (Italy)

09.00 – 11.00 PARALLEL SESSION 6 (CIRCULATION 1) |LECCE ROOM WHO OWNS THE PLACENTAL BLOOD? Chairs: Eirik Nestaas (Norway); Colm Breatnach (Ireland)

09:00 - 09:25 The case for the term infant Ola Andersson (Sweden)

09:25 - 09:50 The case for the preterm infant Heike Rabe (United Kingdom)

09:50 - 10:15 Harvesting placental blood: what is it for? Anders Fasth (Sweden)

10:15 - 10:30 Delayed cord clamping in preterm infants with suspected intrauterine growth restriction J. Mercer; M. Wang; J. Padbury (United States)

10:30 - 10:45 The effects of delayed cord clamping on 12-months brain myelin content: a randomized controlled trial D. Erickson-Owens; J. Mercer; S. Deoni 3; A. Parker 2; J. Collins 2; J. Padbury (United States)

10:45 - 11:00 The use of speckle tracking echocardiography to assess myocardial performance in monochorionic diamniotic twins with and without twin to twin transfusion syndrome C.R. Breatnach; A.T. James; F. Malone; N. McCallion; O. Franklin; A. EL-Khuffash (Ireland)


1st November, 2017

3434

10:00 - 13:00 Respiratory Support in Neonates: How to ventilate term and preterm infants – Insights into new possibilities and neonatal ventilation strategies |MILANO ROOM Industry Supported session - please see page 125

10:10 - 10:30 Invasive closed loop ventilation Andreas W. Flemmer (Germany)

10:30 - 11:00 Basic principles of high frequency ventilation (HFOV) Roland Hentschel (Germany)

11:00 - 11:15 New possibilities in non-invasive closed loop ventilation Andreas W. Flemmer (Germany)

11:00 - 11:15 New insights into HFOV Roland Hentschel (Germany)

11:40 - 13:20 Hands on closed loop ventilation / HFOV in two groups Andreas W. Flemmer (Germany); Roland Henschel (Germany)

11:30 - 12:30 PLENARY SESSION 2 |DARSENA ROOM REGENERATIVE MEDICINE Chairs: Pierre Gressens (France); Petra Hüppi (Switzerland)

11:30 - 12:00 Stem cell therapy for neonatal disorders; Prospects and challenges Won Soon Park (South Korea)

12:00 - 12:30 Stem cells for neonatal disorders Paolo De Coppi (United Kingdom)


12:30 - 13:30 Early optimal nutrition in the NICU A meet-the-expert event |SORRENTO ROOM Industry Supported session - please see page 125 (Lunch will be provided) Chair: Mary Brown-Hise (United States); Boubou Hallberg (Sweden)

12:30 - 12:35 Welcome & conference objectives Mary Brown-Hise (United States)

12:35 - 13:15 Early optimal nutrition in the NICU Boubou Hallberg (Sweden)

13:15 - 13:25 Q&A

13:25 - 13:30 Concluding remarks Mary Brown-Hise (United States)

1st November, 2017

3535

12:30 - 13:30 Strategies and modern technologies of countinuous noninvasive blood gas monitoring |LECCE ROOM Industry Supported session - please see page 125 (Lunch will be provided)

12:30 - 13:00 Intraoperative use of transcutaneous CO2 measuring in paediatric and neonatal anaesthesia Michael Brackhahn (Germany)

13:00 - 13:30 Validation of novel combined transcutaneous sensor - virtually drift free tcPO2 sensing technology Irwin Reiss (The Netherlands)

13:30 - 15:00 Interactive Clinical Session: Are Babies with Serious Hypoxemic Conditions Still Being Missed? |FIRENZE ROOM Industry Supported session - please see page 125 Interactive session with audience participation Chair: Augusto Sola (United States)

Early detection of neonatal sepsis and other hypoxemic conditions Andrew Ewer (United Kingdom)

Recent recommendations from European and Spanish societies for pulse oximetry screening for critical congenital heart defects Maximo Vento Torres (Spain)

The controversies in screening for critical congenital heart defects Thorsten Orlikowsky (Germany)

Perfusion index: can it be a predictive monitoring tool in neonatal illnesses? Augusto Sola (United States)

1st November, 2017

3636

13:30 - 15:00 POSTER SESSION 1 (LUNG 1) |DARSENA ROOM Chairs: Mats Blennow (Sweden); Anna Lavizzari (Sweden)

13:30 - 13:35 Less invasive administration (LISA) not only improves mortality and morbidity but also neurodevelopmental outcome of preterm infants K. Klebermass-Schrehof; A. Grill; M. Hayde; N. Haiden; A. Flunt; R. Fuiko; S. Brandstetter; A. Berger (Austria)

13:35 - 13:40 Surfactant administration and non-invasive ventilation in surfactant deficiency newborn piglets C. Rey-Santano 1; V. Mielgo 1; M. Gomez-Solaetxe 1; F. Ricci 2; F. Bianco 2; F. Salomone 2; B. Loureiro 1; J. López-de-Heredia 1 (1. Spain; 2. Italy)

13:40 - 13:45 Characterization of poractant alfa and budesonide extemporaneous combination for safe and effective intratracheal administration F. Salomone; F. Ricci; C. Catozzi; F. Ravanetti; F. D’Aló; N. Machidani; E. Sgarbi; V. Di Lallo; F. Saccani; M. Pertile; A. Cacchioli; P. Puccini; S. Catinella; G. Villetti; M. Civelli; F. Amadei; G. Aquino; F.F. Stellari; B. Pioselli (Italy)

13:45 - 13:50 The effect of minimally invasive surfactant therapy on diaphragmatic activity C.G. de Waal; G.J. Hutten; F.H.C. de Jongh; A.H.L.C. van Kaam (The Netherlands)

13:50 - 13:55 Evaluation of surfactant dose administered in clinical practice for the treatment of respiratory distress syndrome (RDS): retrospective observational study. Surprais study H. Boix; D. Elorza; S. Rite; L. Arruza; C. Fernández; I. Serrano; I. Baquedano; A. Sanchez; E. Ferreira; V. Martinez ; P. Fernandez; R. Gonzalez (Spain)

13:55 - 14:00 Respiratory distress syndrome: genetic polymorphism of genes encoding surfactant protein B and xenobiotic biotransformation enzymes G. Shishko; M. Artsiusheuskaya; A. Sukharava; E. Mikhalenka; K. Hamolko; I. Valentsiukevich; A. Kilchevski (Belarus)

1st November, 2017

3737

14:00 - 14:05 Effects of surfactant replacement therapy with porcine vs. bovine preparations on cerebral oxygenation and bioelectric activity of preterm infants T. Szczapa; L. Karpinski; H. Szczapa-Krenz; B. Witoslaw; A. Adamczak; J. Moczko; I. Miechowicz; P. Niedbalski; J. Gadzinowski1; J. Mazela (Poland)

14:05 - 14:10 Nasal high-flow therapy (NHFT) as primary respiratory support for preterm infants without use of nasal continuous positive airways pressure (NCPAP) S. Zivanovic 1; A. Scrivens 1; R. Panza 2; P. Reynolds 1; K. Ives 1; N. Laforgia 2; C.C. Roehr 1 (1. United Kingdom; 2. Italy)

14:10 - 14:15 Risk factors associated with CPAP failure in very low birth weight infants D. Dobryanskyy; O. Borysiuk; L. Sekretar; S.Yaremchuk; S. Vereshchak; Z. Salabay (Ukraine)

14:15 - 14:20 Weaning premature infants from nasal continuous positive airway pressure – current practice in Germany A. Kidszun; C. Arnold; J. Winter; C. Whybra-Trümpler; E. Mildenberger (Germany)

14:20 - 14:25 Non-invasive high frequency oscillatory ventilation in preterm infants: a randomised controlled crossover trial D. Klotz; H. Schneider; S. Schumann; B. Mayer ; H. Fuchs (Germany)

14:25 - 14:30 Nasal high flow support during neonatal retrieval in Victoria, Australia V. Abraham; C. Roberts; B. Manley; L. Owen; M. Stewart; P. Davis (Australia)

14:30 - 14:35 The Comparison of heated humidified high-flow nasal cannula versus nasal continuous positive airway pressure for respiratory support in NICU K. Y. Chao; C. E. Chiang; Y. L. Chen; L.Y. Tsai; Y. H. Chien; S. C. Mu; (Taiwan)

14:35 - 14:40 Which nasal CPAP system to use in preterm newborns with respiratory distress syndrome E. Jazexhiu–Postoli; E. Vevecka; E. Petrela; D. Bujari; E. Rapushi (Albania)

1st November, 2017

3838

14:40 - 14:45 Nasal trauma in preterm infants receiving binasal non-invasive respiratory support: a systematic review D. Imbulana; B. Manley; P. Davis; L. Owen (Australia)

14:45 - 14:50 High frequency oscillatory ventilation combined with volume guarantee using very low tidal volumes to prevent lung damage in immature newborns N. González-Pacheco; A. Rodríguez-Sánchez de la Blanca; C. Ramos-Navarro; M. Velilla-Aparicio; I. Marsinyach-Ross; I. Pescador-Chamorro; M. Sánchez-Luna (Spain)

14:50 - 14:55 Continuous positive airway pressure is not well transmitted during less invasive surfactant administration: a physiologic study G. Jourdain 1; M. De Tersant 1; V. Dell’Orto 1; G. Conti 2; D. De Luca 1 (1. France; 2. Italy)

13:30 – 15:00 POSTER SESSION 2 (NICU + PARENTS) |VENEZIA ROOM Chairs: Agnes van den Hoogen (The Netherlands); Jos Latour (United Kingdom)

13:30 - 13:35 Clinical decision support systems for neonatal care - an updated Cochrane systematic review K. Tan 1; P. Dear 2; S. Newell 2 (1. Australia; 2. United Kingdom)

13:35 - 13:40 Skin-to-skin contact in extremely preterm newborns H. Pavlyshyn; I. Sarapuk; O. Klishch (Ukraine)

13:40 - 13:45 Prospective surveillance of risk factors for Intracranial hemorrhage in preterm infants decreases the rate of intracranial hemorrhage and improves neurodevelopmental outcome at the age of 24 months L. Schiefele 1; F. Reister 1; J. Essers 1; B. Mayer 1; M. Schmid 2; H. Hummler 1, 5 (1. Germany; 2. Switzerland; 3. Qatar)

13:45 - 13:50 Thermoregulation and physiological stabilization by skin-to-skincontact at birth in preterm infants A. Linnér; B. Sundberg; B. Westrup; B. Skiold (Sweden)

1st November, 2017

3939

13:50 - 13:55 Is breast milk odor appropriate to manage pain in preterm neonates? G. De Clifford-Faugère; A. Lavallée; M. Aita (Canada)

13:55 - 14:00 Kangaroo families - the meaning of sound environment for the development of prematurely born infants K. Kostilainen 1; K. Mikkola 1; E. Partanen 1; S. Pakarinen 1; M. Huotilainen 1, 2; V. Fellman 1 (1. Finland; 2. Sweden)

14:00 - 14:05 Parents´ experiences of active participation during the ward round in a neonatal intensive care unit L. Börjesson; T. Stendahl (Sweden)

14:05 - 14:10 The role of paediatric physio-/occupational therapists in parental empowerment at the NICU M.J.C. Eijsermans; M.J. Jongmans; C.H. Verhage; F. Jenken; J. van der Net; M.J.N.L. Benders; A. van den Hoogen (The Netherlands)

14:10 - 14:15 Pathways to emotional closeness in neonatal units – a cross-national qualitative study R. Flacking 1; G. Thomson 2; A. Axelin 3 (1. Sweden; 2. United Kingdom; 3. Finland)

14:15 - 14:20 Employing a nutrition nurse in neonatal intensive care unit improved nutrition and growth outcomes in preterm neonates O. Aydemir; A. Calik Saglik; Z Sekili; N. Tekin (Turkey)

14:20 - 14:25 Name bands in preterm infants - what is the nation doing? A. Doerr; A. Glover; F. Emery (United Kingdom)

14:25 - 14:30 Reducing unnecessary blood sampling in neonatal unit - a quality improvement initiative H. McDermott; A. Smith; P. Nath (United Kingdom)

14:30 - 14:35 NIoSIM: Northern Ireland simulation and human factor training R. Little; C. Anderson; M. O’Dowd; R.Tubman (Ireland)

14:35 - 14:40 Current parent feedback response rates and feedback methods in neonatal transport service across the UK P. Bhat; D. Winderbank-Scott; C. Garland; L. Watts; C. Leach; A. Frame; G. Bullimore; C. Lawn (United Kingdom)

1st November, 2017

4040

14:40 - 14:45 Satisfaction level of parents of NICU services provided and connection with their educational attainment E. Papamichael; E. Polycarpou; M. Talias (Cyprus)

14:45 - 14:50 Delivering evidence-based information at the point of care A. Dunlop; L. Osborne; P. Satodia (United Kingdom)

14:50 - 14:55 Increased breast milk use reduced severity of necrotizing enterocolitis in a quality improvement project in a Chinese NICU Q. Zhou 1; S.K. Lee 2; X.J. Hu 1; S.J. Lee 1; S.Y.Jiang 1; Y. Cao 1 (1. China; 2. Canada)

14:55 - 15:00 Online parent satisfaction survey is representative despite low response J. de Boer; M. van Dijk (The Netherlands)

13:30 – 15:00 POSTER SESSION 3 |ROMA ROOM (CARDIOLOGY + MICROCIRCULATION 1) Chairs: Afif El-Khuffash (Ireland); Eirik Nestaas (Norway)

13:30 - 13:35 Ibuprofen and indomethacin differentially regulate VEGF and its receptors in ductus arteriosus endothelial cells H. Sallmon; S. Akanbi; S.C. Weber; A. Gratopp; C. Rheinländer; P. Koehne (Germany)

13:35 - 13:40 Effectiveness of indomethacin, ibuprofen and paracetamol for patent ductus arteriosus (PDA) in preterm infants: a network meta-analysis S. Mitra; I.D. Florez; M.E. Tamayo; Y. Zhang; B. Sadeghirad; A.M. Zea; L. Mbuagbaw; T. Vanniyasingam; L. Thabane (Canada)

13:40 - 13:45 Evaluation of the relationship patent ductus arteriosus and the platelet mass index in preterm infants M. Kara; İ. Caner; K.Ş. Tekgündüz; İ. Polat; H. Keskin (Turkey)

13:45 - 13:50 Treatment for patent ductus arteriosus in preterm infants - less is more? T. Hundscheid; W. de Boode (The Netherlands)

1st November, 2017

4141

13:50 - 13:55 Hemodynamic changes related to ductus closure in preterms A. Rodríguez Sánchez de la Blanca; N.González Pacheco; C. Ramos Navarro; M. Arriada Redondo; N. Navarro Patiño; E. Sanz López; M. Sánchez Luna (Spain)

13:55 - 14:00 A clinical scoring system as a diagnostic tool for hemodynamically significant patent ductus arteriosus in preterm infants N. Okur; H.G. Kanmaz; M. Buyuktiryaki; G. Kadioglu Simsek; F.E. Canpolat; N. Uras; S.S. Oğuz (Turkey)

14:00 - 14:05 New ibuprofen dosage regimen for patent ductus arteriosus following simulations based on pharmacokinetic- pharmacodynamic evidence R. Flint 1; R. ter Heine 1; E. Spaans 1; D. Burger 1; J. de Klerk 1; K. Allegaert 2; C. Knibbe 1; S.H.P. Simons 1 (1. The Netherlands; 2. Belgium)

14:05 - 14:10 Association between size of patent ductus arteriosus and co-morbidities S. Bellis; Y. Singh (United Kingdom)

14:10 - 14:15 Myocardial deformation and rotational mechanics in infants with down syndrome in the early neonatal period C.R. Breatnach 1; A. Smith 1; P.T. Levy 2; N. McCallion 1; O. Franklin 1; A. EL-Khuffash 1 (1. Ireland; 2. United States)

14:15 - 14:20 Left and right myocardial performance assessment in infants born to mothers with gestational hypertension C.R. Breatnach; C. Monteith; L. McSweeney; E.C. Tully; F.D. Malone; E. Kent; A. Doherty; O. Franklin; A. EL-Khuffash (Ireland)

14:20 - 14:25 Left ventricular function in preterm neonates assessment of LV rotational mechanics from 32 weeks post-menstrual age to one year G. Lehman; M.D. Patel; P.T. Levy; S. Choudhry; T.J. Sekarski; A. Hamvas; G.K. Singh (United States)

14:25 - 14:30 Predictions of cardiorespiratory morbidity after discharge from the NICU in the extreme preterm infant without chronic lung disease P.T. Levy; M.D. Patel; S. Choudhry; A.A. Sanchez; M. Wallendorff; G. Hongjie; M.R. Holland; B. Warner; J. Kemp; T. Ferkol; A. Hamvas; G.K. Singh (United States)

1st November, 2017

4242

14:30 - 14:35 Neonatalogist-performed echography in neonatology: a Tunisian experience F.Z. Chioukh; K. Ben Ameur; T. Khemis; H. Ajmi; A. Ben Salem; S. Hamdi; H. Ben Hamida; K. Monastiri (Tunisia)

14:35 - 14:40 Non-invasive cardiac output monitoring by electrical cardiometry in hemodynamically stable neonate infants J. Shin; E.H. Lee; B.M. Choi (Korea)

14:40 - 14:45 Comparison of two techniques of superior vena cava measurement in preterm neonates with birth weight less than 1250g J. Semberova 1, 2; Z. Stranak 2; J. Miletin 1, 2 (1. Ireland; 2. Czech Republic)

14:45 - 14:50 Gut and cerebral oxygenation from birth to six weeks of life in preterm infants: what is normal? C.N. Howarth; T. Leung; J. Banerjee; J. Morris; N. Aladangady (United Kingdom)

14:50 - 14:55 Precision assessment of a novel cerebral tissue oximeter and effects of fluctuations in systemic and cerebral physiological parameters S. Kleiser; D. Ostojic; N. Nasseri; H. Isler; H.U. Bucher; D. Bassler; M. Wolf; F. Scholkmann; T. Karen (Switzerland)

13:30 – 15:00 POSTER SESSION 4 (GI + NEC + BILIRUBIN) |SORRENTO ROOM Chairs: Jon Dorling (United Kingdom); Elsa Kermovant (France)

13:30 - 13:35 The open abdomen: a challenge for neonatologists and neonatal surgeons. The Karolinska’s experience M. Bartocci; E. Palleri; A. Svenningsson; T. Wester (Sweden)

13:35 - 13:40 Anogenital stimulation in rats does not increase gastric emptying C.H. Faleiros Ferreira 1; J. Belik 2 (1. Brazil; 2. Canada)

13:40 - 13:45 Routine probiotics for preterm neonates: experience in a tertiary Australian neonatal unit sive care G. Deshpande; V. Shingde; L. Downe; J. Xiao; M. Taber (Australia)

1st November, 2017

4343

13:45 - 13:50 Outcomes of extremely low birth weight babies receiving surgical treatment for necrotising enterocolitis J. Ashton; C. Charlesworth; P. Yajamanyam (United Kingdom)

13:50 - 13:55 Early biochemical markers associated with development of necrotizing enterocolitis K.W. Olsson; R. Sindelar (Sweden)

13:55 - 14:00 Effect of antibiotic prophylaxis during removal of a central venous catheter on development of the neonatal intestinal microbiota E. d’Haens; R. Zwittink; C. Belzer; M. Hemels; R. van Lingen; I. Renes; J. Knol; D. van Zoeren-Grobben (The Netherlands)

14:00 - 14:05 Stooling pattern and gastric residuals are not useful tools for early diagnosis of necrotising enterocolitis in preterm infants S. Carlsson; M. Domellöf; A. Elfvin 3 (Sweden)

14:05 - 14:10 Is near infrared spectroscopy a reliable technique to measure gut perfusion in preterm infants? J. Banerjee; T.S. Leung; N. Aladangady (United Kingdom)

14:10 - 14:15 Prediction of major bleeding in extremely low birth weight infants (<1000g) by sequential coagulation monitoring M. Thanhaeuser; C. Binder; M. Kornsteiner-Krenn; U. Derhaschnig; B. Jilma; A. Repa; A. Berger; N. Haiden (Austria)

14:15 - 14:20 Investigation of the relationship between umbilical cord blood IRF level and perinatal events Z.E. Erdem Dursun; N. Guzoglu; D. Aliefendioglu (Turkey)

14:20 - 14:25 Relationship between plasma levels of bilirubin and oxidant/ antioxidant status in the early neonatal period in preterm infants G.I. Zoutkamp 1; K. Suzuki 2; C.H.P. van den Akker 1 (1. The Netherlands; 2. Japan)

14:25 - 14:30 The coagulation screen as a biomarker of neonatal encephalopathy outcomes D. Sweetman; J. Murphy; E.J. Molloy (Ireland)

14:30 - 14:35 A preterm model of hyperbilirubinemia-induced cerebellar dysfunction C.F. Bearer; M. He; J.F. Watchko; J.M. Simard; N. Tang (United States)

1st November, 2017

4444

14:35 - 14:40 Comparisons between transcutaneous bilirubinometry, point-of-care whole blood bilirubin and total plasma bilirubin measurement in neonates K. Palmkvist Kaijser; C. Backman Johansson; K. Hemse Nojd; C. Bemgard; K. Kjellson; G. Marchini (Sweden)

14:40 - 14:45 Physiologic free bilirubin redistributes L1 cell adhesion molecule (L1) in lipid rafts N. Tang; M. He; J.F. Watchko; C.F. Bearer (United States)

14:45 - 14:50 Reticulocyte haemoglobin content as an early index of iron deficiency in neonatal period P. Karagianni; E. Chatzitoliou; V. Antari; M. Lithoxopoulou; G. Mitsiakos; C. Tsakalidis; A. Kioumi; V. Soubasi (Greece)

14:50 - 14:55 Effect of probiotic supplementation on breast milk jaundice N. Koksal; O. Bagcı; H. Ozkan; I. Varal; P. Dogan (Turkey)

14:55 - 15:00 An audit of use of emergency O negative blood in neonates for emergency blood transfusions and exchange transfusions P. Tormey; D. Sweetman; J. Quigley; J. Fitzgerald (Ireland)

13:30 – 15:00 POSTER SESSION 5 (NUTRITION 1) |VERONA ROOM Chairs: Silvia Iacobelli (Italy); Sissel Moltu (Norway)

13:30 - 13:35 Comparative clinical effectiveness of two methods of hyperglycemia correction in very low birth weight preterm infants O. Dobush; D. Dobryanskyy; Z. Salabay; O. Borysiuk (Ukraine)

13:35 - 13:40 Role of breast milk and fecal microbial content in development of breast milk jaundice N. Koksal; O Bagcı; H. Ozkan; I. Varal; P Dogan (Turkey)

13:40 - 13:45 Protein and caloric deficit during the neonatal period in infants with birth weight less than 1500 g and its association with blood pressure in the adolescence A. Dinerstein; C. Solana; R. Nieto; M. Casale; R. Conti; M. Moiron; F. General (Argentina)

13:45 - 13:50 Long term growth and neurodevelopmental outcome in preterm infants born small for gestational age (SGA) and infants with intrauterine growth restriction (IUGR) C. Binder; A. Huber-Dangl; J. Binder; A. Kreissl; M. Thanhaeuser; A. Repa; A. Berger; N. Haiden (Austria)

1st November, 2017

4545

13:50 - 13:55 Elevated essential amino acid levels in very preterm infants on total parenteral nutrition L. Burgess; M. Turner; B. Flanagan; C. Morgan (United Kingdom)

13:55 - 14:00 Effect of enteral iron supplementation on health outcomes in preterm and low birth weight infants: a systematic review E. McCarthy; M. Kiely (Ireland)

14:00 - 14:05 Improved nutrition for extremely preterm infants - a population based observational study V. Westin; S. Klevebro; M. Domellöf; M. Vanpée; B. Hallberg; E. Stoltz Sjöström (Sweden)

14:05 - 14:10 Nutrient intake in the first two weeks of life predicts brain macro- and microstructural growth in preterm neonates J. Schneider 1, 2; L. Beauport 2; E. Duerden 1; T. Guo 1; J. Foong 1; M. Bickle Graz 2; P. Hagmann 2; M. Chakravarty 1; P. Hüppi 2; C. Fischer Fumeaux 2; S. Miller 1; A. Truttmann 2 (1. Canada; 2. Switzerland)

14:10 - 14:15 Influence of human milk and parenteral lipid solutions on serum fatty acid profiles in extremely preterm infants A.K. Nilsson 1; C. Löfqvist 1; S. Najm 1; G. Hellgren 1; E. Engström 1; P. Lundgren 1; A-L. Hård 1; A. Lapillonne 2; K. Sävman 1; M.X. Andersson 1; L.E.H. Smith 3; A. Hellström 1 (1. Sweden; 2. France; 3. United States)

14:15 - 14:20 Evaluation of milk and blood irisin levels in preterm newborns diagnosed with either small or appropriate weight for gestational age compared to full term newborns N. Mól; P. Tomasik; M. Zasada; P. Kwinta (Poland)

14:20 - 14:25 Positive relationship between transthyretin and insulin-like growth factor 1 during the anabolic period in very preterm infants I. Hansen Pupp; C. Löfqvist; D. Ley; A. Hellström (Sweden)

14:25 - 14:30 Hormone profile and anthropometric assessment of very preterm newborns at follow-up C. Balcells; B. del Rey Hurtado de Mendoza; M. Izquierdo-Renau; I. Iglesias-Platas (Spain)

14:30 - 14:35 Human milk composition in relation to growth and body composition in preterm infants at term age K.P.T. Vu; D.F.J. Yumani; A.R.C. Laarman; H.N. Lafeber; M.M. van Weissenbruch (The Netherlands)

1st November, 2017

4646

13:30 - 15:00 Respiratory Syncytial Virus: Should We Identify Paediatric Patients at Risk for Severe Disease? |LECCE ROOM Industry Supported session - please see page 125 Chair: Paolo Manzoni (Italy)

Severe RSV disease: the worldwide burden Paolo Manzoni (Italy)

Who needs RSV infection prevention? A closer look at children with chronic diseases Bosco A. Paes (Canada)

Cases in identifying children at risk of severe RSV disease Panel

The acute and long-term consequences of severe RSV disease Maarten O. Blanken (The Netherlands)

“Ask the Faculty” and concluding remarks

15:00 - 17:00 PARALLEL SESSION 7 (PULMONOLOGY 1) PULMONARY SYMPOSIUM |DARSENA ROOM Industry Supported session - please see page 125 Chairs: Charles C. Roehr (United Kingdom); Anna Lavizzari (Italy)

15:00 - 16:00 nCPAP vs HFNC Haresh Kirpalani (United States) vs Peter Davis (Australia)

16:00 - 16:30 Newer strategies for surfactant delivery – who, when, where, why and how Peter Dargaville (Australia)

16:30 - 16:45 Sudden versus pressure wean from nasal CPAP in very preterm infants: a multicenter randomized controlled trial C.F. Jensen; F. Ebbesen; A.S. Sørensen; T.B. Henriksen (Denmark)

16:45 - 17:00 Predictors and outcomes of continuous positive airway pressure and nasal high-flow treatment failure in preterm infants: a secondary analysis of a randomized trial B. Manley 1; C. Roberts 1; D. Frøisland 2; L. Doyle 1; P. Davis 1; L. Owen 1 (1. Australia; 2. Norway)

1st November, 2017

4747

15:00 - 17:00 PARALLEL SESSION 8 (BRAIN 2) MONITORING FOR INFANTS AT RISK |VENEZIA ROOM Chairs: Manon Benders (The Netherlands); Juliane Schneider (Switzerland)

15:00 - 15:20 Cerebral autoregulation in asphyxiated neonates treated with hypothermia A. Hendriksen; L. Dix; W. Baerts; F. van Bel; F. Groenendaal; P. Lemmers (The Netherlands)

15:20 - 15:35 Asynchrony and spectral EEG coherence in term neonates with intrauterine grow restriction B. Reyes Millán; J.R. Castro Conde; C. González Campo; I. Quintero Fuentes; N.L. González González; D. González Barrios (Spain)

15:35 - 15:50 Early amplitude integrated electroencephalogram as a predictor of brain injury in newborns with very low birth weight: a cohort study R.C. Silveira; L.V. Magalhaes; M.I. Winckler; J.A. Bragatti; R.S. Procianoy (Brazil)

15:50 - 16:05 MRI-diagnosed white matter lesions in the brain of VLBW babies: risk factor analysis A. Parodi; S. Raffa; M. Malova; A. Sannia; M. Severino; G. Morana; D. Tortora; M.G. Calevo; A. Rossi; L. A. Ramenghi (Italy)

16:05 - 16:20 Perinatal associations with brain growth evaluated by sequential cranial ultrasonography in very preterm infants R. Cuzzilla 1; A.J. Spittle 1; K.J. Lee 1; S. Rogerson 1; F.M. Cowan 2; L.W. Doyle 1; J.L.Y. Cheong 1 (1. Australia; 2. United Kingdom)

16:20 - 16:35 Bedside monitoring of cerebral metabolism in neonates at risk for hypoxic-ischemic encephalopathy M. El-Dib; S.J. Blackwell; F. Yi; R. Vyas; C.G. Ha; B. Walsh; T.E. Inder; P.E. Grant; S.L. Ferradal (United States)

16:35 - 16:50 Early neonatal EEG markers for dyslexia risk: a pilot study S. Martini; P. Cyr; L. Brightman; L. Amunts; G. Belteki; T. Austin; V. Leong (United Kingdom)

1st November, 2017

4848

15:00 - 17:00 PARALLEL SESSION 9 (CIRCULATION 2) WHAT SHOULD WE MONITOR? GLOBAL HAEMODYNAMICS (SYSTEMIC BLOOD FLOW), END-ORGAN PERFUSION (REGIONAL BLOOD FLOW) OR THE MICROCIRCULATION (CAPILLARY BLOOD FLOW)? |ROMA ROOM Chairs: Afif El-Khuffash (Ireland); Mayka Bravo (Spain)

15:00 - 15:20 It’s all about the heart Willem de Boode (The Netherlands)

15:20 - 15:40 It’s all about the brain Gorm Greisen (Denmark)

15:40 - 16:00 It’s all about the microcirculation Dick Tibboel (The Netherlands)

16:00 - 16:15 Patent ductus arteriosus, cerebral haemodynamics and intraventricular haemorrhage in preterm neonates: a causal pathway study C. Kotidis; M. Weindling; A. Eleuteri; H. Rabe; M. Turner (United Kingdom)

16:15 - 16:30 Electrical velocimetry in preterm infants: effect of time and gestational age L. Van Wyk 1; W.P. De Boode 2; J. Smith 1; J. Lawrenson 1; C.J. Lombaard 1 (1. South Africa; 2. The Netherlands)

16:30 - 16:45 Molecular and genetic markers for prediction of resistance to inotropic therapy in newborns with arterial hypotension D. Kryuchko; A. Donnikov; E. Baibarina; I. Nikitina; O. Ionov; D. Degtyarev (Russia)

16:45 - 17:00 Glial fibrillary acidic protein plasma levels during congenital heart diseases surgery inversely correlate with vineland adaptive behavior scales communication score L.Vedovelli; M. Padalino; M. Salvagno; S. Sartori; A. Suppiej; E. Cainelli; G. Stellin; G. Falasco; V.P. Carnielli; M. Simonato; P. Cogo (Italy)

1st November, 2017

4949

15:00 - 17:00 PARALLEL SESSION 10 (PHARMA 1) CHALLENGES IN NEONATAL DRUG DEVELOPMENT |FIRENZE ROOM Chairs: Sinno Simons (The Netherlands); Catherijne Knibbe (The Netherlands)

15:00 - 15:20 What you need to know from EMA PDCO Mark Turner (United Kingdom)

15:20 - 15:40 The HIP trial story Eugene Dempsey (Ireland)

15:40 - 16:00 Experiences from the NEO-CIRC trial Heike Rabe (United Kingdom)

16:00 - 16:15 Adrin 1 methodology study: adverse drug reactions in neonates: what are the best ways to evaluate suspected adverse drug reactions in neonates? E. Roberts; D. Hawcutt; J.J. Kirkham; M.A. Turner (United Kingdom)

16:15 - 16:30 Large differences in off-label and neonatal drug use still exist: time for consensus? R. Flint; F. Van Beek; P. Andriessen; P. Degraeuwe; D. Liem; I. Reiss; R. de Groot; D. Tibboel; D. Burger; S.H.P. Simons; DINO study group (The Netherlands)

16:30 - 16:45 Urinary 17-α-hydroxy-progesterone as a potential marker of neonatal pain M. Brasseler; T. Hoehn (Germany)

16:45 - 17:00 Β3-adrenoceptor regulation of nitric oxide in the cord vascular system G. Cavallaro 1; A. Griggio 1; L. Provitera 1; G. Raffaeli 1; I. Amodeo 1; S. Gulden 1; G. Zuanetti 1; D. Lattuada 1; G. Ercoli 1; S. Gatti 1; E. Villamor 2; F. Mosca 1 (1. Italy; 2. The Netherlands)

1st November, 2017

5050

15:00 - 17:00 PARALLEL SESSION 11 (NUTRITION 2) |SORRENTO ROOM CONTROVERSIES IN NEONATAL NUTRITION Chairs: Sissel Moltu (Norway); Alexandre Lapillonne (France)

15:00 - 15:20 Preterm parenteral nutrition: too much too soon or too little too late Colin Morgan (United Kingdom) 15:20 - 15:40 Risks and benefits of insulin treatment in hyperglycaemic preterm neonates Elsa Kermorvant (France)

15:40 - 15:55 Target fortification of breast milk with protein, carbohydrate and fat for preterm infants improves growth outcomes: a double blind randomized controlled trial N. Rochow 1; G. Fusch 1; A. Ali 1; A. Bhatia 1; S. Ahmad 1; A. Nguyen 1; L. Chessell 1; S. el Helou 1; C. Fusch 1,2 (1. Canada; 2. Germany)

15:55 - 16:10 Targetting glucose control with real time continuous glucose monitoring L. Thomson; D. Elleri; D. Dunger; K. Beardsall (United Kingdom)

16:10 - 16:25 Bovine colostrum for preterm infants in the first days of life: a randomized controlled pilot trial S.M. Juhl 1; X. Ye 2; P. Zhou 2; Y. Li 1; E.O. Iyore 1; L. Zhang 2; P. Jiang 1; J.B. v. Goudoever 3; G. Greisen 1; P.T. Sangild 1 (1. Denmark; 2. China; 3. The Netherlands)

16:25 - 16:40 Reducing variability in macronutrient intakes improves growth in preterm infants: target fortification of breast milk - a double-blind randomized controlled trial A. Bhatia 1; N. Rochow 1; G. Fusch 1; A. Ali 1; A. Nguyen 1; A. Bahonjic 1; C. Fusch 1,2 (1. Canada; 2. Germany)

16:40 - 16:55 The effect of fish oil emulsions on lung function in preterm infants receiving parenteral nutrition V.P. Carnielli; C. Biagetti; P. Marchionni; A. Correani; M. Carfagna; S. Nobile (Italy)

1st November, 2017

5151

15:00 - 17:00 PARALLEL SESSION 12 (EFCNI 2) FAMILY CENTRED DEVELOPMENTAL SUPPORTIVE CARE – EVIDENCE OR PHILOSOPHY? |LECCE ROOM Chairs: Silke Mader (Germany); Jacques Sizun (France)

15:00 – 15:40 Family integrated care in the NICU - feasible and good for preterm infants? Shoo Lee (Canada)

15:40 – 16:20 Developmental care – impact on the brain Stéphane Sizonenko (Switzerland)

16:20 – 17:00 Influence of auditive NICU environment on the preterm baby Pierre Kuhn (France)


17:30 - 18:30 PLENARY SESSION 3 |DARSENA ROOM BENGT ROBERTSON AWARD Industry Supported session - please see page 126 Chairs: Kajsa Bohlin (Sweden); Virgilio P. Carnielli (Italy)

17:30 – 17:40 Introduction

17:40 – 18:15 Steroids, surfactant and the preterm lung: bench to bedside and back again Roberta and Phil Ballard (United States)

18:15 – 18:30 Impact of preterm birth on respiratory muscle function in childhood Aggeliki Vervenioti (Greece)

1st November, 2017

Medela exists to enhance mother and baby health through the life-giving benefits of human milk. For more information, visit www.medela.com

Mother’s milk – our passion

5353

08:00 - 10:00 PLENARY SESSION 4 |DARSENA ROOM YOUNG INVESTIGATOR PRIZE SESSION Chairs: Umberto Simeoni (Switzerland); Luc Zimmermann (The Netherlands)

08:00 - 08:15 Individualized growth trajectories for preterm infants using a growth trajectory calculator tool E. Landau-Crangle; N. Rochow; T.R. Fenton; K. Liu; H.Y. So; G. Fusch; A. Ali; M.L. Marrin; C. Fusch (Canada)

08:15 - 08:30 Touchscreens for cognitive assessment of toddlers D.M. Twomey 1; C. Wrigley 1; C. Ahearne 1; R. Murphy 1; M. de Haan 2; N. Marlow 2; D.M. Murray 1 (1. Ireland; 2. United Kingdom)

08:30 - 08:45 Tracking childhood height of small for gestational age infants in Ireland F. Maguire; E. Loftus; D. Gibbons; N. O’Connor; O. O’Brien; S. Carolan; J. Byrne; E.J. Molloy (Ireland)

08:45 - 09:00 Evaluation of effect of caffeine onset time on surfactant synthesis of premature infants of 30 gestational weeks and below with respiratory distress N. Okur; M. Buyuktiryaki; H. Bezirganoglu; O. Ertekin; E.D. Alyamac; F.E. Canpolat; S.S. Oguz (Turkey)

09:00 - 09:15 Use of specialist services until two years of age in the epice cohort of very preterm births in Europe A.V. Seppänen 1; F. Bodeau-Livinec 1; E.M. Boyle 2; A.K. Edstedt-Bonamy 3; M. Cuttini 4; L. Toome 3; R.F. Maier 6; E. Cloet 7; C. Koopman-Esseboom 8; J. Gadzinowski 9; J. Zeitlin 1 (1. France; 2. United Kigdom; 3. Sweden; 4. Italy; 5. Estonia; 6. Germany; 7. Belgium; 8. The Netherlands; 9. Poland)

09:15 - 09:30 Impact of neonatal white matter injury and brain volumes to school-age neurodevelopment in children with congenital heart disease N.H.P. Claessens; S.O. Algra; T.L. Ouwehand; N.J.G. Jansen; P. Moeskops; I. Išgum; R. Schappin; I.C. van Haastert; M.J.C. Eijsermans; F. Groenendaal; L.S. de Vries; M.J.N.L. Benders (The Netherlands)

2nd November, 2017

5454

09:30 - 09:45 Nanomolecular signalling in the developing brain: characteristics of exosomes in the cerebrospinal fluid of preterm infants R. Spaull; B. McPherson; A. Clayton; J. Uney; O. Cordero-Llana; A. Heep (United Kingdom)

09:45 - 10:00 Blood plasma profile of temporal microrna expression of inflammation in lipopolysaccharide sensitised porcine model of hypoxic ischaemic encephalopathy A. Avdic-Belltheus 1; I. Lingam 1; C. Meehan 1; K. Martinello 1; S. Ragab 1; I. Tachtsidis 1; C. Tann 1; M. Hristova 1; B. Fleiss 1; T. Wolfs 2; B. Kramer 2; N. Klein 1; H. Hagberg 1; P. Gressens 1; N.J. Robertson 1 (United Kingdom)

10:00 - 10:10 Cerebral monitoring during neonatal surgery for non-cardiac congenital anomalies: a first step to improve outcome Lisanne Stolwijk (The Netherlands)

08:30 – 12:30 NEONATOLOGIST PERFORMED |SORRENTO ROOM ECHOCARDIOGRAPHY (NPE) Chairs: Willem de Boode (The Netherlands); Afif El-Khuffash (Ireland)

08:30 – 08:35 Welcome Afif El-Khuffash (Ireland)

08:35 – 09:00 Physics of ultrasound and artefact recognition Willem de Boode (The Netherlands)

09:00 – 09:30 Routine ultrasound views Afif El-Khuffash (Ireland)

09:30 – 10:00 Assessment of PDA Patrick McNamara (Canada)


10:30 – 11:00 Assessment of PPHN Shahab Noori (United States)

11:00 – 11:30 Assessment of flow and contractility Nick Evans (Australia)

11:30 – 12:00 Advanced ecocardiographic technologies Eirik Nestaas (Norway)

12:00 – 12:30 Panel discussion - All speakers2nd November, 2017

5555

10:30 – 12:30 PARALLEL SESSION 13 (PULMONOLOGY 2) SEVERE BPD |DARSENA ROOM Chairs: Daniele de Luca (France); Kerstin Jost (Switzerland)

10:30 – 10:50 Ethical decision making in lung failure Eduard Verhagen (The Netherland)

10:50 – 11:10 BPD-associated pulmonary hypertension Robin Steinhorn (United States)

11:10 - 11:25 Physiological basis of the NICHD BPD classification: a prospective observational study in very preterm infants J. Svedenkrans 1, 2; B. Stoecklin 2; J.G. Jones 3; A.W. Gill 2; D. Doherty 2; J.J. Pillow 2 (1. Sweden; 2. Australia; 3. United Kigdom)

11:25 - 11:40 Identification of a regulatory alveogenesis gene cluster using a novel genetic approach F. Gao; C. Li; R. Ramanathan; P. Minoo (United States)

11:40 - 11:55 Healthcare burden of bronchopulmonary dysplasia among extremely preterm infants in the United States C. Siffel; M. Mowitz; S. Sarda; A. Mangili; R. Ayyagari; W. Gao; J. Zhao; (United States)

11:55 - 12:10 Relationship between secretory phospholipase A2 pathway and short term outcomes in preterm neonates with RDS S. Shankar-Aguilera 1; C. Fitting 1; R. Raschetti 1; M. Sminato 2; V. Dell’Orto 1; L. Vedovili 1; V.P. Carnielli 2; L. Touqui 1; D. De Luca 1 (1. France; 2. Italy)

12:10 - 12:25 Relaxation rate of the respiratory muscles and prediction of extubation outcome in prematurely born infants T. Dassios; O. Kaltsogianni; A. Greenough (United Kingdom)

2nd November, 2017

5656

10:30 – 12:30 PARALLEL SESSION 14 (BRAIN 3) TRANSITION TO ADULT LIFE |VENEZIA ROOM Chairs: Petteri Hovi (Finland); Neil Marlow (United Kingdom)

10:30 – 10:50 Cognition and attainment Neil Marlow (United Kingdom)

10:50 – 11:10 Psychiatric outcomes Chiara Nosarti (United Kingdom)

11:10 – 11:30 Cardiovascular health Petteri Hovi (Finland)

11:30 – 11:45 Cognitive functioning in adolescents born moderately preterm at 32-26 weeks’ gestation: a Swedish regional population based case control study M. Adamsson; B. Hägglöf; M. Bäckman; A. Farooqi (Sweden)

11:45 – 12:00 Cognitive trajectories from infancy to early adulthood following birth before 26 weeks of gestation L. Linsell; S. Johnson; D. Wolke; H. O’Reilly; J. Morris; J. Kurinczuk; N. Marlow (United Kingdom)

12:00 – 12:15 Persistent mathematics learning difficulties from childhood to adolescence in very preterm children in mainstream school S. Clayton; L. Cragg; C. Gilmore; N. Marlow; V. Simms; R. Spong; S. Johnson (United Kingdom)

12:15 – 12:30 Inhibitory control at 20 months predicts VP/VLBW and term adults’ attention, IQ, and wealth at age 26 years J. Jaekel 1,2; N. Baumann 2; P. Bartmann 3; D. Wolke 2 (1. United States; 2. United Kingdom; 3. Germany)

2nd November, 2017

5757

10:30 – 12:30 PARALLEL SESSION 15 (EFCNI 3) BRIDGING THE GAP BETWEEN NEONATAL PALLIATIVE CARE AND DEVELOPMENTAL CARE |ROMA ROOM Chairs: Jacques Sizun (France); Nicole Thiele (Germany)

10:30 – 10:50 Neonatal palliative care, developmental care: different wording for one single concept? Jacques Sizun (France)

10:50 – 11:10 How involved are parents in difficult life decisions Jos Latour (United Kingdom)

11:10 – 11:25 Retrospective analyses of parental counseling and decision making for extreme preterm birth in a tertiary Dutch perinatal center E. de Booij; J. de Boer; A. Eggink; I. Reiss; S.H.P. Simons; I.A. Brussé (The Netherlands)

11:25 – 11:40 Health care professionals’ and parents’ attitudes toward parental autonomy and the best interest of the extreme preterm infant: a national study in Switzerland M. Hendriks; H. Bucher; S. Klein; R. Baumann-Holzle; J. Streuli; J. Fauchère (Switzerland)

11:40 – 11:55 Children’s outcomes at two-year follow-up after four years of structured multi-professional medical-ethical decision- making in a neonatal intensive care unit J. de Boer; L. Gennissen; M. Williams; M. van Dijk; D. Tibboel; I. Reiss; S. Naghib; J. Sol (The Netherlands)

11:55 – 12:10 The delivery of bad news: a one or 2-step approach? The case for Trisomy 21 M.S. Schimmel; M.Y. kassirer; H.M. Towers (United States)

12:10 – 12:25 Neonatal organ donation: a potential new donor source for cell and organ transplantation C. Jorns; E. Henckel; G. Nowak; A. Karadagi; T. Kjellin; E. Bluhme; Ö. Jynge; M. Hending; A. Croon; M. Söderström; B. Fischler; A. Nemeth; R. Gramignoli; S. Strom; E. Ellis; B. Hallberg (Sweden)

2nd November, 2017

5858

10:30 – 12:30 PARALLEL SESSION 16 (EPIDEMIOLOGY 1) OUTCOME MEASURES IN CLINICAL STUDIES OF PRETERM BABIES |FIRENZE ROOM Chairs: Tine Brink Henriksen (Denmark); Anne-Cathrine Finnemann Viuff (Denmark)

11:00 - 11:20 Composite outcomes in clinical NICU studies - pros and cons Keith Barrington (Canada)

11:20 - 11:40 Measuring risk of postnatal endpoints Olga Basso (Canada)

11:40 - 11:55 Rends in mortality and major morbidity of very preterm neonates in 10 national neonatal database: the international network for evaluation of outcomes (INEO) experience K. Lui 1; S. Lee 2; S. Kusuda 3; M. Adams 4; M. Vento Torres 5; B. Reichman 6; B. Darlow 7; L. Lehtonen 8; N. Modi 9; M. Norman 10; S. Hakansson 11; D. Bassler 4; F. Rusconi 12; P. Shah 2 on behalf of the International Network for Evaluating Outcomes of Neonates (1. Australia; 2. Canada; 3. Japan; 4. Switzerland; 5. Spain; 6. Israel; 7. New Zealand; 8. United Kingdom; 10. Sweden; 11. Italy)

11:55 - 12:10 Impact of major neonatal morbidities on the outcome at 6.5 years of children born extremely preterm: a Swedish national prospective study (express) A. Farooqi; K. Källén; K. Maršál; F. Serenius (Sweden)

12:10 - 12:25 Differential susceptibility effects of maternal sensitivity at age 6 on small for gestational age adults’ attention regulation and wealth at age 26 T. Nichols 1; J. Jaekel 1,2; P. Bartmann 3; D. Wolke 2 (1. United States; 2. United Kingdom; 3. Germany)

12:25 - 12:40 Educational trajectories of school outcome after preterm birth D. Odd; D. Evans; A. Emond (United Kingdom)

12:40 - 12:55 In utero exposure to perfluoroalkyl and polyfluoroalkyl substances and attention and executive function in the offspring C.C. Bach 1; Z. Liew 2; N.B. Matthiesen 1; T.B. Henriksen 1; B.H. Bech 1; E.A. Nohr 1; E.C. Bonefeld-Jørgensen 1; J. Olsen 1,2 (1. Denmark; 2. United States)

2nd November, 2017

5959

10:30 – 12:30 PARALLEL SESSION 17 INFECTIOUS DISEASES |LECCE ROOM Chairs: Christoph Bührer (Germany); Sinno Simons (The Netherlands)

10:30 – 10:50 Antimicrobial – impregnated catheters and prevention of infection in newborn infants Sam Oddie (United Kingdom)

10:50 – 11:10 Food additives for prevention of sepsis and necrotizing enterocolitis Christoph Bührer (Germany)

11:10 – 11:25 Colonisation with gram-negative bacteria (GNB) in infants in a tertiary neonatal unit C. Kortsalioudaki; M. Sellwood; G. Kendall; B. Shuttleworth; N. Shetty; C.J. Tann; P. Wilson (United Kingdom)

11:25 – 11:40 Antimicrobial activity of copper in reducing enviromental burden in a neonatal intensive care unit (NICU) C. Petropoulou; E. Kouskouni; P. Efstathiou; Helen Bouza; Z. Manolidou; K. Karageorgou; A. Efstathiou; M. Logothetis (Greece)

11:40 – 11:55 The antisecretory factor in relation to preterm birth and inflammatory response A. Gustafsson; E. Henckel; E. Johansson; M. Oshalim; S. Lange; A. Olin; P. Brodin; K. Bohlin (Sweden)

11:55 – 12:10 Can endocan predict late neonatal sepsis? M. Buyuktiryaki; N. Okur; C. Tayman; U. Serkant; U. Cakır; H. Halil; M.Y. Oncel; SS. Oguz (Turkey)

12:10 – 12:25 Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates J.F. Hsu; S.M. Chu; M.H. Tsai (Taiwan)

12:30 – 13:30 LUNCH BREAK

2nd November, 2017

6060

12:30 – 13:30 Pulse Oximetry CCHD Screening: focus on the recent EU consensus towards implementation |DARSENA ROOM Industry Supported session - please see page 126 (Lunch will be provided) Chair: Paolo Manzoni (Italy); Manuel Sanchez-Luna (Spain)

12:30 - 13:00 Pulse Oximetry Screening for Critical Congenital Heart defects: a European Consensus Andrew Ewer (United Kingdom)

13:00 - 13:30 Practical aspects of Pulse Oximetry Screening for Critical Congenital Heart defects: any hurdles for implementation? Paolo Manzoni (Italy)

12:30 – 13:30 ROP in 2017 & Beyond - Latest Strategies Improving Patient Care |LECCE ROOM Industry Supported session - please see page 126 (Lunch will be provided) Chair: Maximo Vento Torres (Spain)

Oxygen Targeting in the Delivery Room and International Trends in the Management of ROP in the Neonatal Period Maximo Vento Torres (Spain)

Retinopathy of Prematurity: Improving Patient Safety – Preventative Strategies and Clinical Advances Ann Hellström (Sweden)

Oxidative Stress and Oxygen Monitoring: From Theory to Practice – Are We Improving Outcomes? Augusto Sola (United states)

13:30 – 14:30 Importance of Human Milk in Preterm Nutrition |VENEZIA ROOM Industry Supported session - please see page 126

13:30 - 14:00 Human Milk Oligosaccharides and Necrotizing Enterocolitis Lars Bode (United States)

14:00 - 14:30 Preterm nutrition and HM fortification Jean-Charles Picaud (France)

2nd November, 2017

6161

13:30 – 14:30 POSTER SESSION 6 (LUNG 2)|DARSENA ROOM Chairs: Roland Hentschel (Germany); Ola D. Saugstad (Norway)

13:30 - 13:35 Assessment of cardio-respiratory rates by non-invasive measurement methods in hospitalized preterm neonates L. Antognoli; P. Marchionni; L. Scalis; S. Nobile; E.P. Tomasini; V.P. Carnielli (Italy)

13:35 - 13:40 Oxygen saturation trends in late preterm infants L.Z.J. Williams; D. McNamara; J.M. Alsweiler (New Zealand)

13:40 - 13:45 Reliability of manually collected cardio-pulmonary parameters in patients’ charts P. Marchionni; L. Scalise; L. Antognoli; S. Nobile; E.P. Tomasini; V.P. Carnielli (Italy)

13:45 - 13:50 Correlation between body temperature and cerebral oxygenation in neonates during transition after birth L.P. Mileder; A. Richter; N. Baik-Schneditz; B. Schwaberger; C. Binder-Heschl; B. Urlesberger; G. Pichler (Austria)

13:50 - 13:55 Accuracy of obtaining neonatal heart rate from a novel hat mounted, green wavelength optical device C. Henry; L. Shipley; C. Ward; S. Mirahamdi; B. Hayes-Gill; J. Carpenter; D. McCartney; D. Sharkey (United Kingdom)

13:55 - 14:00 Drops in saturation and heart rate in healthy newborns: more than we think S.J.A. Balink; R.C.J. de Jonge; T.G. Goos; R.H.T. van Beek (The Netherlands)

14:00 - 14:05 Sudden unexpected collapse of newborn infants: incidence, risk factors and role of perinatal transition E. Herlenius; D. Forsberg; G. Drevin; N.J. Pejovic (Sweden)

14:05 - 14:10 Improvement of face mask ventilation technique using a live feedback system S. Bhayat; H. Gowda (United Kingdom)

14:10 - 14:15 Is APGAR score a predictor of severity in preterm infants? W.A. Gonçalves-Ferri; P.P. Paiva; A.B. Gouvea; E. Sacramento; C. Calixto; D.C. Aragon (Brazil)

2nd November, 2017

6262

14:15 - 14:20 Blood glucose level and cerebral oxygenation in neonates immediately after birth B. Urlesberger; C.H. Matterberger; N. Baik-Schneditz; B. Schwaberger; G.M. Schmölzer; L. Mileder; G. Pichler (Austria)

14:20 - 14:25 A neonatal resuscitation algorithm for mid-to-low resource settings in medecins sans frontieres’ programs L. Umphrey 1; M. Blennow 2; M. Breindahl 2; A. Brown 3; O.D. Saugstad 4; M. Thio Lluch 3; D. Trevisanuto 5; C.C. Roehr 6 (1. France; 2. Sweden; 3. Australia; 4. Norway; 5. Italy; 6. United Kingdom)

14:25 - 14:30 Reliability and accuracy of pulse oxymetry to determine SAO2 and PAO2 in preterm infants D. Wackernagel; M. Blennow; A. Hellström (Sweden)

13:30 – 14:30 POSTER SESSION 7 (LUNG 3) |ROMA ROOM Chairs: Daniel Klotz (Germany); Luc Zimmermann (The Netherlands)

13:30 - 13:35 Evaluation of oxidative stress in neonates M. Matyas; M. Hăsmăsanu; D. Leucuta; L. Blaga; G. Zaharie (Romania)

13:35 - 13:40 Simplified Australian and New Zealand neonatal network (ANZNN) shift test accurately predicts rightward shift of the SPO2-PIO2 curve in an extremely preterm infant population Y.J. Choi; B. Stoecklin; M.A. Hakeem; P. Woods; J.J. Pillow (Australia)

13:40 - 13:45 Normalisation of pulmonary gas exchange capacity in very preterm infants following initial hospital discharge defined by shift of the SPO2-PIO2 curve Y.J. Choi; B. Stoecklin; J.J. Pillow (Australia)

13:45 - 13:50 Measuring oxygen diffusion at 36 weeks’ PMA in preterm infants: analysis of the SATO2/FIO2 ratio and its correlation with early respiratory patterns of disease S. Nobile; P. Marchionni; F. Porcarelli; A. Boria; V.P. Carnielli (Italy)

13:50 - 13:55 Macrolide therapy and increased patent ductus arteriosus treatment in ureaplasma-positive premature infants S. Kim; E. Jung; H. Kim; W. Sun Song; J. Hye Hwang; C. Young Kim; B.S. Lee; E. Ai-Rhan Kim; K.S. Kim (Korea)

2nd November, 2017

6363

13:55 - 14:00 Octreotide for chylothorax? A systematic approach to answering the question G. Zuanetti; G. Cavallaro; G. Raffaeli; M. Colnaghi; F. Ciralli; I. Amodeo; S. Gulden; E. Leva; L. Pugni; F. Mosca (Italy)

14:00 - 14:05 Prevention of hypocapnia with inhalative CO2 in neonates with hypoxic-ischemic encephalopathy-the henric study E. Szakmar 1; K. Kovacs 1; U. Meder 1; C.S. Andorka 1; K. Kaila 2; M. Szabo 1; A. Jermendy 1 (1. Hungary; 2. Finland)

14:05 - 14:10 In vitro analyses of gastric aspirates from preterm neonates after corticosteroid therapy V. Milov; D. Manoylov; A. Jordanova; A. Tsanova; V. Stoyanova; E. Stoimenova; D. Petrova; E. Hristova; Z. Lalchev (Bulgaria)

14:10 - 14:15 The SAFE protocol: a sonographic algorithm for liFe-threatening emergencies in the NICU N. Yousef; S. Shankar-Aguilera; D. De Luca (France)

14:15 - 14:20 Changes in expression of connective tissue growth factor (CTGF) in newborn rat lungs after ventilation A. Remesal; E. Gutierrez; L. San Feliciano; M. Mateos; A. García-Sánchez; M. Isidoro-García; D. Ludeña (Spain)

14:20 - 14:25 Oxygen saturation targeting using automated versus manual control of inspired oxygen in preterm infants: a systematic review and meta-analysis S. Mitra; B. Singh; W. El-Naggar; D. McMillan (Canada)

2nd November, 2017

6464

13:30 – 14:30 POSTER SESSION 8 |FIRENZE ROOM (CARDIOLOGY + MICRO CIRCULATION 2) Chairs: Mayka Bravo (Spain); Colm Breatnach (Ireland)

13:30 - 13:35 Resistence index (RI) of arteria cerebri anterior and cerebral oxygenation in preterm infants N. Baik-Schneditz; B. Urlesberger; B. Schwaberger; L. Mileder; N. Höller; G. Pichler (Austria)

13:35 - 13:40 Influence of global hypoxia and remote ischemic postconditioning on natriuretic peptide expression in newborn piglet heart chambers H. Kierkegaard; K.J. Kyng; B.S. Kousholt; S. Kerrn-Jespersen; K. Bennedsgaard; M. Kjeldsen; N. Gregersen; R.K. Olsen; T.B. Henriksen (Denmark)

13:40 - 13:45 Arginase up-regulation and eNOS uncoupling contribute to impaired endothelium-dependent vasodilation in a rat model of intrauterine growth restriction I. Grandvuillemin 1; C. Buffat 1; F. Boubred1; E. Lamy 1; J. Fromonot 1; A.C. Peyter 2; U. Simeoni 2; C. Yzydorczyk 2 (1. France; 2. Switzerland)

13:45 - 13:50 Low serum cortisol levels in asphyxiated infants with haemodynamic instability K. Kovacs; E. Szakmar; U. Meder; A. Cseko; M. Szabo; A. Jermendy (Hungary)

13:50 - 13:55 Changes of NT-PROBNP concentration wthin the first week of life in preterm newborns with birth body mass ≤ 1200g T. Talar; E. Gulczyńska; B. Cyranowicz; J. Moll (Poland)

13:55 - 14:00 Avoiding hypotension in preterm neonates (AHIP) – a single-center randomised controlled study G. Pichler; N. Höller; N. Baik-Schneditz; B. Schwaberger; L. Mileder; A. Avian; J. Pansy; B. Urlesberger (Austria)

14:00 - 14:05 Two year outcomes in extremely preterm infants with differing blood pressure management P. Chisholm; A. Sinha; J. Tan; S. Kempley; A. Matthew; J. Banerjee; J. Morris; N. Aladangady (United Kingdom)

2nd November, 2017

6565

14:05 - 14:10 Experience of infants born with a diagnosis of down syndrome in a tertiary neonatal centre: burden of disease and length of hospital stay T. Martin 1; A. Smith 1; C.R. Breatnach 1; E. Kent 1; I. Shanahan 1; M. Boyle 1; P.T. Levy 2; O. Franklin 1; A. EL-Khuffash 1 (1. Ireland; 2. United States)

14:10 - 14:15 Influence of type of congenital heart defects on epithelial lining fluid composition in infants undergoing cardiac surgery with cardiopulmonary-bypass M. Simonato; A. Baritussio; M. Salvagno; L. Vedovelli; G. Falasco; V.P. Carnielli; M. Padalino; P. Cogo (Italy)

14:15 - 14:20 A randomised crossover study comparing speed of heart rate display in newborns using electrocardiogram plus pulse oximeter versus pulse oximeter alone M. Murphy 1; L. De Angelis 2; E. Fitzgerald 1; L. McCarthy 1; C. O’Donnell 1 (1. Ireland; 2. Italy)

14:20 - 14:25 Computer analysis of infant heart sound recordings D. Wertheim; K. Naicker; J. Chang; M. Chang; M. Rigby; A. Kumar; R. Kayyali (United Kingdom)

14:25 - 14:30 Simulation hemodynamics Neocardiosim™ - perinatal and critical congenital heart scenarios W. Blaz; A. Eberhardt; A. Szadkowska; B. Chmielarz; B. Zych; B. Andraka (Poland)

13:30 – 14:30 POSTER SESSION 9 (INFECTIOUS DISEASE) |SORRENTO ROOM Chairs: Sam Oddie (United Kingdom); Chirstoph Bührer (Germany)

13:30 - 13:35 Maternal contribution to neonatal microbiota R.S. Procianoy 1; L.F. Roesch 1; A.L. Corso 1; V. Mai 2 ; R.C. Silveira 1 (1. Brazil; 2. United States)

13:35 - 13:40 Human breast milk supplies newborn infants with high amounts of S100-alarmins protecting from sepsis S. Pirr; M. Richter; J. Pagel; C. Härtel; B. Fehlhaber; J. Roth; T. Vogl; D. Viemann (Germany)

2nd November, 2017

6666

13:40 - 13:45 Variability in immunological response to oropharyngeal colostrum administration in preterm newborn based on sex E. Martin-Alvarez; L. Serrano-Lopez; J. Díaz-Castro; M. Peña-Caballero; M.B. Sánchez-Martínez; F. Martín-Peregrina; J.J. Ochoa; J.A. Hurtado-Suazo (Spain)

13:45 - 13:50 Neonatal intestinal colonization with ESBL-producing enterobacteriaceae – a 5 year follow up study V. Nordberg; K. Jonsson; C.G. Giske; A. Iversen; O. Aspevall; B. Jonsson; A. Camporeale; M. Norman; L. Navér (Sweden)

13:50 - 13:55 Characterization of resistance plasmids during a nosocomial epe-outbreak using optical DNA mapping S. Kumar Bikkarolla; V. Nordberg; M. Humaun Kabir; V. Müller; T. Ambjörnsson; C.G. Giske; L. Navér; L. Sandegren; F. Westerlund (Sweden)

13:55 - 14:00 Long term follow up of hearing disorders in patients with congenital cytomegalovirus infection A. Giannattasio; R. Alfani; P. Di Costanzo; D. Bruzzese; L. Bucci; M.R. Augurio; L. Capasso; F. Raimondi (Italy)

14:00 - 14:05 Outcomes of congenital cytomegalovirus disease following maternal primary and non-primary infection A. Giannattasio; S. Cenni; D. De Martino; T. Ferrara; L. Capasso; E. Capone; P. Di Costanzo; F. Raimondi (Italy)

14:05 - 14:10 The frequency of mannan-binding lectin (MBL) deficiency in premature babies and the effect on long term morbidities H. Ozkan; P.Dogan; N. Koksal; B. Oral; O. Bagcı; I. Varal (Turkey)

14:10 - 14:15 The early onset risk calculator to evaluate early-onset sepsis in infants born ≥35 weeks gestation ≥35 weeks’ gestation S. Stokes; R. Cuzzilla; A.J. Daley; S.E. Jacobs (Australia)

14:15 - 14:20 HeRO as a tool for predicting morbidity and mortality in preterm infants with late onset sepsis admitted to tertiary level neonatal unit E. Hoyle; C. Dewhurst (United Kingdom)

14:20 - 14:25 S100-alarmin-induced innate immune programming protects newborn infants from sepsis S. Pirr; T. Ulas; B. Fehlhaber; M.S. Bickes; T.G. Loof; T. Vogl; L. Mellinger; A.S. Heinemann; J. Burgmann; J. Schöning; S. Schreek; S. Pfeifer; F. Reuner; L. Völlger; M. Stanulla; M. von Köckritz-Blickwede; S. Glander; K. Barczyk-Kahlert; C.S. von Kaisenberg; J. Friesenhagen; L. Fischer-Riepe; S. Zenker; J.L. Schultze; J. Roth; D. Viemann (Germany)

2nd November, 2017

6767

13:30 – 14:30 POSTER SESSION 10 (NEUROLOGY 1) |LECCE ROOM Chairs: Luca Ramenghi (Italy); Sandra Horsch (Germany)

13:30 - 13:35 Longitudinal study of brain tissue volumes in preterm infants and their relation with neonatal risk factors and neurodevelopmental outcome L. Gui; F. Lazeyras; P.S. Hüppi; C. Borradori (Switzerland)

13:35 - 13:40 A new evaluation index for left-right unequal ventriculomegaly in very low birth weight infants: association with walking disabilities at 1.6 years of corrected age T. Ikuta; M. Mizobuchi; Y. Katayama; S. Yoshimoto; T. Ioroi; M. Yamane; T. Morisawa; A. Takatera; M. Ueda; A. Shibata; K. Maeyama; K. Fujioka; N. Nishimura; K. Iijima; I. Morioka (Japan)

13:40 - 13:45 Differences between intrauterine and extrauterine growth of the cerebellum A.I. Toma; I. Cuzino; A. Cozinov; R.G. Olteanu (Romania)

13:45 - 13:50 Prognostic value of early conventional proton magnetic resonance spectroscopy in cooled asphyxiated newborns H. Barta; A. Jermendy; M. Kolossvary; L. R. Kozak; A. Lakatos; U. Meder; G. Rudas; M. Szabo (Hungary)

13:50 - 13:55 Autism spectrum disorder in ex-preterms is preceded by altered neonatal brain volumes in multimodal association areas and altered patterns of brain asymmetry N. Padilla; E. Eklöf; G. Mårtensson; S. Bölte; H. Lagercrantz; U. Åden (Sweden)

13:55 - 14:00 Characterisation of the neonatal corpus callosum (CC) using MRI and cranial ultrasound (US) M. Mills; V. Pelling; L. Harris; J. Smith; H. Rabe; J.R. Fernandez Alvarez (United Kingdom)

14:00 - 14:05 Brain growth and relationships with illnesses and neurodevelopment outcome R. D’Ascenzo 1; B. Pieroni 1; A. Pianesi 1; A. Peretti 1 ; L. Regnicolo 1; G. Polonara 1; M.J.N.L. Benders 2; V.P. Carnielli 1 (1. Italy; 2. The Netherlands)

14:05 - 14:10 Predicting the development of cerebral palsy: a comparison between DTI-MRI and early hand assessment in infants with unilateral perinatal brain injury B. van Gasselt; N. Wagenaar; C. Verhage; M.J.N.L. Benders; F. Groenendaal; L. de Vries; N. van der Aa (The Netherlands)

2nd November, 2017

6868

14:10 - 14:15 Low-grade IVH and low-grade CBH: which influence on Griffiths score at 2 years of age? A. Parodi; M. Malova; S. Uccella; L. Boeri; E. De Grandis; A. Sannia; M. Severino; G. Morana; D. Tortora; A. Rossi; E. Veneselli; L.A. Ramenghi (Italy)

14:15 - 14:20 Long-term effects of neonatal complications on brain growth at 10 years of age in children born extremely preterm N. Padilla; C. Jimenez-Espinoza; H. Kvanta; U. Adén (Sweden)

14:20 - 14:25 Music effects in preterm infants’ brain: a structural neuroimaging investigation J.R. Alves Sá de Almeida; N. Kunz; L. Lordier; A. Darque; F. Lazeyras; P. Hüppi (Switzerland)

14:25 - 14:30 Noise in the NICU Unit: Introducing a noise reduction policy to Southmead Neonatal Intensive Care Unit: primary results from a 3 month service improvement project J. Hawksley; E. Helliwell; F. Emery (United Kingdom)

14:30 - 16:30 PARALLEL SESSION 18 (PULMONOLOGY 2) VENTILATION SUPPORT |DARSENA ROOM Chairs: Manuel Sanchez-Luna (Spain); Christian Poets (Germany)

14:30 – 15:00 Update on NIVM Corrado Moretti (Italy)

15:00 – 15:30 Closed loop FiO2 controle Nelson Claure (United States)

15:30 – 16:00 Automated oxygen control in the NICU Peter Dargaville (Australia)

16:00 – 16:15 Volume controlled or volume guarantee ventilation in preterm infants: a randomised controlled trial H. Chitty; W. Tin; D. Stocken; R. Agbeko; J Vormoor; S. Sinha (United Kingdom)

16:15 – 16:30 Volume-targeted versus pressure-limited ventilation in neonates - a cochrane systematic review and meta-analysis updated 2017 C. Klingenberg 1; K.I. Wheeler 2; N. McCallion 3; C.J. Morley 4; P.G. Davis 2 (1. Norway; 2. Australia; 3. Irelands; 4. United Kingdom)

2nd November, 2017

6969

14:30 - 16:30 PARALLEL SESSION 19 (NUTRITION 3) NUTRITION OF THE ELBWI: IMPROVING NUTRITIONAL CARE |VENEZIA ROOM Chairs: Alexandre Lapillonne (France); Mark Jonhson (United Kingdom)

14:30 - 14:50 Electrolyte needs and balance in the EBLW, how to avoid disturbances Silvia Iacobelli (France)

14:50 - 15:10 How to integrate enteral intake when administering parenteral nutrition in ELBW infants? Sissel Moltu (Norway)

15:10 - 15:30 Feeding strategies in neonates: the SIFT feeding trial Jon Dorling (United Kingdom)

15:30 - 15:45 The Norwegian preterm infant gut (PINGU) study: a metagenomic approach to gut microbiota composition and resistome in infants supplemented with probiotics E. Esaiassen; E. Hjerde; P. Cavanagh; T. Pedersen; J. Andresen; S. Rettedal; R. Støen; B. Nakstad; N.P. Willassen; C. Klingenberg (Norway)

15:45 - 16:00 Assessment of enzymotherapy efficacy in case of lactase insufficiency in preterm infants O. Vlasova; L. Koliubakina (Ukraine)

16:00 - 16:15 Detrimental mucosal effect of ibuprofen in the immature human intestine E. Tremblay; E. Ferretti; M.P. Thibault; D. Grynspan; K.M. Burghardt; M. Bettolli; C. Babakissa; E. Levy; J.F. Beaulieu (Canada)

16:15 - 16:30 Patched skin bilirubin assay to monitor extremely preterm neonates undergoing phototherapy D. De Luca; V. Dell’Orto (France)

2nd November, 2017

7070

14:30 - 16:30 PARALLEL SESSION 20 |ROMA ROOM NEONATAL ARDS: RECOGNISING THE EXISTENCE OF A SYNDROME ACROSS THE AGE Scientific session endorsed by ESPR and ESPNIC Chairs: Luc Zimmerman (The Netherlands); Virgilio P. Carnielli (Italy)

14:30 – 15:00 Physiopathology of ARDS across the ages Peter Rimensberger (Switzerland)

15:00 – 15:30 Biology of ARDS across the ages Daniele De Luca (France)

15:30 – 16:00 The Montreux definition of neonatal ARDS Martin K. Kneyber (The Netherlands)

16:00 – 16:20 The fate of neonates with ARDS: the second phase of neonatal ARDS project Anton van Kaam (The Netherlands)

14:30 - 16:30 PARALLEL SESSION 21 (EFCNI 4) |FIRENZE ROOM DIGITAL PATIENT CARE – THE NEW DIMENSION? Chairs: Silke Mader (Germany); Agnes Van Den Hoogen (Netherland); 14:30 - 14:50 Digital information – support or challenge? Silke Mader (Germany)

14:50 - 15:10 Web camera use in the neonatal intensive care unit: impact on nursing workflow Gillian Kennedy (United Kingdom)

15:10 - 15:30 Using technology to continue Family Centred Care post discharge Alison McNulty (Ireland)

15:30 - 15:45 Development and implementation of an integrated family delivered neonatal care model including a parent support mobile app J. Banerjee; A. Aloysius; K. Platonos; A. Deierl (United Kingdom)

15:45 - 16:00 Tablet based parental feedback in neonatal transport P. Bhat; C. Garland; A. Frame; G. Bullimore; L. Watts; C. Leach; C. Lawn (United Kingdom)

2nd November, 2017

7171

16:00 - 16:15 Development and evaluation of e learning education to support breastfeeding in NICU W. Higman; L. Wallace; A. Turner; S. Law; K. Blake (United Kingdom)

14:30 - 16:30 PARALLEL SESSION 22 |SORRENTO ROOM OXYGENATION IN THE NEWBORN AND INFANT PERIOD Chairs: Ola D. Saugstad (Norway); Robin Steinhorn (United States)

14:30 – 15:00 Embryonic and fetal oxygenation and oxygen control Satyan Lakshminrusimha (United States)

15:00 – 15:30 Oxygenation in the transition from fetal to newborn life Maximo Vento Torres (Spain)

15:30 – 16:00 Oxygen targets beyond the delivery room Ola D. Saugstad (Norway)

16:00 – 16:30 Oxygenation and growth in BPD Robin Steinhorn (United States)

14:30 - 16:30 PARALLEL SESSION 23 (BRAIN) BIOMARKERS IN TERM NEONATAL ENCEPHALOPATHY |LECCE ROOM Chairs: Deirdre Murray (Ireland); Bobbi Fleiss (France)

14:30 - 14:50 Biomarkers in neonatal brak injury: can a systems biology approach lead us to the Holy Grail? Deidre Murray (Ireland)

14:50 - 15:10 Metabolic phenotyping to understand neonatal encephalopathy Bobbi Fleiss (France)

15:10 - 15:25 Depression during pregnancy and DNA methylation changes in cord blood A.C. Viuff 1; G. Sharp 2.; D. Raj 2; K.J. Kyng 1; L.H. Pedersen 1; T.B. Henriksen 1; C.L. Relton 2 (1. Denmark; 2. United Kingdom)

2nd November, 2017

7272

15:25 - 15:40 A novel cerebral ultrasound scoring system is associated with neurological outcome in neonates with hypoxic-ischemic encephalopathy K. Annink; F. Groenendaal; M. Lequin; D. Vijlbrief; L. de Vries; M.J.N.L. Benders; J. Dudink (The Netherlands)

15:40 - 15:55 Placental histology findings as possible risk factors for MRI-detected brain lesions in VLBW infants A. Parodi; M. Re; D. Brignole; MP Brisigotti; M.G. Calevo; M. Malova; A. Sannia; M. Severino; G. Morana; D. Tortora; A. Rossi; E. Fulcheri; L.A. Ramenghi (Italy)

15:55 - 16:10 MicroRNA panel validation in hypoxic schemic encephalopathy M.P. O’Sullivan 1; A.M. Looney 1; G. Moloney 1; B. Hallberg 2; G. Clarke 1; G.B. Boylan 1; D.M. Murray 1 (1. Ireland; 2. Sweden)

16:10 - 16:25 Phospholipid synthesis related biomarkers in plasma from newborns with hypoxic-ischemic encephalopathy M. Vento Torres; J. Kuligowski; Á. Sánchez-Illana; J.D. Piñeiro-Ramos; A. Núñez-Ramiro; M. Cernada; A. Parra; E. Valverde; D. Blanco; M.T. Moral-Pumarega; F. Cabañas; H. Boix; A. Pavon; M. Chaffanel; I. Benavente-Fernández; I. Tofe; B. Loureir (Spain)


17:00 - 18:00 PLENARY SESSION 5 |DARSENA ROOM WILL BIG DATA CHANGE THE FUTURE? Chairs: Manon Benders (The Netherlands); Pierre Gressens (France)

17:00 – 17:30 Using big data for cognitive computing approaches to personalised medicine for neonatal care Carolyn McGregor (Canada)

17:30 – 18:00 Big data and genetic encephalopathic epilepsy Michael Johnson (United Kingdom)

2nd November, 2017

7373

18:00 - 19:30 Enhancing the Success of Respiratory Management in nRDS|VENEZIA ROOM Industry Supported session - please see page 126 Chair: Anton Van Kaam (The Netherlands) 18:00 - 18:30 BPD: from trials to clinical practice Wolfgang Gopel (Germany) 18:30 - 19:00 Less Invasive Surfactant Administration (LISA), a new chapter in neonatal management Peter Dargaville (Australia) 19:00 - 19:30 Success of intervention: the importance of Training with LISA Maximo Vento Torres (Spain)

2nd November, 2017

7474

KI17

451

Up to 35% Special Congress Discount

Karger – Medical and Scientific PublishersCH–4009 Basel, [email protected], f: +41 61 306 12 34www.karger.com

Special offers include the digital version.Prices subject to change, VAT not included.EUR price for eurozone countries, USD price for USA and Latin America only

Medical and Scientific Publishers

Editor: Z. Hochberg (Haifa)List price: CHF 53.00 / EUR 50.00 / USD 62.00Special offer: CHF 42.00 / EUR 40.00 / USD 50.00ISBN 978–3–318–05917–5

Order at: www.karger.com/pape and use the promotional code: DPAPE17

Editors: Koletzko, B. (Munich); Poindexter, B. (Indianapolis, Ind.); Uauy, R. (Santiago de Chile)List price: CHF 148.00 / EUR 138.00 / USD 174.00Special offer: CHF 96.00 / EUR 90.00 / USD 113.00 ISBN 978–3–318–02640–5 (hard cover)

Order at: www.karger.com/wrund and use the promotional code: DJENS17

Practical

Algorithms in

Pediatric

Endocrinology

Practical Algorithms in PediatricsSeries Editor: Z. Hochberg

Editor

Z. Hochberg

3rd, revised edition

World Review of Nutrition and Dietetics

Editor: B. Koletzko

Vol. 110

Nutritional Care of Preterm InfantsScientific Basis and Practical Guidelines

Editors

B. KoletzkoB. PoindexterR. Uauy

dexterR. Uauy

Editors: V.S. Blanchette (Toronto, Ont.); L.R. Brandão (Toronto, Ont.); V.R. Breakey (Hamilton, Ont.); S. Revel-Vilk (Jerusalem)List price: CHF 127.00 / EUR 119.00 / USD 149.00Special offer: CHF 83.00 /EUR 77.00 / USD 97.00 ISBN 978–3–318–03026–6

Order at: www.karger.com/sickkids and use the promotional code: DJENS17

Editors: Mimouni, F.B. (Tel Aviv); van den Anker, J.N. (Washington, D.C./Basel/Rotterdam)List price: CHF 126.00 / EUR 118.00 / USD 148.00Special offer: CHF 82.00 / EUR 77.00 / USD 96.00ISBN 978–3–318–02735–8 (hard cover)

Order at: www.karger.com/pamedand use the promotional code: DJENS17

SickKids Handbook of Pediatric Thrombosis and HemostasisEditorsVictor S. BlanchetteLeonardo R. BrandãoVicky R. BreakeyShoshana Revel-Vilk 2nd, revised and extended edition

Pediatric and Adolescent Medicine

Editor: W. Kiess

Vol. 18

Neonatal Pharmacology and Nutrition UpdateEditors

F.B. MimouniJ.N. van den AnkerBMA Medical Book Awards 2017 ‘highly commended’ in Paediatrics

7575

08:00 – 09:00 POSTER WALK | GROUND FLOOR Neonatal Hematology and Bilirubin Chairs: Elsa Kermorvant (France)

ID 020 PROLONGED JAUNDICE SCREENING: FBC OR NO FBC! N. Storring; R. Doherty; V. Ponnusamy (United Kingdom)

ID 042 LABORATORY FINDINGS; DIAGNOSIS AND TREATMENT OF THE NEWBORN ADMITTED DUE TO HEMATEMESIS OR BLOODY STOOL IN 11 YEARS I. Hokuto; Y. Ito; T. Mori; S. Komachi (Japan)

ID 154 AN UNUSUAL CAUSE OF CYANOSIS: SEVERE METHEMOGLOBINEMIA IN A PRETERM INFANT WITH SEPSIS F. Bakar; M. Berber (Turkey)

ID 171 THE INFLUENCE OF INTRAUTERINE TRANSFUSION ON THE OUTCOMES OF NEWBORNS WITH SEVERE HEMOLYTIC DISEASE E. Balashova; O. Bystrykh; T. Fedorova; O. Ionov; A. Kirtbaya; D. Sharafutdinova; V. Zubkov; D. Degtyarev; O. Horoshkeeva; N. Fedorova; N. Tetruashvili; K. Kostukov; N. Karetnikova (Russia)

ID 491 IV FLUID SUPPLEMENTATION IN SEVERE NEONATAL HYPERBILIRUBINEMIA: YES or NO M.T. Saleh; S. El Doory; S. Saleh; M.E.l. Halik (Saudi Arabia)

ID 543 RIGHT SUBCLAVIAN ARTERY THROMBOSIS. A CASE REPORT G. Uclés; T. Fuentes; R. Villarino; M. González-Valcárcel; A. Martínez (Spain)

ID 555 RISK FACTORS FOR PORTAL VENOUS THROMBOSIS IN NEWBORNS: A RETROSPECTIVE STUDY A. Zanin; M. Colella; C. Farnoux; S. Soudee; M. Leport; R. Stern; O. Bequet; M. Alison; V. Biran; O. Baud (France)

ID 611 RELATIONSHIP BETWEEN LEUKOCYTES AND PLATELETS AND PREMATURE RETINOPATHY V. Filip; C. Lazar (Romania)

ID 692 CONGENITAL HEPATOCELLULAR CARCINOMA ASSOCIATED WITH NEONATAL HEMOCHROMATOSIS P. Francalanci; C. Grimaldi; M.C. Saffioti; R. Angelico; R. Boldrini; F. Callea (Italy)

ID 740 OUTCOME OF BABIES WITH SERUM BILIRUBIN LEVEL OF GREATER THAN 400mmol/L R. Prasad; S.V. Rasiah (United Kingdom)

3rd November, 2017

7676

Neurology Chairs: Nicola Roberston (United Kingdom)

ID 003 PRETERM BIRTH AND THE TIMING OF PUBERTY E. James; C. Wood; H. Nair; T. Williams (United Kigdom)

ID 036 PREVENTION OF CEREBRAL PALSY: FEASIBILITY OF UMBILICAL CORD BLOOD STEM CELLS AND UMBILICAL CORD MESENCHYMAL STROMAL CELLS H. Shintaku; M. Nabetani; T. Hamazaki; S. Kusuda; M. Tamura; S. Watabe; M. Hayakawa; Y. Sato; M. Tsuji; A. Taguchi; H. Ichiba; O. Akira; R. Mori; A. Taki; T. Mukai; T. Nagamura-Inoue (Japan)

ID 039 NO GENDER-RELATED DIFFERENCES IN FETAL CORPUS CALLOSUM THICKNESS: IN-UTERO MRI STUDY R. Bercovitz; R. Achiron; C. Hoffmann; A. Achiron (Israel)

ID 040 NEUROMOTOR PROFILE OF HIGH-RISK INFANTS AT TERM OR NEAR TERM I. Ereno; W.Y. Teh (Singapore)

ID 043 THE PREDICTIVE VALUE OF SEVERE BRONCHOPULMONARY DYSPLASIA FOR NEUROLOGICAL IMPAIRMENT IN 2-YEARS-OLD VERY PRETERM INFANTS IS HIGHER WHEN DIAGNOSED AT 40 THAN AT 36 WEEKS’ POSTMENSTRUAL WEEKS A.M. Malavolti 1; D. Bassler 1; R. Arlettaz-Mieth 1; G. Faldella 2; B. Latal 1 G. Natalucci 1 (1. Switzerland; 2. Italy)

ID 055 PSYCHOSOCIAL OUTCOME OF INFANTS WITH CONGENITAL MALFORMATIONS AFTER POSTNATAL SURGICAL REPAIR N. Doberschuetz; A. Allendorf; R. Dewitz; B. Wittekindt; U. Rolle; R. Schloesser (Germany)

ID 060 THERAPEUTIC HYPOTHERMIA AND HEARING IMPAIRMENT: INCIDENCE AND ASSOCIATED FACTORS M. PFitzgerald; G. Norman; C. Mc Garvey; A. Reynolds; M. King; B. Hayes (Ireland)

ID 070 PRETERM INFANTS 33-35 WEEKS’ GESTATION WITH SEVERE HYPOXIC- ISCHEMIC ENCEPHALOPATHY TREATED WITH HYPOTHERMIA DO NOT PRESENT MORE ORGAN DYSFUNCTION THAN TERM NEWBORNS M. Alsina; A. Martin-Ancel; M. Leon; G . Arca; E. Perez; A. García-Alix (Spain)

ID 080 IMPACT OF ENVIRONMENTAL FACTORS ON MOTOR AND COGNITIVE PERFORMANCE OF LATE PRETERM INFANTS. M.M. Santos; C. Corsi; A.C. Campos; N.A.C.F. Rocha (Brazil)

3rd November, 2017

7777

ID 094 NEONATAL ADMISSIONS FOR HYPOXIC ISCHEMIC ENCEPHALOPATHY: WEEKEND AND OUT OF HOURS EFFECT F. Ceroni; M. Parmar; S. Narayanan; N. Merchant (United Kingdom)

ID 100 WHICH PARTS OF GROWTH SHOULD BE MONITORED FOR NEURODEVELOPMENT OF PRETERM INFANTS I.G. Song; H.R. Yoon; Y.M. Yoon; J.S. Shin; S.H. Shin; E.K. Kim; H.S. Kim (Korea)

ID 103 TARGETED METHYLATION TESTING OF A 154 PATIENT’S COHORT WITH CLINICAL FEATURES OF IMPRINTING DISORDERS: EVIDENCE OF MULTILOCUS METHYLATION DEFECTS A. Touati; S. Nouri; F. Chioukh; M. Haddaji Mastouri; N. Ben Salah; S. Trabelsi; S. Hammami; S. Mougou; M. Gribaa; N. Guedich; H. Seboui; A. Nouri; K. Monastiri; A. Saad; D. H’mida-Ben Brahim (Tunisia)

ID 105 STEINERT MYOTONIC DYSTROPHY (DM1): WHAT ABOUT CARDIAC INVOLVEMENT? H. Hadj Abdallah; Y. Halleb; N. Ben Salah; F.Z. Chioukh; K. Ben Ameur; F. Kallel; L. Ben Slamia; S. Hidar; M. Bellallah; S. Nouri; S. Ben Amor; A. Hsin; M. Grira; H. Ajmi; S. Zardi; S. Abroug; N. Mahdhaoui; H. Sboui; S. Ben Ammou; K. Mestiri; A. Saad; D. H’mida (Tunisia)

ID 150 HEAD MIDLINE POSITION FOR THE PREVENTION OF GERMINAL MATRIX-INTRAVENTRICULAR HEMORRHAGE IN PRETERM INFANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS O. Romantsik 1; M.G. Calevo 2; M. Bruschettini 1 (1. Sweden; 2. Italy)

ID 157 MOTOR FUNCTION AT EARLY SHCOOL-AGE IN EXTREMELY PRETERM BORN CHILDREN WITHOUT MAJOR IMPAIRMETNS IN RELATION TO PERINATAL FACTORS: NATIONAL POPULATION-BASED STUDY (EXPRESS) J. Bolk; A. Farooqi; M. Hafström; U. Åden; F. Serenius (Sweden)

ID 169 EARLY RISK FACTORS FOR ADVERSE NEUROMOTOR DEVELOPMENT IN TERM INFANTS AFTER MODERATE HYPOXIC-ISCHAEMIC ENCEPHALOPATHY A. Matic (Serbia)

ID 175 THERAPEUTIC HYPOTHERMIA IN BABIES WITH HYPOXIC-ISCHAEMIC ENCEPHALOPATHY: EVIDENCE AND CLINICAL PRACTICE K. Ghazal; A. Panickar; S. Garg (United Kingdom)

ID 196 SECRETONEURIN SERUM CONCENTRATIONS CORRELATE WITH ABNORMAL NEURODEVELOPMENTAL OUTCOME AT THE AGE OF 24 MONTHS IN TERM NEONATES WITH ASPHYXIA K. Wechselberger; A. Schmid; M. Höck; A. Posod; M. Urbanek (Austria)

ID 206 SCREENING C677T POLYMORPHISM IN METHYLENETETRAHYDROFOLATE REDUCTASE GENE IN TAIWAN POPULATION C.Y. Chuang; C.C. Hung; Y.N. Su; P.N. Tsao (Taiwan)

3rd November, 2017

7878

ID 230 COGNITIVE OUTCOME IN ADULTS BORN WITH VERY LOW BIRTH WEIGHT OR SMALL FOR GESTATIONAL AGE S. Weider; A.M.W. Lærum; K. AI Evensen; S. Lydersen; A.M. Brubakk; M.S. Indredavik (Norway)

ID 281 REACHING SKILLS OF INFANTS BORN VERY PRETERM PREDICT NEURODEVELOPMENT AT 3 YEARS Y. Fredriksson Kaul; K. Rosander; H. Grönqvist; K. Strand Brodd; L. Hellström-Westas; C. von Hofsten (Sweden)

ID 315 UNDERSTANDING ADHD AND ASD IN VERY PRETERM CHILDREN FROM A SENSORY PROCESSING PERSPECTIVE: A CONTROLLED NEUROPSYCHOLOGICAL STUDY T. Bröring; K. Oostrom; M. Königs; E. van Dijk-Lokkart; H. Lafeber; A. Brugman; J. Oosterlaan (The Netherlands)

ID 319 SOCIAL-EMOTIONAL DEVELOPMENT IN VERY PRETERM INFANTS DURING EARLY INFANCY P.H. Gray; D.M. Edwards; M. Pritchard (Australia)

ID 323 NEUROPROTECTIVE INTERVENTION AFTER HYPOXIA-ISCHEMIA MAY CHANGE INTRACEREBRAL METABOLIC MEASURES IN A NEWBORN PIGLET MODEL T.C. Andelius; N. Bøgh; M.V. Pedersen; C. Omann; V.E. Hjortdal; M. Pedersen; T.B. Henriksen; K.J. Kyng (Denmark)

ID 353 BRAIN VOLUMES BY CEREBRAL MRI AND CORRELATIONS WITH PSYCHIATRIC SYMPTOMS IN LOW BIRTHWEIGHT ADULTS A.M.W. Lærum; L.M. Rimol; S.K. Reitan; A. Brubakk; K.A.I. Evensen; K.J. Bjuland; S. Lydersen; J. Skranes; M.S. Indredavik (Norway)

ID 371 POSTURE AND MOBILITY INFLUENCE ON ATTENTION ABILITIES IN HEALTHY 7 YEARS OLD CHILDREN H. Ceyte; J. Rosenbaum; S. Caudron; J-M. Hascoet (France)

ID 424 SURGICAL DECISION MANAGEMENT IN CHIARI TYPE 2 MALFORMATION: SINGLE CENTER EXPERIENCE S. Alkan Ozdemir; N. Ozdemir; A. Karadag; E. Arun Ozer (Turkey)

ID 427 EFFECTS OF NEURAL STEM CELL MEDIA ON HYPOXIC INJURY IN RAT HIPPOCAMPAL SLICE CULTURES N.M. Lee; S.A. Chae; H.J. Lee (Turkey)

ID 438 CEREBROSPINAL FLUID LACTATE IN NEW-BORN AND PRETERM INFANTS. PILOT DATA G. Uclés; D. Arjona; R. Borrego; R. Díaz; M.D. Sánchez-Redondo; A. Escobar (Spain)

3rd November, 2017

7979

ID 484 EARLY CRANIAL ULTRASOUND AND MRI AT TERM IN VERY PRETERM INFANTS: DIAGNOSIS OF BRAIN INJURY VERSUS NEURODEVELOPMENTAL OUTCOME AT 12 AND 24 MONTHS CORRECTED GESTATIONAL AGE K. Chatzidimitriou; A. Chebsey; D. Odd; M. El Brookle; M. Likeman; A. Heep (United Kingdom)

ID 485 CRANIAL ULTRASOUND AT DAY 7 AND CLINICAL MRI AT TERM IN VERY PRETERM INFANTS BORN AT LESS THAN 28 WEEKS: VENTRICULOMEGALY IS RELATED TO SUBTLE BRAIN PATHOLOGY AND UNFAVORABLE DEVELOPMENTAL OUTCOME AT 24 MONTH K. Chatzidimitriou; A Chebsey; D. Odd; M. El Brookle; M. Likeman; A. Heep (United Kingdom)

ID 502 VALIDITY OF THE KOREAN DEVELOPMENTAL SCREENING TEST FOR VERY LOW BIRTH WEIGHT INFANTS C.Y. Kim; J.H. Hwang; E. Jung; B.S. Lee; K.S. Kim; A.R. Kim (Korea)

ID 547 CYTOKINES TRAJECTORIES IN NEWBORNS WITH HYPOXIC-ISCHEMIC ENCEPHALOPATHY: THE ROLE OF HYPOTHERMIA S. Perrone 1; S. Cornacchione 1; M.D. Weiss 2; R. Candace 2; M. Longini 1; F. Proietti 1; M. Calderisi 1; G. Buonocore 1 (1. Italy; 2. United States)

ID 563 COLD-INDUCIBLE RBM3 AUGMENTS IGF2 EXPRESSION IN NEURAL STEM CELLS BY INTERACTING WITH IMP2 IN AN RNA-DEPENDENT MANNER J. Yan; X. Zhu; Z. Andrea; J. Kapfhammer; S. Wellmann (Switzerland)

ID 591 CHILDREN BORN VERY PRETERM WITH AUTISM EXPERIENCE INCREASED RISK OF PARENTING RELATIONSHIP PROBLEMS H. Haydon; M. Pritchard; L. Johnston; J. Paynter (Canada)

ID 596 STABILITY of AUTISM DIAGNOSIS IN CHILDREN BORN VERY-PRETERM FROM AGE 2 TO 4 YEARS M. Pritchard; H. Haydon; T. de Dassel; E. Beller; F. Bogossian; L. Johnston; J. Paynter; S. Russo; J.G. Scott (Canada)

ID 620 OUTBORN PRETERM INFANTS WITH POST-HAEMORRHAGIC VENTRICULAR DILATATION: ARE THEY TRANSFERRED TOO LATE? A. Parodi; M. Malova; A. Sannia; A. Cama; M. Ravegnani; C. Bellini; L.A. Ramenghi (Italy)

ID 631 GENETIC CASUSES IN NEWBORNS WITH EPILEPTIC ENCEPHALOPATHIES A. Soltirovska Salamon; D. Paro-Panjan (Slovenia)

ID 643 OUTCOME AT FIVE YEARS OLD IN A SWISS NATIONAL COHORT OF VERY PRETERM INFANTS BORN IN 2006 M.P. Pittet; M. Adams; M. Bickle-Graz; S. Grunt; I. Mürner-Lavanchy; R.E. Pfister; G. Natalucci; C. Borradori Tolsa (Switzerland)

3rd November, 2017

8080

ID 680 OUTCOME PREDICTION IN HIE GRADE II K. Goeral; B. Urlesberger; V. Giordano; G. Kasprian; M. Wagner; L. Schmidt; A. Berger; K. Klebermass-Schrehof; M. Olischar (Austria)

ID 696 COMPARISON OF 1-DIMENSIONAL AND 2-DIMENSIONAL SONOGRAPHIC (US) AND MRI MEASUREMENTS OF THE CEREBELLUM IN TERM NEWBORNS B. Reulecke; R. Fernandez; M. Mills; V. Pelling; H. Rabe; L. Harris (United Kingdom)

ID 713 MILD HYPOXIC ISCHAEMIC ENCEPHALOPATHY AND LONG TERM NEURODEVELOPMENTAL OUTCOME- A SYSTEMATIC REVIEW J. Conway 1,2; B.H. Walsh 3; M. Dozier 2; G.B. Boylan 1; D.M. Murray 1 (1. Ireland; 2. United Kingdom; 3. United States)

ID 722 NEURODEVELOPMENTAL AND SENSORY OUTCOME AT TWO YEARS IN VLBW BABIES: CORRELATIONS WITH BRAIN LESIONS DETECTED AT TERM MRI M. Malova; L. Ceschi; C. Traggiai; S. Uccella; A. Parodi; A. Sannia; L. Boeri; E. De Grandis; M. Severino; G. Morana; D. Tortora; M.G. Calevo; A. Rossi; E. Veneselli; C. Bellini; L.A. Ramenghi (Italy)

ID 818 PERSISTENT MONOCYTE AND NEUTROPHIL ACTIVATION IN SCHOOL AGE CHILDREN POST NEONATAL ENCEPHALOPATHY Z. Zareen; V. Mc Eneaney; N.A. Taher; L. Kelly; D. Sweetman; D. Doherty; E.J. Molloy (Ireland)

ID 831 ARE THE 2 YEAR GRIFFITHS SCORES OF BABIES WITH CBH AND IVH SIGNIFICANTLY DIFFERENT COMPARED TO THOSE OF BABIES SUFFERING FROM ISOLATED IVH? S. Uccella; A. Parodi; M. Malova; L. Boeri; E. De Grandis; C. Traggiai; A. Sannia; M. Severino; G. Morana; D. Tortora; A. Rossi; E. Veneselli; L.A. Ramenghi (Italy)

ID 836 INCIDENCE AND CHARACTERISTICS OF INFANTS WITH RETINOPATHY OF PREMATURITY IN CROATIA M. Vucinovic; L.J. Znaor; A. Vucinovic (Croatia)

ID 873 NEUROPROTECTIVE DRUGS IN INFANTS WITH A CONGENITAL HEART DISEASE REQUIRING CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS: A SYSTEMATIC REVIEW R. Stegeman; K.D. Lamur; A. van den Hoogen; J. (H.) M.P.J. Breur; F. Groenendaal; N.J.G. Jansen; M.J.N.L. Benders (The Netherlands)

ID 884 NEUROPHYSIOLOGICAL; NEURORADIOLOGICAL AND NEUROPATHOLOGICAL FINDINGS IN LETHAL NEONATAL RIGIDITY AND MULTIFOCAL SEIZURES SYNDROME ASSOCIATED WITH BRAT1 MUTATIONS M-C. Cornet; R. Schubert; E. Huang; J. Shimotake; O. Danhaive; J. McGuire; M-R. Cilio (United States)

3rd November, 2017

8181

NICU Quality Improvement, Family Centre Care Chairs: Hugo Lagercrantz (Sweden)

ID 026 PRETERM INFANTS WITH MEDICAL COMPLEXITY: IMPATC ON HEALTH CARE RESSOURCE USE; FAMILY EMPLOYMENT AND NEURODEVELOPMENTAL OUTCOMES D. Nassel 1,2; C. Chartrand 2 ; M-J. Doré-Bergeron2; M. Ballantyne 2; F. Lefebvre 2; T.M. Luu 2 (1. Belgium; 2. Canada)

ID 046 BREAST MILK DONATION IN THE MUSLIM POPULATION S. Jebali; E. Ayachi; R. Terki Hassaine; A. Giuseppi; D. Vaiman; S. Brunet; V. Rigourd (France)

ID 065 TO DETERMINE HOW MANYMOTHERS OF PRETERM BABIES WHO WERE DELIVERED BETWEEN 24 AND 34 WEEK GESTATION AND WERE ADMITTED TO NEONATAL UNIT AT ST.MARY’S HOSPITAL; DID NOT RECEIVE ANTENATAL STERIOD Arunoday; A. Manou; I. Sadasivam (United Kingdom)

ID 085 MOVING BABIES: A CALENDAR YEAR OF TRANSPORT TO AND FROM A REGIONAL NEONATAL CENTRE C.M. Moore; M. Cassidy; M. Byrne; A. Bowden; J. Franta; I. Farombi; J.J. Fitzsimons (Ireland)

ID 144 REDUCING THE WASTAGE OF PAEDIATRIC RED CELLS C.C. Roehr; J. Staves; S. Hemmatpour; N. Mohanraj; S. Pavord (United Kingdom)

ID 155 ACCURATE DETECTION OF CEREBROSPINAL FLUID FROM THE TIP OF INJEQ IQ-NEEDLE(TM) IN PEDIATRIC LUMBAR PUNCTURE – PRELIMINARY RESULTS OF CLINICAL STUDY S. Halonen; J. Kari; O. Tammela; K. Kronström; V. Eskola (Finland)

ID 235 CONSERVATIVE TREATMENT OF IATROGENIC PERFORATIONS CAUSED BY GASTRIC TUBES IN EXTREMELY LOW BIRTH WEIGHT INFANTS – EXPERIENCE OF A SINGLE CENTER M. Thanhaeuser; A. Repa; A. Berger; N. Haiden (Austria)

ID 270 SCARRED FOR LIFE? M. Kristiansen; C-A. Olsson Mägi (sweden)

ID 272 HOW CAN NEONATAL NURSES ENHANCE PARENT-INFANT BOND BY EMPOWERING PARENTS M.J. Ravn; J.B. Wigdel (Norway)

ID 348 THE EFFECT OF BATHING AT TWO DIFFERENT TIMES ON BODY TEMPERATURE AND SKIN MOISTURE LEVEL IN NEWBORNS D. Gözen; S. Yalnızoğlu Çaka; S. Ateş Beşirik; Y. Perk (Turkey)

3rd November, 2017

8282

ID 370 THE FIRST MINUTES WHEN MY EXTREMLY PRETERM INFANT WAS BORN C. Israelsson; F. Thorolfson (Sweden)

ID 386 NEUROPROTECTIVE DEVELOPMENTAL CARE: STATE OF KNOWLEDGE AND IMPLICATIONS FOR PRACTICE A. Lavallée; G. De Clifford-Faugère; A. N. Fernandez Oviedo; C. Garcia; M. Héon; M. Aita (Canada)

ID 446 EVALUATION OF PROLONGED PAIN IN PRETERM INFANTS WITH PNEUMOTHORAX USING HRV ANALYSIS AND EDIN SCORES M. Buyuktiryaki; N. Uras; N. Okur; M.Y. Oncel; G. Kadioglu Simsek; S. Isik; S.S. Oguz (Turkey)

ID 487 COST-EFFECTIVENESS OF TRANSCUTANEOUS BILIRUBIN (TcB) MONITORING IN A GROWING HEALTH ECONOMY L. Mohammed; B.N. Ofoegbu (Saudi Arabia)

ID 495 IMPROVING THE QUALITY OF DISCHARGE IN BABIES WITH DOWN SYNDROME C.M. Moore; S.M. Eldaw; M. McCormack; J.J. Fitzsimons (Ireland)

ID 582 NOT A MONITORING PROBE LESION A. Olariu; S.Nallagonda; J. Egyepong (United Kingdom)

ID 605 QUALITY IMPROVEMENT PROJECT: TOWARDS NEONATAL MANAGEMENT OF PREGNANCIES COMPLICATED BY POLYHYDRAMNIOS R. Mardare; A. Olariu; M. Noureldein; J. Egyepong (United Kingdom)

ID 632 SITUATIONAL FAMILY INTERACTION N. Betzelos; J. Nilsson; J. Högström; M. Corrias; S. Lilliesköld; M. Norman; K. Bohlin (Sweden)

ID 695 MILK ANALYSIS USING MILK ANALYZERS IN A STANDARDIZED SETTING (MAMAS) STUDY G. Fusch 1; C. Kwan 1; N. Rochow 1; M. Belfort 2; J. Festival 1; A. Hair 2; J-M. Hascoet 3; T. Kuehn 4; MIRIS 5; M. Nelle 6; D. O’Connor 1; G. Pelligra 1; B. Poindexter 2; B. Urlesberger 7; A. Wesolowska 8; C. Fusch 1,4 (1. Canada; 2. United States; 3. France; 4. Germany; 5. Sweden; 6. Switzerland; 7. Austria; 8. Poland)

ID 705 A SYSTEMATIC REVIEW OF THE EFFECTIVENESS OF INTERVENTIONS DURING NICU HOSPITALIZATION ON THE SHORT-TERM NEURODEVELOPMENT OF PRETERM INFANTS M. Aita; R. Stremler; N. Feeley; A. Lavallée; G. De Clifford-Faugère (Canada)

ID 731 SAFETY CULTURE ASSESSMENT IN A NEONATAL UNIT FOLLOWING A PLAN TO IMPROVE PATIENT SAFETY M. Arriaga-Redondo; A. Rodriguez-Sanchez de la Blanca; E. Sanz-Lopez; A. Diaz-Redondo; R. Gregorio-Hernandez; P. Chimenti-Camacho; M. Sanchez-Luna (Spain)

3rd November, 2017

8383

ID 742 SHORT AND LONG TERM OUTCOMES RELATED TO UMBILICAL VENOUS CATHETER PLACEMENT IN PRETERM INFANTS L. Arques; R. del Rio; C. Balcells; E. Inarejos; V. Aldecoa-Bilbao; I. Iglesias-Platas (Spain)

ID 756 ACHIEVING NORMOTHERMIA IN INFANTS ADMITTED TO THE NEONATOLOGY DEPARTMENT-A QUALITY IMPROVEMENT PROJECT AT THE KAROLINSKA UNIVERSITY HOSPITAL K. Jonsson; A. Gudmundsdottir; A. Chakhunashvili; A-S. Ingman; C. Branvik-Ingelsson; E. Wilson; I. Edqvist; M. Viberg; B. Hallberg; M. Breindahl (Sweden)

ID 776 PERSONALITY TRAITS AND STYLES OF COPING WITH STRESS AMONG MIDWIVES B. Zych; W. Blaz; M. Muster; M. Mazur-Magoła; G. Raba (Poland)

ID 784 EVALUATING MATERNAL CLOSSENESS AND SEPARATION IN NICU. GUIDELINES FOR THE CREATION OF PERINATAL CENTERS A. Karkani; K. Kwnstadinidi; M. Theodoraki; S. Gancheva; M. Papadopoulou (Greece)

ID 823 ENHANCING NEONATAL AND PARENTAL OUTCOMES THROUGH THE OPTIMIZATION OF EVIDENCE-BASED NURSING PRACTICES M. Aita; S. Semenic; N. Feeley; L. Haiek; M. Héon; A. Larone Juneau; K. Levasseur; G. Roch; L. Talbot (Canada)

ID 856 WHAT DOES THE PREMATURE BABY’S PARENTS FEEL AND HOW DOES THEY SEE THE STAFF TAKING CARE OF THEIR CHILD? A. Bialas (Poland)

ID 861 CROSS-CULTURAL ADAPTATION AND VALIDATION OF THE NEONATAL INFANT PAIN SCALE (NIPS) FOR BRAZILIAN PORTUGUESE G. de Cássia Pinheiro da Motta; M.L. Chollopetz da Cunha (Brazil)

ID 864 EARLY OUTCOME OF NEONATES AFTER CONTINUOUS AMNIOINFUSION VIA A SUBCUTANEOUSLY IMPLANTED PORT SYSTEM WITH PPROM AND ANHYDRAMNIOS <28 + 0 WEEKS OF GESTATION (FIRST EXPERIENCES IN RUSSIA) Y. Naberezhnev 1; M. Beluga 2; O. Golovchenko 2; E. Golosovsky 2; M. Tchirikov 1 (1. Germany; 2. Russia)

ID 865 EVALUATION OF DYNAMIC THIOL-DISULFIDE HOMEOSTASIS IN HEALTHY VERY LOW BIRTH WEIGHTED PRETERMS S. Unal; D. Ulubas Isik; A. Yagmur Bas; S. Erol; İ. Arifoglu; M. Alisik; O. Erel; N. Demirel (Turkey)

ID 867 THE EFFECT OF THE MODE OF DELIVERY ON THE MATERNAL AND NEONATAL DYNAMIC THIOL-DISULFIDE HOMEOSTASIS D. Ulubas Isik; Y. Akdaş Reis; A. Yagmur Bas; S. Unal; B. Özcan; L. Mollamahmutoglu; S. Neşelioglu; O. Erel4; N. Demirel (Turkey)

3rd November, 2017

8484

ID 870 READMISSION RATES IN THE FIRST MONTH FOLLOWING DISCHARGE AMONG BABIES DISCHARGED FROM THE NEONATAL SERVICE: A SINGLE CENTRE EXPERIENCE R. Calthorpe; A.M. Mustafa Kamal; D. Jayasinghe (United Kingdom)

ID 871 SOUNDS MEASUREMENTS IN A WARD TO IMPROVE THE NICU ENVIRONMENT A-A. Vinaixa Vergés; J. Romeu Garbí; M. Nicolau Manzano; P. Morales De Mata; R. Puigarnau Vallhonrat; E. Quintana Rio; A. Mirada Vives (Spain)

ID 872 REFERRAL REASONS AND OUTCOMES OF NEWBORN INFANT PHYSICAL EXAMINATION HIP REFERRALS J. Hussain (United Kingdom)

ID 883 EFFICACY OF INTRAVENOUS; ENDOTRACHEAL OR NASAL ADRENALINE ADMINISTRATION DURING RESUSCITATION OF NEAR-TERM ASPHYXIATED LAMBS N.T. Songstad 1; C. Klingenberg 1; K.J. Crossley 2; E.V. McGillick 2; G.R. Polglase 2; P.G. Davis 2; S.B. Hooper 2 (1. Norway; 2. Australia)

Perinatal Practices Chairs: Pierre Kuhn (France); Shoo Lee (Canada)

ID 054 VACUUM EXTRACTION AND RISK OF NEONATAL COMPLICATIONS: A POPULATION-BASED COHORT STUDY D. Rossetti; AS Laganà; G. Valenti; B. Chiofalo; S. Butticè; G. Sanpietro; A.M.C. Rapisarda; F. Sapia; M. Noventa; A. Vitagliano; S.G. Vitale (Italy)

ID 109 ELECTIVE CAESAREAN SECTION AND RESPIRATORY MORBIDITIES IN TERM INFANTS P. Mallya; S. Garg (United Kingdom)

ID 124 CESAREAN DELIVERY AMONG FOREIGN-BORN CHINESE AND US BORN-CHINESE WOMEN IN THE U.S T.A. Yen 1; M. Lahiff 2; N. Hosang 2; E. Brenda 2 (1. Taiwan; 2. United States)

ID 170 RISK FACTORS AND OUTCOME IN PREVIABLE PPROM AND CURRENT TREATMENT PRACTICE A. van Gennip; E.E.M. Mulder; R.M. Brohet; J. van Eyck; R.A. van Lingen (The Netherlands)

ID 303 ASSESSMENT OF FUNCTIONAL STATUS IN PRETERM INFANTS: ONLINE SURVEY TO INFORM SCORING OF A CLINICIAN-REPORTED OUTCOMES (CLINRO) TOOL M. Turner 1; I. Hansen-Pupp 2; J. Higginson 3; R. Ward 3; M. Vanya 3; E. Flood 3; E. Schwartz 3; H. Doll 3; A. Tocoian 4; A. Mangili 3; N. Barton 3; S. Sarda 3 (1. United Kingdom; 2. Sweden; 3. United States; 4. Switzerland)

3rd November, 2017

8585

ID 355 INFANTS AND MATERNAL OUTCOME OF PREGNANCIES COMPLICATED BY H1N1 INFECTION NEEDING ECMO THERAPY: A UK ECMO CENTRE EXPERIENCE N. Singh; J. Behrsin; F. Siddiqui; R. Porter; M. Charlton; A. Akuma; S. Mittal (United Kingdom)

ID 447 THE ASSOCIATION OF NEONATAL MORBIDITIES AND MORTALITY OF PRETERM INFANTS WITH DIFFERENT COURSES OF ANTENATAL STEROIDS M. Buyuktiryaki; F.N. Sari; H. Bezirganoglu; N. Okur; E. Alyamac Dizdar; N. Uras; F.E. Canpolat; S.S. Oguz (Turkey)

ID 475 REFERRAL CASE OF NEONATAL ADMISSION AND OUTCOME AT NEONATAL UNIT IN TERTIARY HOSPITAL IN LOW-MIDDLE INCOME COUNTRY P.M.T. Marsubrin; E. Ameliana; R. Sari; R. Rohsiswatmo (Indonesia)

ID 479 MONITORING AND ASSESMENT OF NEONATAL CARE IN KYRGYZSTAN S.Abduvalieva; C.Rakmanova; G.Jumagulova; E. Jumalieva (Kyrgyzstan)

ID 561 EVOLUTION OF PERINATAL MANAGEMENT AT THE LIMIT OF VIABILITY IN THE LAST DECADE S. Zeballos Sarrato; C. Ramos Navarro; G. Zeballos Sarrato; N. Navarro; M. Sánchez-Luna (Spain)

ID 649 EARLY ONSET INTRAUTERINE GROWTH RESTRICTION: AN INDEPENDENT RISK FACTOR FOR POOR PERINATAL OUTCOME IN VERY PRETERM INFANTS? T.D. Nguyen; D. Bassler; N. Ochsenbein-Kölble; G. Natalucci (Switzerland)

ID 651 THE EFFECT OF GENDER ON NEONATAL MORBIDITIES AND MORTALITY ON TWIN PAIRS B. Ozer Bekmez; H. G. Kanmaz Kutman; C. Tayman; M. Buyuktiryaki (Turkey)

ID 679 IS FETAL ARTERIAL AND VENOUS DOPPLER VELOCIMETRY MANDATORY IN THE CASE OF THE IUGR RISK PREGNANCIES? M. Tunescu; G. Olariu; A. Ratiu; D. Bujorescu (Romania)

ID 710 IN VITRO FERTILIZATION - NEONATAL OUTCOME M.L. Ognean; R. Chicea; R. Dumitra; O. Boantă; M. Codru (Romania)

ID 732 NEONATAL JAUNDICE AND PHOTOTHERAPY: ARE WE DOING IT RIGHT? - A RETROSPECTIVE STUDY M. Nogueira; C. Teles Silva; A. Reis e Melo; M. Rosário; J. Santos Silva; G. Silva; H. Guimarães (Portugal)

ID 768 REVIEW OF OUTCOMES OF BABIES WITH BIRTH WEIGHT LESS THAN 500 GRAMS IN A NEONATAL INTENSIVE CARE UNIT N. Gulati; N. Mahalingam; S. Vishna Rasiah; A. Singh (United Kingdom)

3rd November, 2017

8686

9:00 - 11:00 PARALLEL SESSION 24 |DARSENA ROOM STRESS AND DEVELOPMENT Chairs: Petra Hüppi (Switzerland); Aijaz Farooqi (Sweden)

09:00 - 09:20 Prenatal stress and its effects on the fetus and the child Francesca Cirulli (Italy)

09:20 - 09:40 Stress in health and disease; stress, learning and plasticity Marian Joels (The Netherland)

09:40 - 09:55 Differentiating the preterm phenotype: distinct profiles of development after late and moderately preterm birth S. Johnson; G. Waheed; B. N. Manktelow; D. Field; N. Marlow; E.S. Draper; E.M. Boyle (United Kingdom)

09:55 - 10:10 Prenatal methadone exposure and neurodevelopmental and neuroimaging outcomes: a systematic review V. Monnelly; R. Hamilton; F. Chappell; H. Mactier; J. Boardman (United Kingdom)

10:10 - 10:25 Atypical brain development associated with prenatal methadone exposure V. Monnelly; D. Anblagan; A. Quigley; E. Cooper; H. Mactier; S. Semple; M. Bastin; J. Boardman (United Kingdom)

10:25 - 10:40 Epigenetic differences in cord blood of newborns exposed to antidepressant medication during pregnancy – a study in the Aarhus birth cohort A-C. Viuff 1; G.C. Sharp 1; L.H. Pedersen 1,2; N.H. Staunstrup 2; K.J. Kyng2; D. Rai 3; C.L. Relton 1; T.B. Henriksen 1,2 (1. United Kingdom; 2. Denmark)

10:40 - 10:55 Mental health in adolescents born at 23-25 weeks of gestation A. Farooqi; M. Samuelsson; A. Holsti; M. Adamsson; F. Serenius; B. Hägglöf (Sweden)

3rd November, 2017

8787

9:00 - 11:00 PARALLEL SESSION 25 (BRAIN 5) NEUROPROTECTION, EPO TRIAL |VENEZIA ROOM Chairs: Nicola Robertson (United Kingdom); Ivo Bendix (Germany)

09:00 - 09:20 Current global issues for optimising brain protection of the term infant Nicola Robertson (United Kingdom)

09:20 - 09:40 Preterm Epo Neuroprotection: the PENUT Trial Sandra Juul (United States)

09:40 - 09:55 A mixed lipid emulsion – rich in docosahexaenoic acid (DHA)- and its effect on brain maturation in extremely low birth weight infants C. Binder 1; A. Repa 1; V. Giordano 1; M. Thanhaeuser 1; A. Kreissl 1; N. Haiden 1; A. Berger 1; N. Longford 2; K. Klebermass-Schrehof 1 (1. Austria; 2. United Kingdom)

09: 55 - 10:10 Thrombocytopenia is associated with severe retinopathy of prematurity clinically; in mice platelet transfusion suppresses retinopathy P. Lundgren 1; R. Liegl 2; S. Klevebro 3; G. Hellgren 1; C. Löfqvist 1; C. Mannheimer 1; Y. Sun 2; Z-J. Liu 2; M.C. Sola-Visner 2; B. Hallberg 1; L.E.H. Smith 2; A. Hellström 1 (1. Sweden; 2. United States)

10:10 - 10:25 Peripheral T-cell depletion by fingolimod is associated with exacerbated hypoxic-ischemic brain injury in neonatal mice I. Bendix; M. Crasmöller; C. Köster; M. Serdar; U. Felderhoff-Müser; J. Herz (Germany)

10:25 - 10:40 Intranasally applied mesenchymal stem cells migrate to injured brain regions of newborn non-human primates N. Wagenaar 1; F. van Bel 1; M.J.N.L. Benders 1; C. Blanco 2; D. McCurmin 2; S. Mustafa 2; F. Groenendaal 1; L. de Vries 1; C. Heijnen 2; C. Nijboer 1 (1. The Netherlands; 2. United States)

10:40 - 10:55 Maternal swimming during pregnancy protects the neonatal rat brain from hypoxic-ischemic injury E.F. Sanches; Y. van de Looij; A. Silva; J. Romero; S.V. Sizonenko (Switzerland)

3rd November, 2017

8888

9:00 - 11:00 PARALLEL SESSION 26 (PHARMA 2)|ROMA ROOM NEW INSIGHTS IN FUTURE NEONATAL CARE Chairs: Sinno Simons (The Netherlands); Eugene Dempsey (Ireland)

09:00 - 09:20 Tick-tock… pharmacotherapy and our body clock Bert van der Horst (The Netherlands)

09:20 - 09:40 Chronobiology in neonatology Irwin Reiss (The Netherlands)

09:40 - 09:55 Late cord clamping trial William Tarnow-Mordi (Australia)

09:55 - 10:10 Pharmacokinetic and pharmacodynamic studies aiming for rational drug dosing in preterm neonates: the DINO study R.B. Flint; S. Völler; R. de Groot; D. Liem; P. Andriessen; P. Degrauewe; I. Reiss; D. Burger; D. Tibboel; C.A.J. Knibbe; S.H.P. Simons; DINO Research group (The Netherlands)

10:10 - 10:25 Fentanyl for procedural pain in preterm newborn infants – a pharmacokinetic and pharmacodynamic study E. Norman 1; J.M. Kindblom 1; A-C. Berg 1; C. Halzius 1; G. Printz 1; A. Rane 1; H. Lagercrantz 1; B. Hallberg 1; V. Fellman 2 (1. Sweden; 2. Finland)

10:25 - 10:40 Big data analyses for continuous evaluation of pharmacotherapy: a proof of principle with doxapram for preterm infants R.B. Flint; W. van Weteringen; S. Völler; J. Poppe; B. Koch; R. de Groot; D. Tibboel; C. Knibbe; I. Reiss; S.H.P. Simons; DINO Research group (The Netherlands)

10:40 - 10:55 Ibuprofen pharmacogenetic study in human milk Samples V. Rigourd; C. Verstyuft; J.F. Méritet; P. Seraissol; B. De Villepin; A. Amirouche; R. Serreau (France)

3rd November, 2017

8989

9:00 - 11:00 PARALLEL SESSION 27 (CIRCULATION 3) TRAINING GUIDELINES FOR NEONATOLOGIST PERFORMED ECHOCARDIOGRAPHY (NPE) - AN INTERCONTINENTAL DEBATE |SORRENTO ROOM Chairs: Willem de Boode (The Netherlands); Colm Breatnach (Ireland)

09:00 - 09:20 The North-American perspective Patrick McNamara (Canada)

09:20 - 09:40 The Australian perspective Nick Evans (Australia)

09:40 - 10:00 The United Kingdom perspective Yogen Singh (United Kingdom)

10:00 - 10:20 The European perspective Afif El-Khuffash (Ireland) 10:20 - 10:35 Incidental findings on routine targeted neonatal echocardiography performed in preterm infants less than 29 weeks gestation A. Smith; C.R. Breatnach; A.T. James; O. Franklin; A. El-Khuffash (Ireland)

10:35 - 10:50 Emerging quantitative echocardiographic markers of pulmonary vasculae disease and right ventricular dysfunction in extreme preterm infants with late pulmonary hypertension P. Levy 1; C. Brennan 1; M. Patel; S. Choudhry 1; A.A. Sanchez 1; A. EL-Khuffash 2; C. Breatnach 2; O. Franklin 2; A. Hamvas 1; S. Gautam 1 (1. United States; 2. Ireland)

10:50 - 11:00 Novel methods to characterize right ventricular - pulmonary arterial coupling in extreme preterm infants with late onset pulmonary hypertension P. Levy; M. Patel; S. Choudhry; M. Holland; T. Sekarski; A. Hamvas; G. Singh (United States)

3rd November, 2017

9090

9:00 - 11:00 PARALLEL SESSION 28 (EFCNI 4) |LECCE ROOM MEASURING QUALITY OF CARE IN NEONATAL CARE Chairs: Boubou Hallberg (Sweden); Silke Mader (Germany); 09:00 - 09:20 Value based health care and improvement of health in the very youngest infants Boubou Hallberg (Sweden)

09:20 - 09:40 Nature and nurture – improving quality of care in a genetic cohort study Wolfgang Göpel (Germany)

09:40 - 09:55 The implementation of the close collaboration with parents training program in 5 neonatal units - a qualitative study M. Toivonen; L. Lehtonen; S. Ahlqvist-Björkroth; A. Axelin (Finland)

09:55 - 10:10 A pilot study assessing the effectiveness of a family- centered care intervention in preterm infants in China R. Zhang 1; R. Huang 1; X. Gao 1; X. Peng 1; L. Zhu 1; R. Ramanathan 2; J. Latour 1,3 (1. China; 2. United States; 3. United Kingdom)

10:10 - 10:25 Core outcomes in neonatology: preliminary results J.W.H. Webbe; N. Modi; C. Gale On behalf of the COIN Steering Group (United Kingdom)

10:25 - 10:40 Close collaboration with parents™ intervention prevents prolonged maternal postpartum depressive symptoms S. Ahlqvist-Björkroth; A. Axelin; R. Korja; M. Huhtala; L. Lehtonen (Finland)

10:40 - 10:55 Reducing medication errors on NICU - a quality improvement project D.A. Al Masri; B. Ofoegbu; L. Yahya; K. Catroon; A. Saliba; H. Ibrahim (United Arab Emirates)


3rd November, 2017

9191

11:30 – 12:30 IPRF PLENARY SESSION 6 |DARSENA ROOM Chairs: Heike Rabe (United Kingdom); Topun Austin (United Kingdom)

11:30 – 12:00 Human cerebral organoids as a new tool to study human neocortex development Wieland Huttner (Germany)

12:00 – 12:30 From Population and Personalized Genomics to Personalized Medicine Manolis Dermitzakis (Switzerland)

12:30 – 12:45 ESPR AWARDS SESSION |DARSENA ROOM Chairs: Charles C. Roehr (United Kingdom); Luc Zimmermann (The Netherlands)

Young Investigator Awards ESPR Research Grants 2017


13:30 - 15:00 Human Milk Fortification: Benefits of an Exclusive Human Milk Diet for Premature Infants |VENEZIA ROOM Industry supported session - please see page 125 Chairs: Victoria Niklas (United States); Enrico Bertino (Italy)

13:30 - 13:40 Introduction to human milk in the NICU - use and challenges Enrico Bertino (Italy)

13:40 - 14:10 Science and clinical impact of human breast milk feeding for premature infants Alan Lucas (United Kingdom)

14:10 - 14:40 Clinical benefits of an exclusive human milk diet in premature infants Sergio Golombek (United States)

14:40 - 15:00 Conclusion and discussion Victoria Niklas (United States)3rd November, 2017

9292

13:30 - 15:00 POSTER SESSION 11 (NEUROLOGY 2) |FIRENZE ROOM Chairs: Pierre Gressens (France); Ola D. Saugstad (Norway)

13:30 - 13:35 Impact of parturition on maternal neuronal integrity K.S. Evers 1; S. Fouzas 2; C. Barro 1; J. Kuhle 1; U. Fisch 1; O. Lapaire 1; S. Wellmann 1 (1. Switzerland; 2. Greece)

13:35 - 13:40 Mild germinal matrix-intraventricular hemorrhage in preterm infants: anatomical insights provided by SWI-venography D. Tortora 1; M. Malova 1; M. Severino 1; A Parodi 1; G. Morana 1; P. Govaert 2; J.J. Volpe 3; A. Rossi 1; L.A. Ramenghi 1 (1. Italy; 2. Belgium; 3. United States)

13:40 - 13:45 Association between transient neonatal hypoglycemia and adverse neurological development at 2-6 years of age R. Wickström 1; B. Skiöld 1; G. Petersson 2; O. Stephansson 1; M. Altman 1,2 (1. Sweden; 2. Italy)

13:45 - 13:50 Neurofilament serum levels as biomarker of neuronal injury in very preterm born infants A. Depoorter; C. Barro; R. Neumann; J. Kuhle; S. Wellmann (Switzerland)

13:50 - 13:55 Effect of dehydroepiandrosterone and its sulfate ester on neonatal hypoxic-ischemic brain injury – preliminary data A. Posod; M. Lachinger; B. Vejnoska; E. Huber; M. Urbanek; U. Kiechl-Kohlendorfer; E. Griesmaier (Austria)

13:55 - 14:00 Long-term neurodevelopmental outcomes among young adults born preterm M. Tei; S. Negro; M.C. Muraca; M.G. Gatti; D. Urilli; G. Buonocore; S. Perrone (Italy)

14:00 - 14:05 Genetic contributions to the development of intraventricular hemorrhage in preterm newborns D. Szpecht; J. Gadzinowski; A. Seremak-Mrozikiewicz; G. Kurzawińska; K. Drews; M. Szymankiewicz (Poland)

14:05 - 14:10 Neurodevelopment follow-up for high-risk babies in liverpool: a qualitative study. foundation study “follow-up for neurodevelopmentally at risk infants of neonatal care” A. Komoriyama; F. Paize; C. Dewhurst; M. Gladstone (United Kingdom)

3rd November, 2017

9393

14:10 - 14:15 Reduced prevalence of severe intraventricular hemorrhage in very preterm infants delivered after maternal pre-eclampsia E. Morsing; K. Maršál; D. Ley (Sweden)

14:15 - 14:20 Neurodevelopment in 7-year old children born with marginally low birth weight J. Starnberg; M. Norman; B. Westrup; M. Domellöf; S.K. Berglund (Sweden)

14:20 - 14:25 Performance of the German version of the PARCA-R questionnaire as a cognitive screening tool in very preterm infants at 2 years of corrected age G. Natalucci; N. Bechtel; C. Borradori-Tolsa; M. Bickle-Graz; M. Adams; S. Grunt for the Swiss Neonatal Network & Follow-Up Group (Switzerland)

14:25 - 14:30 Cold-inducible RBM3 promotes neurogenesis after brain hypoxic-ischemia/reperfusion injury X. Zhu; C. Brégère; J. Yan; U. Fisch; J. Kapfhammer; R. Guzman; S. Wellmann (Switzerland)

14:30 - 14:35 Monitoring the energy metabolism in plasma from newborns with hypoxic-ischemic encephalopathy (HIE) during therapeutic hypothermia Á. Sánchez-Illana; A. Núñez-Ramiro; M. Cernada; A. Parra; E. Valverde; D. Blanco; M.T. Moral-Pumarega; F. Cabañas; H. Boix; A. Pavon; M. Chaffanel; I. Benavente-Fernández; I. Tofe; B. Loureiro; JR. Fernández-Lorenzo; B. Fernández-Colomer; J. Kuligowski; M. Vento Torres and the HYPOTOP Study Group (Spain)

14:35 - 14:40 Decreased impact of poor weight gain as a predictor for ROP after implementation of higher oxygen saturation targets P. Lundgren 1; A–L. Hård 1; Å. Wilde1; C. Löfqvist 1; L.E.H. Smith 3; A. Hellström 1 (1. Sweden; 2. United States)

3rd November, 2017

9494

13:30 - 15:00 POSTER SESSION 12 (EPIDEMIOLOGY 2) |SORRENTO ROOM Chairs: Thomas Williams (United Kingdom) Anne-Cathrine Finnemann Viuff (Denmark)

13:30 - 13:35 Incidence of bronchopulmonary dysplasia and intraventricular haemorrhage among extremely preterm infants in Europe: a systematic literature review C. Siffel; K. Kistler; J. Lewis; S. Sarda (United States)

13:35 - 13:40 Chronic conditions and health care needs of adolescents born moderately preterm at 32-26 weeks’ gestation: a Swedish regional population based case control study A. Farooqi; A. Sjöström; M. Adamsson; M. Bäckman; B. Hägglöf (Sweden)

13:40 - 13:45 A registry-based descriptive analysis of end stage renal disease and renal replacement therapy in Swedish neonates S. Nolbrant; O. Andersson; B. Hallberg; L. Sartz (Sweden)

13:45 - 13:50 Preterm children’s social inhibition before school entry predicts their friendships in 2nd grade J. Jaekel 1,2; K. Heuser 3; L. Miranda 1; D. Wolke 2 (1. United States; 2. United Kingdom; 3. Germany)

13:50 - 13:55 Children with cerebral palsy (non-post-neonatal) born at term, non-admitted to neonatal intensive care, from the Portuguese national register D. Virella; T. Folha; M.G. Andrada; A. Cadete; R. Gouveia; T. Gaia; J.J. Alvarelhão; E. Calado (Portugal)

13:55 - 14:00 Risk factors associated with mortality at the limit of viability S. Zeballos Sarrato; N. González Pacheco; I. Pescador Chamorro; A. Rodriguez Sánchez de la Blanca; M. Sánchez-Luna (Spain)

14:00 - 14:05 Epidemiology of esbl-producing multidrug-resistant gram-negative bacilli in three NICUs in Italy D. Vecchio; L. Saporito; C. Achille; D.M. Geraci; S. Giampietro; M. Trancassini; C. Tzialla; C.M. Maida; M. Mario (Italy)

14:05 - 14:10 Temporal trends in preterm infant mortality over the last 15 years (2001-2015), with particular reference to 23 week gestation infants. Results from a UK single centre case series with comparison to the Vermont Oxford network A. Doerr; D. Odd (United Kingdom)

3rd November, 2017

9595

14:10 - 14:15 Femoral pulse examination’s ability to predict coarctation of the aorta F. Khammari Nystroem; S. Johansson; O. Stephansson; M. Altman (Sweden)

14:15 - 14:20 Variations in initial oxygen concentration at resuscitation of preterm neonates <29 weeks gestation: an international survey K. Lui 1; M. Vento Torres 2; A. Noguchi 3; S. Hakannson 4; B. Reichman 5; P. Shah 6; G. Sjörs 4; F. Rusconi 7; M. Adams 8; S. Lee 6; L. Lehtonen 9; S. Kusuda 10; T. Isayama 6; N. Modi 11; D. Bassler 6; M. Beltempo 6; K. Helenius 9; N. Morisaki 10 ; B.A. Darlow 12 (1. Australia; 2. Spain; 3. United States; 4. Sweden; 5. Israel; 6. Canada; 7. Italy; 8. Switzerland; 9. Finland; 10. Japan; 11. United Kingdom; 12. New Zealand)

14:20 - 14:25 Morbidity, mortality and 2-year outcome of babies born with birth weight ≤ 500g over 11 years in a tertiary neonatal unit M. Noureldein; A. Olariu; J. Egyepong (United Kingdom)

14:25 - 14:30 Trends in mortality rates at the limit of viability in the last decade A. Rodriguez Sánchez de la Blanca; S. Zeballos Sarrato; G. Zeballos Sarrato; I. Pescador Chamorro; A. Rodriguez; S. Villar Castro; M. Sánchez-Luna (Spain)

14:30 - 14:35 Applying data mining techniques to predict bronchopulmonary dysplasia in very-low-birth-weight (VLBW) infants- a population-based study Y.J. Lin; C.H. Lin; Y.C. Lin; Y.S. Chang; C.C. Huang; K.I. Tsou (Taiwan)

14:35 - 14:40 Caregiver burden associated with extremely preterm birth S. Sarda; W. Lenderking; R. Pokrzywinski; S. Stringer; A. Mangili (United States)

14:40 - 14:45 The gestation study – deep machine learning algorithm for accurate postnatal gestational age assessment C. Henry; C. Ward; M. Torres Torres; M. Valstar; D. Sharkey (United Kingdom)

14:45 - 14:50 A systematic review of incidence of neonatal necrotising enterocolitis in high income countries C. Battersby; T. Santhalingam; K. Costeloe; N. Modi (United Kingdom)

14:50 - 14:55 Impact of elective caesarian section on neonatal retrieval in Western Australia during a 12 year period A. Tho; S. Resnick; J.W. Davis (Australia)

3rd November, 2017

9696

13:30 - 15:00 POSTER SESSION 13 (NUTRITION 2) |FIRENZE ROOM Chairs: Umberto Simeoni (Switzerland); Petteri Hovi (Finland)

13:30 - 13:35 Individualized fortification of human milk improves nutritional supplies and growth in preterm infants V. de Halleux; C. Pieltain; T. Senterre; F. Studzinski; J. Rigo (Belgium)

13:35 - 13:40 Birth weight percentiles based on maternal height are universally applicable and valid for different ethnic groups D. Olbertz 1; N. Rochow 2; M. Al Samnan 2; J. Däbritz 1; R. Hentschel 1; U. Wittwer-Backofen 1; M. Voigt 1 (1. Germany; 2. Canada)

13:40 - 13:45 Comparison of the postnatal catch up growth according to the definition of small for gestational age infants J. Huh; J.Y. Kwon; E.H. Lee; H.R. Kim; K.H. Lee (Korea)

13:45 - 13:50 Measuring postnatal growth: a comparison of neonatal growth using international intergrowth-21st standards and established UK charts O.M. Bendor-Samuel; S. Zivanovic; C.C. Roehr (United Kingdom)

13:50 - 13:55 Human milk and human milk derived products: how bioactive component analysis may inform clinical outcomes in the NICU V. Niklas; D. Rechtman; M. Lee; A. Lebouedec; A. Sun (United States)

13:55 - 14:00 Effect of a nationwide program for promoting breastfeeding in-hospital in China Y. Zhang; H.S. Wang; X. Jin; B. Cao; D.H. Wang; M. Jiang; L.X. Wang; S.M. Wang; W.W. Feng; L.M. Yao (China)

14:00 - 14:05 Association between maternal knowledge on breastfeeding and the assessment of the newborn’s latch in a maternity center in the university hospital of the south region of Brazil S.S. Nader; P.J.H. Nader; N.T. Canabarro (Brazil)

14:05 - 14:10 Prevalence of breastfeeding at 6th months in sick neonates S. Kositamongkol; K. Moungsuwan (Thailand)

14:10 - 14:15 Is there any association between lamellar body counts and cord blood vitamin d levels of term and late preterm infants N.Okur; H.G. Kanmaz; M. Buyuktiryaki; H. Bezirganoglu; G. Kadioglu Simsek; F.E. Canpolat; N. Uras; S.S. Oguz (Turkey)

3rd November, 2017

9797

14:15 - 14:20 Use of pasteurised human donor milk in England C. Battersby; R. Marciano Alves Mousinho; N. Longford; N. Modi for the UK Neonatal Collaborative Necrotising Enterocolitis (UKNC-NEC) Study Group (United Kingdom)

14:20 - 14:25 Neonatal body composition of infants born to mothers with gestational diabetes mellitus FA.M. Pavel; M. O’Riordan; L. Culliney; T. Nabialek; J. De Meulemeester; F. Caulfield; A. Stanescu; Z. Coffrey; D. Coffey; A. Doolan (Ireland)

14:25 - 14:30 Current practice and beliefs: survey of breast milk handling routines in German, Swiss and Austrian neonatal units reveals large centre specific differences D. Klotz; S. Jansen; H. Schneider; C. Gebauer; H. Fuchs (Germany)

14:30 - 14:35 Variability in the protein and fat content of the donor human milk supply revealed by mid-infrared spectrometer analysis: a fist step towards preventing disruption of “per natal programming” V. Rigourd; Z. Assaf; A. Lapillonne; J.F. Magny (France)

14:35 - 14:40 Decreasing extrauterine growth restriction in very low birth weight (VLBW) infants after implementation of a nutritional protocol J.A. Asaro; R. Snyder; C. Aikey; I. Griffin; A. Herdt; M. Rogido (United States)

13:30 - 15:00 POSTER SESSION 14 (LUNG 4)|SORRENTO ROOM Chairs: Kajsa Bohlin (Sweden); Kerstin Jost (Switzerland)

13:30 - 13:35 Perinatal inflammation and intrauterine growth retardation are both associated with lung function impairment at 12 years of age in very preterm infants C. Hagman; L.J. Björklund; E. Tufvesson; I. Hansen Pupp (Sweden)

13:35 - 13:40 Early predictive factors for insure failure in the management of preterm infants with neonatal respiratory distress syndrome: a systematic review B. De Bisschop; F. Derriks; F. Cools (Belgium)

3rd November, 2017

9898

13:40 - 13:45 Outcomes of postnatal hydrocortısone therapy ın preterm infants wıth bronchopulmonary dysplasıa: experıence ın a tertıary center M. Buyuktiryaki; E. Alyamac Dizdar; N. Okur; H. Bezirganoglu; F.N. Sari; N. Uras; F.E. Canpolat; S.S. Oguz (Turkey)

13:45 - 13:50 Maternal preeclampsia and the risk of respiratory distress syndrome in VLBW infants T.A. Yen; Y.H. Wen; H.I. Yang; W.S. Hsieh; H.C. Chou; C.Y. Chen; K.I. Tsou; P.N. Tsao (Taiwan)

13:50 - 13:55 Comparison of RSV hospitalisation in preterm infants with chronic lung disease who do not qualify for palivizumab prophylaxis with those who qualify in Nottingham, UK S. Tsilika; D. Batra (United Kingdom)

13:55 - 14:00 The effect of antenatal steroid on different gestational age of VLBW infant - a population study Y-T. Chen; S-Y. Liu; H-I Yang; C-Y. Chen; H-C. Chou; W-S. Hsieh; K-I. Tsou; P-N. Tsao (Taiwan)

14:00 - 14:05 Effects of passive smoking on lung function tests in preschool children born late-preterm A. Günlemez; I. Er; C. Baydemir; A.E. Arısoy; A.S. Gökalp (Turkey)

14:05 - 14:10 Transfusion-related acute lung injury in (pre)term infants in the neonatal intensive care M. van Tuyl; L. Snoek; R.M. Wösten-van Asperen; A.H.L.C. van Kaam; W. Onland (The Netherlands)

14:15 - 14:20 Lung ultrasound for the diagnosis of pulmonary consolidations in patients with bronchopulmonary dysplasia I. Koltunov; M. Degtyareva; A. Mazaev; A. Gorbunov; A. Erokhina (Russia)

14:20 - 14:25 Bedside lung ultrasonography for the diagnosis of neonatal respiratory distress in the first 24 hours of life I. Corsini; N. Parri; E. Gozzini; C. Coviello; V. Leonardi; C. Poggi; M. Giacalone; T. Bianconi; L. Tofani; C. Dani (Italy)

14:25 - 14:30 Is the double lung point an accurate diagnostic marker for TTN? A prospective, international study F. Migliaro; N. Yousef; J. Rodriguez Fanjul; D. De Luca; I. Corsini; C. Dani; V. Di Guardo; M. Giampietri; L. Capasso; A. Sodano; F. Raimondi (Italy)

3rd November, 2017

9999

14:30 - 14:35 Protocolized weaning in mechanical ventilation B. Bol 1; H. van Zanten 1; J. Wielenga 1; A. vd Hoogen 1; P. Mansvelt 1; B. Blackwood 2; O.K. Helder 1 (1. The Netherlands; 2. United Kingdom)

14:35 - 14:40 NEO (Neonatal Esophageal Observation) Tube - a feeding tube with monitoring function P. Simmen; B. Jesacher; P-A. Tran; L. Suter; A. Haeberlin; S.M. Schulzke; T. Niederhauser; K. Jost (Switzerland)

14:40 - 14:45 Helping babies breathe, second edition: strengthening the program to increase global newborn survival B. Kamath-Rayne 1; M. Visick 1; W. Keenan 1; G. Little 1; N. Singhal 2; S. Niermeyer 1 (1. United States; 2. Canada)

14:45 - 14:50 Ventfirst: a multicenter RCT of assested ventilation during delayed cord clamping for extremely preterm infants K. Fairchild; S. Niermeyer; J. Winter; C. Chisholm; J. Kattwinkel; on behalf of the VentFirst Steering Committee (J. Fang, C. Colby; J. Barry; M. Al-Hosni; M. Strand; T. Gorman; L. van Marter; R. Schelonka; J. Warren; S. Thomas; G. Schmolzer; A. Camblos; S. Fowler; M. Haynes; G. Petroni; M. Thielen) (United States)

14:50 - 14:55 Inhaled nitric oxide improves survival in preterm infants diagnosed with pulmonary hypoplasia K.R. Ellsworth; M. Ellsworth; L. Sangaralingham; R. Clark; G. Asay; C. Colby; W.A. Carey (United States)

14:55 - 15:00 Inhaled nitric oxide in congenital diaphragmatic hernia – results from the European inhaled nitric oxide registr R. Kettle; N.V. Subhedar (United Kingdom)

3rd November, 2017

100100

13:30 - 15:00 POSTER SESSION 15 (ETHICS + PERINATAL PRACTICE) |LECCE ROOM Chairs: Sandra Horsch (Germany); Gorm Greisen (Denmark)

13:30 - 13:35 Changing parental perceptions in trisomies – a potential ethical dilemma for neonatologists? E.A. Simons; P. Nath; P. Parthasarathy (United Kingdom)

13:35 - 13:40 Evaluation of parental informed consent procedure in neonatal intensive care unit E.(P.G.) van ’t Verlaat; E. de Kort; I. Reiss; M. van Weissenbruch; S.H.P. Simons (The Netherlands)

13:40 - 13:45 Alarm visibility and infusion continuity: environmental change and technology assistance M. Bastanie; H. Blom; L. Mahieu; M. Meeus; S. Laroche; D. Van Laere; M. Voeten; V. Demeulemeester; R. Vermeulen; A. Mulder (Belgium)

13:45 - 13:50 Fast and meticulous: improving quality of neonatal resuscitation documentation M. Karam; N. Merchant; A. Sierra; S. Narayanan (The Netherlands)

13:50 - 13:55 Early discharge of premature infants <36 weeks gestational age with nasogastric tube feeding, new standard of care? F.S. van Kampen; A.C. de Mol; J.P. Korstanje; F. Maingay-de Groof; L. van Meurs-Asseler; H.G. Stas; R. Willemsen; G.M.S.J. Stoelhorst (The Netherlands)

13:55 - 14:00 Incidence of hypothermia associated with birth and intrahospital transport of newborn infants requiring admission to a NICU - a quantitative observational study V. Hansson; M. Hedin; A. Örtenstrand; M. Viberg (Sweden)

15:00 - 17:00 PARALLEL SESSION 29 (BRAIN 6) |DARSENA ROOM CONGENITAL BRAIN INFECTIONS Chairs: Pierre Gressens (France); Steven Miller (Canada)

15:00 - 15:20 CMV cellular and molecular mechanisms Pierre Szepetowski (France)

15:20 - 15:40 ZIKA congenital encephalopathies Ferdinando Di Cunto (Italy)

3rd November, 2017

101101

15:40 - 15:55 Neonatal neuroimaging in symptomatic congenital CMV (cCMV) and its correlation with outcome: emphasis on white matter disease A. Alarcon 1,2; A. Garcia-Alix 2; M. Martinez-Biarge 3; I. van Straaten 3; F. Cabañas 2; J. Quero 2; L. de Vries 3 (1. United Kingdom; 2. Spain; 3. The Netherlands)

15:55 - 16:10 Postnatal MR-imaging and ADC measures in congential cytomegalovirus infection provide an added diagnostic value on cerebral ultrasound in characterizing white matter disease C. Martins 1; J. Schneider 2; M. Bickle Graz 1; M. Kobas 1; S. Asner 1; A.C. Truttmann 1 (1. Switzerland; 2. Canada)

16:10 - 16:25 Hyperechogenicity of the lenticulostriate arteries: incidense and clinical impact in a tertiary NICU P. Triantafyllidou; M. Papadopoulou; S. Gantseva-Patsoura; F. Kokkori; E. Varxalama; M. Theodoraki; A. Gounaris (Greece)

16:25 - 16:40 Systemic alterations in Hypoxia-inducible factor 1 expression and the NLRP3 inflammasome in post neonatal encephalopathy in school age children and response to melatonin in vitro L. Russo; V. Mc Eneaney; Z. Zareen; L.A Kelly; E.J. Molloy (Ireland)

16:40 - 16:55 Systemic inflammasome activation in neonatal encephalopathy M. O’Dea; L. Kelly; J.J. O’Leary; E.J. Molloy (Ireland)

15:00 - 17:00 PARALLEL SESSION 30 (PULMONOLOGY 4) PHARMACOLOGY OF LUNG PROTECTION |VENEZIA ROOM Chairs: Anton van Kaam (Netherland); Daniele De Luca (France)

15:00 - 15:20 Antenatal corticosteroids – current controversies Lex Doyle (Australia)

15:20 - 15:40 Update on postnatal systemic and inhaled corticosteroids Olivier Baud (Switzerland)

15:40 - 16:00 Update on respiratory stimulants and diuretics in BPD prevention Christian Poets (Germany)3rd November, 2017

102102

16:00 - 16:15 Using the combination of surfactant and budesonide the prevention of chronic lung disease in preterm infants with RDS O. Sapun; E. Kleshchenko; O. Shishkina; T. Senyuk; N. Petrukhina; D. Kryuchko (Russia)

16:15 - 16:30 Antenatal glucocorticoids attenuate changes by ventilation in expression of connective tissue growth factor (CTGF) in newborn rat lung M. Mateos; E. Gutierrez; L. San Feliciano; A. Remesal; M. Isidoro-García; A. García-Sánchez; D. Ludeña (Spain)

16:30 - 16:45 Effect of commercially available surfactants on mortality and respiratory outcomes in preterm neonates with RDS: systematic reviews and meta-analysis L. De Martino; D. De Luca (France)

16:45 - 17:00 Secretory phospholipase A2 and inflammation profile in preterm babies with RDS receiving one or multiple surfactant doses S. Shankar-Aguilera 1; C. Fitting 1; L. Vedovelli 2; V. Dell’Orto 1; V.P. Carnielli 2; L. Touqui 1; D. De Luca 1; M. Simonato 2 (1. France; 2. Italy)

15:00 - 17:00 PARALLEL SESSION 31 (EPIDEMIOLOGY 2) PERINATAL EPIDEMIOLOGY |ROMA ROOM Chairs: Tine Brink Henriksen (Denmark); Thomas Williams (United Kingdom)

15:00 - 15:40 Registry based perinatal epidemiology: the importance of sibling and generation data Rolv Skjaerven (Norway)

15:40 - 15:55 Association between maternal body mass index in early pregnancy and incidence of cerebral palsy S. Johansson; E. Villamor; K. Tedroff; M. Peterson; M. Neovius; G. Petersson; S. Cnattingius (Sweden)

15:55 - 16:10 Prevalence of long-term neurodevelopmental impairment following extremely preterm birth in Europe: a systematic literature review S. Sarda; G. Sarri; S. Abogunrin; C. Siffel (United Kingdom)

3rd November, 2017

103103

16:10 - 16:25 Perinatal infections and cerebral palsy: are prolonged ruptures of membranes a risk factor in children born at term? M. Mynarek; S. Bjellmo; S. Lydersen; J. Afset; G. Andersen; T. Vik (Norway)

16:25 - 16:40 Congenital heart defects and the risk of spontaneous preterm birth: a nationwide study of 924,422 liveborn infants N.B. Matthiesen; J.R. Østergaard; C.C. Bach; V. Hjortdal; T.B. Henriksen (Denmark)

16:40 - 16:55 The dose-effect relationship between gestational age and severe school difficulties - a Danish population-based register study R. Wiingreen; G. Greisen; J. Svensson; BM. Hansen (Denmark)

15:00 - 17:00 PARALLEL SESSION 32 |FIRENZE ROOM CHILDREN BORN PRETERM Chairs: Neil Marlow (United Kingdom); Hugo Lagercrantz (Sweden)

15:00 - 15:20 RECAP, a EU Horizon2020 collaborative effort to harmonize existing and new follow-up data on preterm survivor children, adolsecents and adults Dieter Wolke (United Kingdom)

15:20 – 15:40 Psychiatric outcomes following very preterm birth Peter Anderson (Australia)

15:40 – 16:00 The brain and neuropsychiatric disorders in children born preterm Nelly Padilla (Sweden)

16:00 - 16:15 Two-year outcome of extremely preterm infants < 26 weeks of gestation born in Switzerland: is intensity of perinatal care associated with increased neurodevelopmental impairment? G. Natalucci; T.M. Berger; C. Borradori-Tolsa; M. Bickle-Graz; S. Grunt; R. Gerull; D. Bassler; M. Adams (Switzerland)

16:15 - 16:30 Cognitive and behavioral aspects of executive functioning at age 6.5 years in children born extremely preterm: a Swedish national prospective study (EXPRESS) A. Farooqi; F. Serenius; M. Adamsson; M. Hafström; U. Åden; K. Stjernqvist (Sweden)

3rd November, 2017

104104

16:30 - 16:45 Delineating the behavioural phenotype among children born extremely preterm J. Trickett; D. Wolke; C. Hollis; N. Marlow; S. Johnson (United Kingdom)

16:45 - 17:00 Prevalence of autism in extreme preterm children born in Stockholm 2004-2007 E. Eklöf; A. Hedfors Moretti; H. Lagercrantz; S. Bolte; U. Aden (Sweden)

15:00 - 17:00 PARALLEL SESSION 33 |SORRENTO ROOM IUGR across SPECIALITIES Chairs: Chiara Mandò (Italy); Luca Ramenghi (Italy)

15:00 – 15:20 Metabolic and oxidative phenotype of IUGR Chiara Mandò (Italy)

15.20 – 15:40 Cardiovascular assessment and outcome of the early IUGR Tiziana Frusca (Italy)

15:40 – 16:00 The very preterm IUGR between lung and nutrition Virgilio P. Carnielli (Italy)

16:00 – 16:20 1The premature brain and the IUGR brain developmental trajectories Petra Hüppi (Switzerland)

16:20 – 16:40 IVH and IUGR: thoughts for improving neonatal care? Luca Ramenghi (Italy)

16:40 – 17:00 Discussion

3rd November, 2017

105105

15:00 – 17:00 PARALLEL SESSION 34 |LECCE ROOM COINN Global perspectives in neonatal care Chairs: Agnes van den Hoogen (The Netherlands); Karen Walker (Australia)

15:00 – 15:30 COINN’s leadership and partnerships to decrease mortality and morbidity and improve neonatal care – global perspective Karen New (Australia)

15:30 – 16:00 Using parent experiences for learning - exploring the use of parent narratives to inform education in neonatal care Julia Petty (United Kingdom)

16:00 – 16:30 Global neonatal nursing - opportunities and challanges Carole Kenner (United States)

16:30 – 17:00 Developmental Surveillance in children born very preterm Margo Pritchard (Australia)


17:30 - 19:00 PLENARY SESSION 7 |DARSENA ROOM THE NEED OF MULTIDISCIPLINARY APPROACHES IN RESEARCH Chairs: Silke Mader (Germany); Neil Marlow (United Kingdom)

17:30 – 18:00 The benefit of an equal partnership with parents in research Mark Turner (United Kingdom)

18:00 – 18:30 How to involve and empower parents in research projects Nicole Thiele (Germany) 18:30 – 19:00 The benefit of an active partnership with nurses in research Agnes van den Hoogen (The Netherlands)

3rd November, 2017

106106

107107

08:00 – 09:00 POSTER WALK | GROUND FLOOR Cardiac Physiology Pathology Chairs: Daria Kryuchko (Russia); Lizelle Van Wyk (South Africa)

ID 106 DIAGNOSIS OF DIGEORGE SYNDROME: THE CONTRIBUTION OF MOLECULAR GENETICS Y. Halleb; H. Hadj-Abdallah; S. Nouri; A. Touati; M. Bellallah; J. Mathlouthi; N. Mahdhaoui; H. Sboui; A. Saad; D. H’mida (Tunisia)

ID 168 EFFICACY OF MEDICAL TREATMENT IN CLOSING PATENT DUCTUS ARTERIOSUS IN ELBW INFANTS S. Bellis; Y. Singh (United Kingdom)

ID 178 ACETAMINOPHEN FOR CLOSING PDA. SHOULD IT BE A FIRST LINE THERAPEUTIC OPTION? I. Tofé; M.D. Ruiz; M.P. Jaraba; M.V. Rodriguez; R.L. Rueda; M.D. Ordoñez; M.J. Parraga (Spain)

ID 190 PATENT DUCTUS ARTERIOSUS WITH HEMODYNAMIC REPERCUSSION IN VERY LOW WEIGHT PRETERM INFANTS TREATED WITH ORAL IBUPROFEN PRESENT A HIGH RATE OF BRONCHOPULMONARY DYSPLASIA M.M. Lourenço; E. Sacramento; F. Carmona; C. Calixto; F. Martin-Celini; G.H. Seribelli; W.A. Gonçalves-Ferri (Brazil)

ID 231 PRENATAL DIAGNOSIS OF THE SYSTEMIC BLOOD FLOW RESTRICTION DEFECTS IMPROVES HEMODYNAMIC STABILITY OF THE NEONATES WITH CONGENITAL CARDIAC DEFECT AT THE ADMITTANCE IN NEONATAL INTENSIVE CARE UNIT M. Cucerea; M. Simon; M. Ungureanu; R. Marian; E. Moldovan; M. Rusneac; C. Gliga; L. Suciu (Romania)

ID 247 ASSOCIATION BETWEEN ASYMPTOMATIC PATENT DUCTUS ARTERIOSUS BEYOND THE EARLY POSTNATAL PERIOD AND 3-YEAR NEUROLOGICAL OUTCOME K. Inomata; S. Taniguchi; T. Inoue; A. Kawase; Y. Kondo (Japan)

ID 380 THE SUDDEN CHANGE IN CARDIAC FUNCTION AFTER PATENT DUCTUS ARTERIOSUS LIGATION MEASURED BY ELECTRICAL CARDIOMETRY IN AN EXTREME LOW BIRTH WEIGHT INFANT Y.H. Chien; K.Y. Chao; Y.L. Chen; L.Y. Tsai; C.E. Chiang; S.C. Mu (Taiwan)

ID 509 PULSE OXIMETRY SCREENING IN THE ASYMPTOMATIC NEWBORNS S. Chaudhry; Y. Singh (United Kingdom)

ID 513 CHANGES IN THE MANAGEMENT OF PATENT DUCTUS ARTERIOSUS OVER 10 YEARS IN A TERTIARY NEONATAL CENTRE D. Panjwani; S. Mittal (United Kingdom)

4th November, 2017

108108

ID 515 COARCTATION OF THE AORTA - THE CONGENITAL HEART DEFECT WITH A MILLION FACES M. Simon; R. Sánta; L.M. Suciu; Z.S. Gáll; R. Marian; M. Rusneac; C. Gliga; M.C. Cucerea (Romania) ID 550 RARE CONGENITAL MITRAL VALVE MALFORMATION R. Stroescu; A. Popoiu; M. Gafencu; O. Marginean; G. Doros (Romania)

ID 628 ASSESSMENT OF NEONATAL HEART RATE IMMEDIATELY AFTER BIRTH USING DIGITAL STETHOSCOPE; HAND HELD ULTRASOUND AND ELECTROCARDIOGRAPHY B. Treston; J. Semberova; R. Kernan; E. Crothers; A. Branagan; N. O’Cathain; J. Miletin (Ireland)

ID 639 COINCIDENTAL LEFT ATRIAL THROMBUS I. Mungan Akin; P. Canizci; S. Sevuk Ozumut; S. Arslanoglu (Turkey)

ID 683 PERICARDIAL EFFUSION: SEVERE COMPLICATION OF CENTRAL VENOUS CATHETERIZATION IN THE NEWBORN (REPORT OF 12 SURVIVORS) S. Nouri Merchaoui; J. Methlouthi; H. Ayache; M. Bellalah; I. Kacem; H. Barbouche; A. Ghith; N. Mahdhaoui; H. Seboui (Tunisia)

ID 694 GENETIC ABNORMALITIES AND CONGENITAL HEART DISEASE S. Nouri Merchaoui; J. Methlouthi; H. Ayech; M. Bellaleh; I. Kacem; H. Barbouche; A. Ghith; S. Mougou; D. Hmida; N. Mahdhaoui; H. Seboui (Tunisia)

ID 704 USE OF PROSTIN IN A TERTIARY NEONATAL UNIT R. Prasad; H. Wood; O. Nolan; S.V. Rasiah (United Kingdom)

ID 769 THE USABILITY OF ICON FOR NEONATOLOGY W.P. de Boode; B.M. Wulterkens; B.A.M. Nieuweweme (The Netherlands)

ID 810 WHAT IS THAT PULSATING ON THE ANTERIOR ABDOMINAL WALL? O. Nolan; R. Prasad; P. Miller; M. Singh; SV. Rasiah (United Kingdom)

Circulation Macro Microcirculation Chairs: Willem de Boode (The Netherlands)

ID 236 THE INFLUENCE OF MATERNAL MEDICATION ON CLOSURE OF THE DUCTUS ARTERIOSUS IN THE PREMATURE NEWBORN W.P. de Boode; J. van Drongelen; M.J.A. Raaymakers (The Netherlands)

ID 263 CHRONOLOGICAL EX-UTERINE ADAPTATION OF HEMODYNAMIC PERFORMANCE IN VERY LOW BIRTH WEIGHT (VLBW) PRETERM INFANTS R. Lien; S. Hsu; D. Mok; W.M. Chen; L.C. See (Taiwan)

4th November, 2017

109109

ID 273 HEMODYNAMIC RELEVANCE OF PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS ASSESSED BY CEREBRAL OXYGENATION OF FREQUENCY DOMAIN NEAR-INFRARED SPECTROSCOPY; ECHOCARDIOGRAPHIC AND DOPPLER-ULTRASOUND PARAMETERS AND NT-PROBNP: A PROSPECTIVE OBSERVATIONAL STUDY C.E. Schwarz; A. Preusche; M. Wolf; C.F. Poets; A.R. Franz (Germany)

ID 417 ULTRASONOGRAPHIC MONITORING FOR POSTNATAL ADAPTATION IN PRETERM INFANTS V. Nardi 1; M.L. Tataranno 2; S. Di Fabio 1 (1. Italy; 2. The Netherlands)

ID 464 RETROSPECTIVE ANALYSIS OF CATHETER RELATED VEIN THROMBOSIS AMONG NEWBORNS IN THE NICU SETTINGS. K. Chojnacka; Z. Krasinski; K. Wróblewska-Seniuk; J. Mazela (Poland)

ID 676 TREATMENT FOR PATENT DUCTUS ARTERIOSUS AND NEUROCOGNITIVE OUTCOME AT 6.5 YEARS OF AGE IN CHILDREN BORN EXTREMELY PRETERM A. Gudmundsdottir; L. Broström; B. Skiöld; K. Källén; M. Norman; U. Ådén; A-K. Edstedt Bonamy (Sweden) ID 715 SYSTEMIC HYPOPERFUSION AND REGIONAL OXYGENATION IN PDA: A CASE REPORT V. Comito; A. Falcone; L. Bruno; E. Paviglianiti; I. Mondello; A. Rossi (Italy)

ID 724 LONG-TERM OUTCOME AFTER PATENT DUCTUS ARTERIOSUS TREATMENT IN EXTREMELY PRETERM INFANTS M.S. Veldhuis; L.M.L. Dix; J.M.P. Breur; W.B. de Vries; I.C. van Haastert; P.M.A. Lemmers; D.C. Vijlbrief (The Netherlands)

ID 794 PROGNOSTIC VALUE OF THE VALUE OF SUPERIOR VENA CAVA FLOW DURING THE FIRST DAY IN PRETERM INFANTS ≤32 WEEKS GESTATION G.C. Zaharie; T. Drugan; D. Muresan; M. Matyas; H. Rabe; Behalf of the NEO-Circ; M. Hasmasanu (Romania)

ID 796 COMPARISON OF CARDIAC OUTPUT MEASURED BY BIOREACTANCE WITH ECHOCARDIOGRAPHY MEASUREMENTS IN INFANTS WITH BIRTH WEIGHT BELOW 1250G. J. Miletin 1,2; J. Semberova 1,2; Z. Stranak 1,2 (1. Ireland; 2. Czech Republic)

ID 807 SPONTANEOUS NEONATAL ARTERIAL THROMBOSIS: A REPORT OF 6 NEONATES J. Mathlouthi; S. Nouri; H. Ayech; M. Bellaleh; I. Kacem; H. Barbouch; N. Mahdhaoui (Tunisia)

ID 859 THE USE OF ETCO2 (CAPNOGRAPHY) IN NEONATAL INTUBATION A. Davies; A. Walker; L. Elsaadany; P. Shires; D. Batra (United Kingdom)

4th November, 2017

110110

ID 877 COMPARISON BETWEEN NIRS AND THE TRADITIONAL AND NOVEL APPROACH OF SVC FLOW ASSESSMENT IN VLBW INFANTS B. Ficial; A. Boschetti; E. Bonafiglia; A. Pietrobelli; P. Biban (Italy)

Neonatal Fetal Nutrition and Metabolism Chairs: Colin Morgan (United Kingdom); Sissel Moltu (Norway); Mark Johnson (United Kingdom)

ID 033 GUIDE LINES FOR MULTIVITAMINS ADMINISTRATION IN FORTIFIED HUMAN MILK PREPARE FOR PRETERM INFANT V. Rigourd; I. Dridi Brahim; H. Razafimahefa; F. Quetin; E. Leroy; C. Pichon; A. Giuseppi; L. Berthie (France)

ID 077 EFFECTS OF EXCLUSIVE DONOR HUMAN MILK FEEDING IN A SHORT PERIOD AFTER BIRTH ON MORBIDITY AND GROWTH OF PRETERM INFANTS DURING HOSPITALIZATION S.H. Chung; E.J. Kim (Korea)

ID 130 ASSAY OF IRISIN CONCENTRATION IN INFANT FORMULAS AND BREAST MILK N. Mól; P. Tomasik; M. Zasada; P. Kwinta (Poland)

ID 140 ENTERAL FEEDING STRATEGIES FOR VERY LOW BIRTH WEIGHT INFANTS: A NATIONWIDE SURVEY IN JAPAN M. Ashina; K. Fujioka; S. Totsu; H. Shoji; T. Miyazawa; K. Wada; K. Iijima; I. Morioka (Japan)

ID 160 DONOR HUMAN MILK MACRONUTRIENT CONTENT: THE EFFECT OF HOLDER PASTEURIZATION P. Piemontese; D. Mallardi; N. Liotto; C. Menis; C. Tabasso; M. Perrone; M.L. Giannì; P. Roggero; F. Mosca (Italy)

ID 161 NEW PARENTERAL NUTRITION AND ACIDOSIS IN PRETERM INFANTS F. Bonsante; JB. Gouyon; S. Iacobelli (France)

ID 172 IMPACT ON BREASTFEEDING RATES OF PRETERM INFANTS WITH LESS THAN 29 WEEKS WITH RESTRICTION OF RAW HUMAN MILK IN THE FIRST EIGHT WEEKS OF LIFE DUE TO THE RISK OF PERINATAL CYTOMEGALOVIRUS INFECTION F.P. Martins-Celini; W.A. Gonçalves-Ferri; B.B. Lima; D.C. Aragon; M.M. Mussi (Brazil)

ID 179 VITAMIN D STATUS AMONG PRETERM INFANTS AS A HIGH RISK MORBIDITY MARKER I. Tofe; M.D. Cañete M.J. de la Torre; J.L. Perez-Navero; J. Caballero-Villarraso (Spain)

4th November, 2017

111111

ID 202 PROACTIVE USE OF BREAST MILK FORTIFIER AND BREASTMILK AT DISCHARGE: IS THERE A LINK? A NATIONAL SURVEY OF PRACTICE S. Stiles; L. de Rooy (United Kingdom)

ID 220 SODIUM SUPPLY BUT NOT HYPERNATREMIA IS ASSOCIATED WITH SEVERE INTRAVENTRICULAR HEMORRHAGE IN EXTREMELY PRETERM INFANTS C. Späth; E. Stoltz Sjöström; J. Ågren; F. Ahlsson; M. Domellöf (Sweden)

ID 245 RELATION OF CORD SERUM LEVELS OF INSULIN-LIKE GROWTH FACTOR-I; INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3; GLUCAGON AND LEPTIN ON BIRTH INDICES BETWEEN KOREAN PRETERM AND TERM INFANTS J.H. Park; S.J. Kang; L.H. Lee; S.Y. Shin; C.S. Kim; S.L. Lee; J.G. Bae; S. Kim (Korea)

ID 264 USE OF DONOR BREAST MILK IN A TERTIARY NEONATAL UNIT – COMPLIANCE WITH A GUIDELINE C. Apsey; K; Williams; K. Johnson; H. Shore (United Kingdom)

ID 265 COPPER AND ZINC CONTENT OF BREASTMILK FROM WOMEN SUFFERING FROM WILSON’S DISEASE T. Reicherzer; G. Schütze; M. Vogeser; A. Schulze; A.W. Flemmer (Germany)

ID 276 EARLY ENERGY AND PROTEIN INTAKE AFFECTS GROWTH AND MORBIDITY IN EXTREMELY PRETERM INFANTS S. Klevebro; V. Westin; E. Stoltz Sjöström; M. Norman; M Domellöf; A-K Edstedt Bonamy; B Hallberg (Sweden)

ID 293 USE OF PROBIOTICS IN PRETERM NEWBORNS. DOES FEEDING TOLERANCE IMPROVE? M.I. Huescar; M.G. Espinosa; T. Sanchez; E. Salguero (Spain)

ID 339 EXTRAUTERINE GROWTH RESTRICTION ASSOCIATED FACTORS IN SMALL AND APPROPRIATE FOR GESTATIONAL AGE INFANTS: A COHORT STUDY C. Morcelli-Tovar; A.A.Vieira (Brazil)

ID 362 NEONATAL INTESTINAL FAILURE IN THE UK – WHO CARES? R. Jones; P. Cairns (United Kingdom)

ID 398 HYPOARGININAEMIA AND SEPSIS IN VERY PRETERM INFANTS RECEIVING PARENTERAL NUTRITION C. Morgan; L. Burgess (United Kingdom)

ID 399 TARGET PARENTERAL PROTEIN ATTAINMENT IN PARENTERALLY FED PRETERM INFANTS FOLLOWING THE IMPLEMENTATION OF THE CONCENTRATED MACRONUTRIENTS IN PARENTERAL STANDARDISED SOLUTIONS (CoMPaSS) PROGRAMME F. Callaghan; C. Morgan (United Kingdom)

4th November, 2017

112112

ID 435 LEVELS OF GLUCOSE IN CORD BLOOD SAMPLES (LOGICS) N. Ó Catháin 1; A. Stanzelova 1; B. Treston 1; R. O’Kelly 2; A. Killalea 2; J. Kelly 2; J. Semberova 1; J. Miletin 1,2 (1. Ireland; 2. Czech Republic)

ID 455 SANJAD SAKATI SYNDROME: ABOUT NEW TUNISIAN CASES A. Touati 1; S. Nouri 1 ;Y. Hallab 1; J. mathlouthi 1; N. Ben Salah 1; M. Mastouri Haddeji 1; Y. El Abed 1; A. Ben Ahmed 1; A. Saad 1; C. Ben Singor 2; D. H’mida Ben Brahim 1 (1. Tunisia; 2. France)

ID 466 THE EFFECT OF DRESSING AFTER TUB BATHING ON MOISTURE LOSS IN PRETERM INFANTS Z. Kan Onturk; D. Gozen (Turkey)

ID 508 THE IMPACT OF EARLY VERSUS LATE NUTRITIONAL SUPPORT ON GROWTH AND NEURODEVELOPMENTAL OUTCOME IN VERY LOW BIRTH WEIGHT INFANTS C.Y. Kim; J.H. Hwang; E. Jung; B.S. Lee; A.R. Kim; K.S. Kim (Korea)

ID 574 INSULIN INFUSION FOR HYPERGLYCEMIA IN EXTREMELY PRETERM - A PILOT STUDY W. Hellström; S. Najm; K. Sävman; I. Pupp Hansen; D. Ley; G. Hellgren; A. Hellström; C. Löfqvist (Sweden)

ID 600 PONDERAL INDEX IN SGA NEONATES: IS IT RELIABLE INDEX? S. Erçin; T. Gursoy (Turkey)

ID 609 POSTNATAL GROWTH VELOCITY CALCULATION: ACCURACY OF DIFFERENT METHODS A. Ali 1; N. Rochow 1; A; Alkhoraidly 2; R. Iskander 1; G. Fusch 1; C. Fusch 1,3 (1. Canada; 2. Saudi Arabia; Germany)

ID 640 NEONATAL HYPOGLYCEMIA DETECTED BY A GLUCOSE METER: IS IT RELIABLE? K. Ben Ameur; K. Msalbi; T. Khemis; H. Ben Hamida; F.Z. Chioukh; K. Monastiri (Tunisia)

ID 688 CLINICAL EFFECTS OF OROPHARYNGEAL COLOSTRUM ADMINISTRATION IN VERY LOW BIRTH WEIGHT INFANTS IN THE FIRST MONTH OF LIFE E. Martin-Alvarez; M. Peña-Caballero; L. Serrano-Lopez; M.B. Sánchez-Martínez; M. Alonso-Moya; J.J. Ochoa; J. Maldonado; J.A. Hurtado-Suazo (Spain)

ID 719 MACRONUTRIENT PROFILE OF DONATED BREAST MILK: DOES LONG TIME BREASTFEEDING MODIFY IT? N. Sarmiento-Carrera; N. Gonzalez-Freiria; A. Concheiro-Guisan; M. Suarez-Albo; S. Alonso-Clemente; Jr Fernandez-Lorenzo (Spain)

4th November, 2017

113113

ID 721 TYPE OF FEEDING IN BABIES FROM THE NEONATAL INTENSIVE THERAPY UNIT OF A BABY FRIENDLY HOSPITAL AT THE TIME OF HOSPITAL DISCHARGE A.M. Miranda; A.L.L. Ledesma; G.M. Fernandes; I.C.L. Firmino; G. Berretim-Felix (Brazil)

ID 725 DONOR HUMAN MILK IMPACT ON NUTRITIONAL STATUS OF VERY PRETERM INFANTS S. Salas; D. Cañizo; M. Izquierdo; I. Iglesias (Spain)

ID 730 INFLUENCE OF THE USE OF DONOR HUMAN MILK IN THE CLINICAL COURSE OF TWO COHORTS OF VERY PRETERM INFANTS D. Cañizo; S. Salas; M. Izquierdo; I.Iglesias (Spain)

ID 770 GROWTH AND BODY COMPOSITION ASSESSMENT AT FOLLOW-UP OF VERY PRETERM INFANTS B. del Rey Hurtado de Mendoza; C. Balcells; M. Izquierdo-Renau; I. Iglesias-Platas (Spain)

ID 782 GROWTH OF VERY PRETERM INFANTS (<32 WEEKS) WITHIN 3 YEARS AFTER BIRTH K. Suzuki; Y Murayama; H Masaki (Japan)

ID 786 THE ASSOCİATİON BETWEEN 25 OH-D VİTAMİN LEVELS AND AORTİC; CAROTİD İNTİMA MEDİA THİCKNESS İN HEALTY NEWBORN İNFANTS D. Arman; Z. Cetiner; A. Erdil; E.Yurdakul (Turkey)

ID 828 GROWTH PARAMETERS AT BIRTH IN INFANTS WITH CONGENITAL ZIKA VIRUS SYNDROME AND MICROCEPHALY I. García-García; L. Gely; J. Negrón; L. García-Fragoso (Puerto Rico)

ID 848 MICROBIOA AND SCFA OF TERM INFANTS A. Bartnicka; M. Szewc; K. Mielnik; M. Gałęcka; J. Mazela (Poland)

ID 857 URINARY METABOLIC PROFILE OF NEONATES IN WESTERN GREECE: PRELIMINARY DATA I. Giannakopoulos; A. Tsintoni; I. Christopoulou; L. Vitsa; N. Malic; M.M. Pogka; S. E. Bariamis; I. Georgakopoulou; S.A. Chasapi; G.A. Spyroulias; A. Varvarigou (Greece)

ID 858 DIETARY MANIPULATION OF MOTHERS OF PRETERM INFANTS: EFFECT ON BREASTMILK COMPOSITION AND MEETING MACRONUTRIENT REQUIREMENTS K. Megaw (South Africa)

ID 866 THE CONSEQUENCE OF PHOTOTHERAPY EXPOSURE ON OXIDATIVE STRESS STATUS OF EXPRESSED HUMAN MILK S. Unal; N. Demirel; D. Yaprak Sul; D. Ulubas Isik; S. Erol; S. Neselioglu; O. Erel; A. Yagmur Bas (Turkey)

4th November, 2017

114114

ID 869 MONITORING THE GUT MICROBIOTA ESTABLISHMENT IN VERY LOW-WEIGHT PRETERM INFANTS E. Escribano; C. Saralegui; R. del Campo; S. del Pozo; L. Moles; J.M. Rodríguez; M. Saenz de Pipaon (Spain)

ID 876 BABIES WITH FEEDING DIFFICULTIES HAVE HIGHER CONCENTRATIONS OF BETA-HYDROXYBUTYRATE D.L. Harris; P.J. Weston; J.E.Harding (New Zealand)

Neonatal Infections Diseases / Immunology Chairs: Sinno Simons (The Netherlands)

ID 019 UPTAKE OF PERTUSSIS AND INFLUENZA VACCINES IN PREGNANCY A. Saso; B. Donaldson; B. Kampmann (United Kingdom)

ID 034 SEVERE COMBINED IMMUNE DEFICIENCY AND CONTINUED BREASTFEEDING: REPORT OF 5 OWN MOTHER’S MILK DONATION (OMM) AT THE REGIONAL ILE DE FRANCE MILK BANK V. Rigourd; D. Moshous; J.F. Méritet; M. Nicloux; C. Hovhannisyan; M. Dorsi; T. Hachem; P. Frange; A. Lapillonne; J.F. Magny (France)

ID 251 ANTIBIOTIC EXPOSURE IN NEONATES AND IMPACT ON GUT MICROBIOTA AND ANTIBIOTIC RESISTANCE DEVELOPMENT: A SYSTEMATIC REVIEW J. Fjalstad 1; E. Esaiassen 1; L. Juvet 1; J. van den Anker 2; C. Klingenberg 3 (1. Norway; 2. Switzerland; 3. United States)

ID 252 EFFECT OF CATHETER DWELL TIME ON RISK OF CENTRAL LINE ASSOCIATED BLOOD STREAM INFECTION IN NEONATES IN A DEVELOPING HEALTHCARE SYSTEM S.B. Chaaya; R. Durmush; C.P.H. Ibrahim (United Arab Emirates)

ID 258 20 YEARS OF EARLY NEONATAL SEPSIS DUE TO ESCHERICHIA COLI: SHOULD WE CHANGE EMPIRICAL ANTIBIOTIC THERAPY? M.C. Céspedes; N. Mendoza; M. Balasch; S. Gonzalez; A. Andreu; M.A. Frick; MA. Linde; J.J. Gonzalez; P. Soler (Spain)

ID 288 HAND HYGIENE COMPILENCE IN NICU; A OBSERVATIONAL STUDY A. Gürol; K.Ş. Tekgündüz; S. Polat; S.E. Tekgündüz; S. Ejder Apay (Turkey)

ID 296 NEONATAL SEPTIC ARTHRITIS IN NICU F. Krasniqi; I. Krasniqi; X. Gojnovci; H. Jashari (Kosovo)

ID 301 CURRENT PRACTICE AND NEONATAL STAFF’S KNOWLEDGE ON ANTIBIOTIC USE AND ANTIBIOTIC STEWARDSHIP PROGRAMMES ACROSS TWO NEONATAL NETWORKS M. Scott; M. Carpenter; P. Satodia; P. Nath (United Kingdom)

ID 333 PREDICTORS OF MORTALITY IN NEONATAL SEPSIS G. Irawan Sarosa; R. Rahim (Indonesia)

4th November, 2017

115115

ID 352 C-REACTIVE PROTEIN: AN ADJUNCT OR DILEMMA FOR DIAGNOSIS OF NEONATAL MENINGITIS F. Yasin; S.F. Virupachi; R.A. Khan (Ireland)

ID 408 DNA VIRUSES: THEIR ROLE IN ACUTE RESPIRATORY INFECTIONS IN NEONATAL UNIT IN TUNISIA I. Brini 1,2; N. Hannachi 1; A. Guerrero 2; B. Hetzer 2; W. Borena 2; S. Nouri Merchaoui 1; H. Sboui 1; D. Von Laer 2; J. Boukadida 1; H. Stoiber 2 (1. Tunisia; 2. Austria)

ID 429 REVIEW OF ADVERSE VACCINE REACTIONS IN AN IRISH NEONATAL UNIT C. Fox; E. Gordon (Ireland)

ID 445 DOES DURATION OF BLOOD CULTURE REPORTING IMPACT ON THE CARE OF NEONATES AT RISK OF EARLY ONSET NEONATAL SEPSIS? L. Woodgate; C. Chetcuti Ganado (United Kingdom)

ID 459 A CANDIDA TROPICALIS OUTBREAK DURING EL NINO IN A NEONATAL INTENSIVE CARE UNIT IN SOUTHERN PHILIPPINES C. Masilungan; R. Aunal; J. Peralta (Philippines)

ID 483 CONGENITAL CYTOMEGALOVIRUS INFECTION- NEONATOLOGICAL ASPECT S. Stefanovic; V. Stefanovic; V. Stefanovic (Serbia)

ID 548 DIAGNOSTIC VALUE OF SERUM AMYLOID A IN NEONATAL BACTERIAL INFECTIONS AND ASSOCIATIONS WITH CIRCULATING HDL AND CYTOKINE LEVELS V. Bourika; E. Hantzi; A. Margeli; I. Papassotiriou; T. Siahanidou (Greece)

ID 558 CONGENITAL TUBERCULOSIS AS A RESUL OF DISSEMINATED MATERNAL DISEASE. IS CORRECT THE ACTUAL MANAGEMENT? A.B. Escobar Izquierdo; G. Uclés López; M.J. Cobas Pazos; Y. Lopez Lozano; M.D. Sanchez-Redondo Sanchez-Gabriel; A. Martinez Gimeno (Spain)

ID 562 NEONATAL SEPSIS: FREQUENCY; RISK FACTORS AND OUTCOME IN A LEVEL II NICU UNIT L. Blaga; M. Matyas; C. Vidra; M. Hasmasanu; G. Abrudan; G. Zaharie (Romania)

ID 567 LUMBAR PUNCTURE SUCCESS & FAILURE IN A TERTIARY NEONATAL UNIT - A PROSPECTIVE COHORT STUDY A. Marshall 1; M. Sadarangani 1; C.C. Roehr 1,2; M. Anthony 1 (1. United Kingdom; 2. Germany)

ID 614 HOSPITALISATION FOR RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN PREMATURE INFANTS BORN IN MULTIPLE BIRTHS R. Thwaites; S. Buchan; C. Morris; B. Rodgers-Gray; J. Fullarton; J. Coutts (United Kingdom)

4th November, 2017

116116

ID 619 ANTIBIOTICS FOR EARLY ONSET NEONATAL SEPSIS: AUDITING PRACTICE AND ANALYSING COST O. Kazeem; M. Saunders; R. Roy; C. Tremlett (United Kingdom)

ID 630 DYSFUNCTIONAL INFLAMMATION; THE SIGNIFICANCE OF TLR2 SIGNALING IN HYPOXIC NEONATES PREDISPOSED TO NEURAL ENCEPHALOPATHY B. Wright; K. Lynne; M. Eleanor; M. Omer; N. A Taher; M. O’Dea; A. Melorz; A. Moreno (Ireland)

ID 658 NEONATAL THYMIC CHARACTERISTICS IN A RAT MODEL OF INTRAUTERINE GROWTH RESTRICTION J.B. Armengaud; K. Nardou; F. Pre-Curto; F. Candotti; F. Angelini; M. Hofer; U. Simeoni; C. Yzydorczyk (Switzerland)

ID 682 IMPACT OF MICROBIAL-ASSOCIATED INTRA-AMNIOTIC INFLAMMATION AND “STERILE” INTRA-AMNIOTIC INFLAMMATION ON SHORT-TERM NEONATAL OUTCOME IN WOMEN WITH PRETERM LABOR AND INTACT MEMBRANES A. Herranz Barbero; R. Amoedo Blanco; M. Izquierdo Renau; C. Murillo; C. Rueda; J. Ponce; T. Cobo (Spain)

ID 685 PCT; IL-6 AND IL-8; BUT NOT HA ARE USEFUL FOR DIAGNOSTIC UTILITY IN NEONATES AT RISK THAT FULFILL THE NORWEGIAN CONSENSUS DEFINITION OF NEONATAL SEPSIS B. Nakstad; H.C.D. Østerholt; A.L. Solevåg (Norway)

ID 699 NEONATAL INVASIVE CANDIDIASIS: STUDY OF 108 CASES COLLECTED IN NEONATOLOGY DEPARTMENT OF SOUSSE (TUNISIA) S. Nouri Merchaoui; N. Mahdhaoui ; H. Ayache; F. Saghrouni; M. Bellalah; I. Kacem; H. Barbouche; A. Ghith; J. Methlouthi; H. Seboui (Tunisia)

ID 706 NEWBORN SCREENING TESTS IN INFANTS WITH CONGENITAL ZIKA VIRUS SYNDROME AND MICROCEPHALY L. García-Fragoso; L. Gely; S. Rivera-Sánchez; I. García-García (Puerto Rico)

ID 716 PREVENTIVE EFFECT OF LACTATIONAL MASTITIS BY ADMINISTRATION OF LACTOBACILLUS FERMENTUM CECT5716. A RANDOMIZED CONTROLLED TRIAL. L. Serrano López; E. Martín Álvarez; M. Peña Caballero; J. Fonollá Joya; J.A. Hurtado Suazo (Spain)

ID 728 UMBILICAL CORD CARE AND OMPHALITIS IN NEWBORNS OF NORTHERN PORTUGAL: A MULTICENTRIC RETROSPECTIVE STUDY C. Teles Silva; M. Nogueira; I. Falcão; A.L. Santos; M. Rodrigues; G. Silva; H. Guimarães (Portugal)

ID 743 CENTRAL LINE ASSOCIATED INFECTION IN NEWBORNS ADMITTED TO A PORTUGUESE NEONATAL INTENSIVE CARE UNIT T. Lopes; M. Branco; A. Freitas; I. Falcão; C. Carvalho; E. Proença; A. Almeida (Portugal)

4th November, 2017

117117

ID 750 NEONATAL INFECTIONS AT PREMATURE AND AT TERM NEWBORN M. Dima; I. Petre; A Baros; E.R. Iacob; D. Iacob (Romania)

ID 752 PROSTAGLANDIN E2 URINARY METABOLITE IN PRETERM INFANTS – A BIOMARKER FOR INFLAMMATION? V. Siljehav; L. Gerbaulet; G. Aquilano; A. Honore; S. Psyllidou; M. Vanpée; E. Herlenius (Sweden)

ID 755 APPLICATION OF EVIDENCE-BASED MEDICINE METHODS TO DIAGNOSE EARLY NEONATAL SEPSIS O.Vlasova; L. Koliubakina; L. Bezrukov (Ukraine)

ID 787 NEONATAL BRONCHIOLITIS: CLINICAL PRESENTATION; MANAGEMENT AND PREVENTION H. Ben Salem; M.T. Lamouchi; M. Sellami; I. Kasraoui; N. Kasdallah; S. Blibech; M. Doagi (Tunisia)

ID 801 SHOULD WE LUMBAR PUNCTURE TERM BABIES BASED ON CRP CRITERIA SET BY NICE? H. Wood; S. Steadman; J. Gray; V. Rasiah (United Kingdom)

ID 840 MENB (BEXSERO®) IMMUNISATION IN NICU: EXPERIENCE IN A UK TERTIARY NEONATAL UNIT POST INTRODUCTION OF VACCINE A. Mukherjee; S. Senthil; A. Razai; D. Mukherjee (United Kingdom)

4th November, 2017

118118

9:00 - 11:00 PARALLEL SESSION 35 SENSORY OUTCOMES AND PAIN |DARSENA ROOM Chairs: Jurgen C. de Graaff (The Netherlands); Ola D. Saugstad (Norway)

09:00 – 09:20 Long term effects of neonatal pain Suellen Walker (United Kingdom)

09:20 – 09:40 Anaesthetic toxicity in children Jurgen C. de Graaff (The Netherlands)

09:40 - 09:55 Neonatal pain, opioid and anaesthetic exposure; what remains in the human brain after the wheels of time? G.E. van den Bosch; D. Tibboel; J.C. de Graaff; H. El Marroun; A. van der Lugt; T. White; M. van Dijk (The Netherlands)

09:55 - 10:10 Mode of delivery influences nociceptive sensitivity in newborn infants – the NociCop trial N. Klarer 1; S. Kasser 1; H. Rickenbacher 1; C. Hartley 2; A. Depoorter 1; A.N. Datta 1; W. Magerl 3; E.A. Huhn 1; G. Green 2; R. Slater 2; Wellmann 1 (1. Switzerland; 2. United Kingdom; 3. Germany)

10:10 - 10:25 Can differences in early functional connectivity in healthy newborns exposed to olfactory stimulation help us understand crying behaviour at 6 weeks of life? L. Freitas; A. Adam-Darque; F. Grouiller; J. Sauser; F. Lazeyras; A. Merglen; P. Pollien; C.L. Garcia-Rodenas; G. Bergonzelli Degonda; D. Van De Ville; P. Hüppi; R. Ha-Vinh Leuchter (Switzerland)

10:25 - 10:40 The effect of morphine on early brain activity in extremely preterm infants: an observational multi-center study M.L. Tataranno1; L.S. deVries 1; L. Hellström-Westas 1; O. Dammann 2; M. Toet 1; F. Groenendaal 1; N.H.P. Claessens 1; V. Fellman 3; K. Sävman 3; M.J.N.L. Benders 1 (1. The Netherlands; 2. Germany; 3. Sweden)

10:40 - 10:55 Self-reported widespread pain in adults born early and late preterm K.A.I. Evensen 1; M. Tikanmäki 2; K. Heinonen 2; H-M. Matinolli 2; M. Sipola-Leppänen 2; A. Lano 2; D. Wolke 3; M. Vääräsmäki 2; J.G. Eriksson 2; S. Andersson 2,3; M-R. Järvelin 1; P. Hovi 2; K. Räikkönen 1; E. Kajantie 2 (1. Norway; 2. Finland; 3. United Kingdom)

4th November, 2017

119119

09:00 – 11:00 PARALLEL SESSION 36 (BRAIN 5) AUTOPHAGY IN DEVELOPING BRAIN |VENEZIA ROOM Chairs: Anita Truttmann (Switzerland); Ingran Lingam (United Kingdom)

09:00 – 09:20 Role of mitochondria and autophagy in perinatal brain damage Henrik Hagberg (United Kingdom)

09:20 – 09:40 Autophagic cell death in perinatal brain injury: does it matter? Anita Truttmann (Switzerland)

09:40 - 09:55 Blood based proteins that differentiate inflammation- sensitized hypoxia versus hypoxia alone within the 6h therapeutic window in a piglet model I. Lingam 1; A. Avdic-Belltheus 1; K. Martinello 1; C. Meehan 1; S. Ragab 1; I. Tachtsidis 1; C. Tann 1; M. Hristova 1; B. Fleiss 1; T. Wolfs 2; B. Kramer 2; N. Klein 1; H. Hagberg 1; P. Gressens 1; N.J. Robertson 1 (1. United Kingdom; 2. The Netherlands)

09:55 - 10:10 Autophagy inhibition protects in a preterm rat model of excitotoxic brain injury C. Descloux; V. Ginetì; J. Puyal; A.C. Truttmann (Switzerland)

10:10 - 10:25 Interaction between acute therapeutic hypothermia and a delayed mesenchymal stem cell therapy in neonatal hypoxia-ischemia J. Herz; C. Köster; B. S. Reinboth; M. Dzietko; I. Bendix; U. Felderhoff-Müser (Germany)

10:25 - 10:40 A comparison of the effects of short term whole body vibration, as experienced during neonatal ambulance transportation, on the developing brain L. Shipley; I. Bloor; D. Sharkey (United Kingdom)

10:40 - 10:55 CEACAM1 expression in the cerebellum S. Prager; B.B. Singer; I. Bendix; J. Herz; U. Felderhoff-Müser (Germany)

4th November, 2017

120120

09:00 – 11:00 PARALLEL SESSION 37 (PULMONOLOGY 6) FETAL GROWTH – SIZE MATTERS |ROMA ROOM Chairs: Olivier Danhaive (Belgium)

09:00 – 09:30 A database on fetal growth Stephen Kennedy (United KIngdom)

09:30 - 09:45 Can we assess the severity of neonatal respiratory distress by ultrasound? A comparison of three methods F. Raimondi; F. Migliaro; L. Verdoliva; D. Gragnaniello; G. Poggi; C. Sansone; R. Kosova; L. Capasso (Italy)

09:45 - 10:00 PCO2 levels and clinical and neurodevelopmental outcomes of extremely low birthweight infants T.H. Ulrich 1; J. Dreyhaupt 1; O. Genzel-Boroviczeny 1; B. Bohnhorst 1; M. Schmid 2; H. Fuchs 1; O. Rohde 1; S. Avenarius 1; H-G. Topf 1; A. Zimmermann 1; D. Faas 1; K. Timme 1; B. Kleinlein 1; H. Buxmann 1; W. Schenk 1; H. Segerer 1; N. Teig 1; F. Pulzer 1; R. Hentschel 1; M. Heckmann 1; R. Schlösser 1; J. Peters 1; R. Rossi 1; W. Rascher 1; R. Böttger 1; J. Seidenberg 1; G. Hansen 1; M. Zernickel 1; R. Muche 1; H.D. Hummler 1; for the PHELBI Study Group (1. Germany; 2. Switzerland)

10:00 - 10:15 Alveolar surfactant composition in preterm infants with respiratory distress syndrome before exogenous surfactant administration: effect of gestational age and inflammation G. Verlato; M. Simonato; E. Bassi; M. Fantinato; A. Correani; I. Giretti; E. Baraldi; P. Cogo; V.P. Carnielli (Italy)

10:15 - 10:30 TGFβ signaling is critical for regulating a proximal differentiation program and lung branching morphogenesis through activating notch signaling P.N. Tsao 1; H.K. Chen 1; T.Y. Ling 1; W.V. Cardoso 2 (1. Taiwan; 2. United States)

10:30 - 10:45 A randomised controlled trial of needle aspiration or chest drain insertion for pneumothorax in newborns (The NORD Trial), ISRCTN65161530 M. Murphy 1; C. Heiring 2; N. Doglioni 3; D. Trevisanuto 3; M. Blennow 4; K. Bohlin 4; G. Lista 3; I. Stucchi 3; C. O’Donnell 1 (1. Ireland; 2. Denmark; 3. Italy; 4. Sweden)

4th November, 2017

121121

09:00 – 11:00 PARALLEL SESSION 38 (NUTRITION 5) PROGRAMMING BY EARLY NUTRITION IN PRETERM INFANTS: WHAT IS KNOWN, WHAT IS HYPOTHESIZED? |FIRENZE ROOM Chairs: Umberto Simeoni (Switzerland);

09:00 – 09:20 Early nutrition and long term cardiovascular health Umberto Simeoni (Switzerland)

09:20 – 09:40 Decisions in early nutrition and later metabolic consequences Petteri Hovi (Finland)

09:40 - 09:55 Early-life protein intake in infants born extremely preterm is associated with higher blood pressure at school-age - Itay I. Zamir; E. Stoltz Sjöström; A.K. Edstedt Bonamy; L.A. Mohlkert; M. Norman; M. Domellöf (Sweden)

09:55 - 10:10 Prevalence of prediabetes and type 2 diabetes in young adults born with very low birth weight M. Talman; P. Nixon; E. Jensen; L. Washburn (United States)

10:10 - 10:25 Transient postnatal overfeeding in mice leads to metabolic and hepatic disorders at adulthood C. Yzydorczyk 1; N. Li 2; D. Mosig1; M. Bidho 1; B. Keshavjee 1; J.B. Armengaud 1; C. Vergely 2; U. Simeoni 1 (1. Switzerland; 2.France)

10:25 - 10:40 Effect of infant formula with protein content of 1.6g/100kcal fed between 3-12 months on body composition and adiposity at age 5 years E.E. Ziegler 1; D.A. Fields 1; S.D. Chernausek 1; D. Grathwohl 3; J.M. Jeter 1; S.E. Nelson 1; M. Chen 1; N.P. Hays 1; F. Haschke 3 (1. United States; 2. Switzerland; 3. Austria)

10:40 - 10:55 Newborn bone health is affected by maternal bariatric surgery E. Malchau Carlsen; K. Martha Renault; B. KanijoMøller; K. Nørgaard; L. Nilas; J-E. Bech Jensen; J. Lauenborg; D. Cortes; O. Pryds (Denmark)

4th November, 2017

122122

09:00 - 11:00 PARALLEL SESSION 39 NURSE SPECIALIST AND NURSE PRACTIONER ROLES AND PRACTICES |SORRENTO ROOM Chairs: Karen New (Australia); Carol Kenner (United States)

09:00 - 09:30 New professional role in neonatology, challenges and regulations Odile Frauenfelder (The Netherlands)

09:30 - 10:00 Neonatal nursing, where we are and where we are going – the evolving role of NPs Karen Walker (Australia)

10:00 - 10:30 Case presentation: a neonate who suddenly collapses- deciphering the differential diagnoses Karen Walker (Australia)

10:30 - 11:00 Not just neonatal survival – the effects of cerebral palsy and long term morbidity & long term outcomes in terms of autism etc Margo Pritchard (Australia)

09:00 - 11:00 PARALLEL SESSION 40 (EFCNI 5) BRIDGING THE GAP BETWEEN HOSPITAL AND OUT-PATIENT CARE FOR HOSPITALISED NEWBORNS |LECCE ROOM Chairs: Silke Mader (Germany)

09:00 - 09:20 Being a neonatal nurse practitioner working with parents is: transferring, supporting and accompanying towards parenthood George Damhuis (The Netherlands)

09:20 – 09:40 Graduating from the NICU and transition to the outpatient setting - what the primary care physician likes to know Kai König (Switzerland)

09:40 - 09:55 Mother-infant closeness supports the breastfeeding of preterm infants at discharge S. Raiskila 1; A. Axelin 1; L. Toome 2; S. Caballero 3; B. Tandberg 4; R. Montirosso 5; E. Normann 6; B. Hallberg 6; B. Westrup 6; U. Ewald 6; L. Lehtonen 1 (1. Finland; 2. Estonia; 3. Spain; 4. Norway; 5. Italy; 6. Sweden)

4th November, 2017

123123

09:55 - 10:10 Supporting the peer supporter G. Thomson; M-C. Balaam (United Kingdom)

10:10 - 10:25 Postpartum depression, bonding and coping strategies in mothers of newborns admitted to the neonatal unit R. Porta; G. Lasheras; E. Capdevila; B. Farré-Sender ; J.M. Farré (Spain)

10:25 - 10:40 Two year neurodevelopmental follow up data: meeting metrics vs delivering quality assessments M. Parmar; F. Ceroni; S. Narayanan; N. Merchant (United Kingdom)

10:40 – 11:00 Discussion


11:30 - 13:00 CLOSING SESSION |DARSENA ROOM PERSONALIZED MEDICINE Chairs: Charles C. Roehr (United Kingdom); Corrado Moretti (Italy)

11:30 – 12:10 Epigenetics: an evolutionary perspective on chronic disease Jonathan Wells (United Kigdom)

12:10 – 12:50 The impact of early life experiences in neurodevelopmental disorders Pierre Gressens (France)

12:50 – 13:00 Closing Words

4th November, 2017

124124

125125

SPONSORED SESSIONS

30/10/2017

09:00 - 17:30 PRE-CONGRESS COURSE | CAPRI ROOM (PALAZZO DEL CASINÒ)

ESN COURSE 1 - Neonatal Infections Supported by an unrestricted educational grant from

31/10/2017

09:00 - 17:00 PRE-CONGRESS COURSE |CAPRI ROOM (PALAZZO DEL CASINÒ)

ESN COURSE 2 - Neonatal Haemodynamics Supported by an unrestricted educational grant from

01/11/2017

12:30 - 13:30 WORKSHOP |SORRENTO ROOM (MOSAICI 1)

Respiratory Support in Neonates: How to ventilate term and preterm infants – Insights into new possibilities and neonatal ventilation strategies Supported by

12:30 - 13:30 LUNCHEON SYMPOSIUM |SORRENTO ROOM (MOSAICI 1)

Early optimal nutrition in the NICU Supported by

12:30 - 13:30 LUNCHEON SYMPOSIUM |LECCE ROOM (MOSAICI 2)

Strategies and modern technologies of continuous noninvasive blood gas monitoring Supported by

13:30 - 15:00 ROUND TABLE |FIRENZE ROOM Interactive clinical session: are babies with serious hypoxemic conditions still being missed? Supported by

13:30 - 15:00 SATELLITE SYMPOSIUM |LECCE ROOM (MOSAICI 2)

Respiratory syncytial virus: should we identify paediatric patients at risk for severe disease? Peer Voice (This activity is supported by an educational grant from Abbvie)

15:00 - 17:00 PARALLEL SESSION 7 (PULMONOLOGY 1) |DARSENA ROOM Pulmonary Symposium Supported by an unrestricted educational grant from

126126

SPONSORED SESSIONS

01/11/2017

17:30 - 18:30 PLENARY SESSION 3 |DARSENA ROOM Bengt Robertson Award Supported by an unrestricted educational grant from

02/11/2017

12:30 - 13:30 LUNCHEON SYMPOSIUM |DARSENA ROOM Pulse Oximetry CCHD Screening: focus on the recent EU consensus towards implementation Supported by

12:30 - 13:30 LUNCHEON SYMPOSIUM |LECCE ROOM (MOSAICI 2)

ROP in 2017 & beyond - Present and future of the prevention and treatment of retinopathy of prematurity Supported by

13:30 - 14:30 SATELLITE SYMPOSIUM |VENEZIA ROOM Importance of human milk in preterm nutrition Supported by

18:00 - 19:30 EXECUTIVE SATELLITE SYMPOSIUM |VENEZIA ROOM Enhancing the success of respiratory management in nRDS Supported by

03/11/2017

13:30 - 15:00 EXECUTIVE SATELLITE SYMPOSIUM |VENEZIA ROOM Human milk fortification: benefits of an exclusive human milk diet for premature infants Supported by

Despeena. 6 Years. “When I was born at 24 weeks of gestation, I couldn’t

breathe by myself. Thanks to your neonatal care, I can now discover the world just like my friends do and live the

happy life of a six years old girl.”

The European Foundation for the Care of Newborn Infants (EFCNI) is the first pan-European organisation

and network to represent the interests of preterm and newborn infants and their families.


Become a supporter for the best start in life.

www.efcni.org/donate

Chiesi Satellite SymposiumThursday, November 2nd 2017h. 18:00 - 19:30 | Hall Venezia, ground floor

ENHANCING THE SUCCESS OF RESPIRATORY MANAGEMENT IN nRDSChair Prof. A. Van Kaam, The Netherlands

BPD: from trials to clinical practice Prof. W. Göpel, Germany

Less Invasive Surfactant Administration (LISA), a new chapter in Neonatal ManagementProf. P. Dargaville, Australia

Success of intervention: the importance of Training with LISA Prof. M. Vento, Spain

LISA Training with LISAcath®

Prof. P. Dargaville, Australia

Wednesday, November 1st

Thursday, November 2nd

Friday, November 3rd

h. 11:00 - 11:30 I Chiesi booth, Stand nb.1, Exhibitory Area, third floor During morning coffee breaks*

*Please verify in the official congress agenda the definitive slots of morning coffee breaks

130130

SPONSORS & EXHIBITORS

131131

132132

EXHIBITORS FLOOR PLANTHIRD FLOOR - PALAZZO DEL CASINÒ

1

2

3&5

4

6

7

8

9

10

11

12

13

14

15

16

FUTURECONGRESSES

133133

17

18

19

20

21&22

23

24

25

26

32

33

34

platform

platform

134134

ACUTRONIC Medical Systems AG

Address: Fabrik im Schiffli, CH-8816 Hirzel, SwitzerlandWebsite: www.acutronic-medical.chEmail: [email protected] number: +41 44 729 70 80Booth N°. : 10

ACUTRONIC is a swiss company developing, manufacturing and di-stributing high tech ventilation solutions for worldwide NICU’s/PICU’s, ICU’s and Intensive Care Transportation. We are the leading partner for hospitals when it comes to the most critical areas of respiratory care: Neonatalogy/Pediatrics, Jet Ventilation and Difficult Airway Management.Our innovative products simplify the busy clinical routine for caregi-vers and increase the safety of patients. We challenge ourselves to continuously improve and set standards – like the ‘fabian’, the most silent neo-ventilator in the marketplace today. And we strive every-day to provide the technologically best solutions that are needed for the most medically challenging patients.ACUTRONIC. Ventilation Beyond Limits.

BAXTER

Address: Thurgauerstrasse 130, CH-8152 Glattpark – Opfikon, SwitzerlandWebsite: www.baxterhealthcare.ieBooth N°. : 9

Baxter assisted clinicians in treating patients’ diverse nutrient needs since the 1940s, when the company first introduced liquid proteins. Since then, Baxter has continued to advance parenteral nutrition (PN) therapy. For example, Baxter pioneered the world’s first “triple-cham-ber system” internationally for IV nutrition, which provides many of the essential ingredients of balanced nutrition – protein, carbohydrates, lipids and electrolytes in a single container – simplifying the prepara-tion of PN. Today, Baxter provides one of the broadest PN portfolios globally, which includes premix IV solutions, vitamins and lipids, as well as pharmacy workflow management, labeling, compounding tech-nology and enteral nutrition syringes and accessories.

135135

CHIESI FARMACEUTICI S.p.A. Address: Via Palermo 26/A – 43122 Parma - ItalyWebsite: www.chiesi.comEmail: [email protected] number: +39 0521 2791Booth N°. : 1

Based in Parma, Italy, Chiesi Farmaceutici is an international rese-arch-focused Healthcare Group, with over 80 years of experience, present in 26 countries. Chiesi researches, develops and markets in-novative drugs in respiratory therapeutics, specialist medicine and rare disease areas. Its R&D organisation is headquartered in Parma and integrated with 6 other R&D groups. Curosurf is the leading surfactant for the treatment of RDS in pre-matures, launched 25 years ago. Curosurf is now available in 94 countries. The Less Invasive Surfactant Administration (LISA) was ap-proved in 2016, while in 2011 Chiesi launched Peyona, a pharma-ceutical standard caffeine citrate for the treatment of AoP.

Drägerwerk AG & Co. KGaA - Medical Division

Address: Moislinger Allee 53/55, 23558 Lübeck, GermanyWebsite: www.draeger.comEmail: [email protected] number: +49 451 882- 0Booth N°. : 7

Technology for Life: Dräger is an international leader in the fields of medical and safety technology. Dräger products protect, support and save lives. The current product range of the medical division includes anaesthesia workstations, medical ventilation, patient monitoring as well as neonatal care for premature babies and newborns. With ceiling supply units, IT solutions for the OR, and gas management systems the company is at the customer’s side throu-ghout the entire hospital. Dräger has more than 13,000 employees worldwide and is currently present in more than 190 countries.

136136

EMERGENCY NGO

Address: Via Santa Croce 19 – 20122 Milan, ItalyWebsite: www.emergency.itEmail: fo.recruitingmergency.itTelephone number: +39 02 86316316Booth N°. : 20

EMERGENCY is an independent Italian organization that provides free, high quality medical and surgical treatment to the victims of war, landmines and poverty. It promotes a culture of peace, solidarity and respect for human rights.Since 1994 over 8 million people have received free, high quality he-alth care by EMERGENCY.

Foundation Acta Paediatrica Address: Tomtebodavägen 9, 171 65 Solna, SwedenWebsite: www.actapaediatrica.comEmail: [email protected] number: +46 730 202 44 47Booth N°. : 25

Acta Paediatrica is a monthly peer-reviewed journal at the forefront of international paediatric research. Our latest impact factor rose by 25% this year, making us one of the top three general paediatric journals in Europe. Editor-in-chief Professor Hugo Lagercrantz welco-mes original clinical and experimental research papers, reviews and commentaries on a wide range of established and emerging pae-diatric subjects. Our particular areas of interest include non-invasive neonatology, such as CPAP, breastfeeding and Kangaroo care, and sudden infant death syndrome. We also focus on lifestyles and health, including how modern technology affects childhood development and the growing paediatric obesity crisis.

137137

Fritz Stephan GmbH

Address: Kirchstr. 19, 56412 Gackenbach, Germany Website: www.stephan-gmbh.comEmail: [email protected] Telephone number: +49 6439-9125-0 Booth N°. : 23

Fritz Stephan GmbH, Germany has been providing innovative me-dicai technology and constantly setting new standards in artificial respiration, anesthesia and oxygen supply systems since 1978. Particular emphasis is placed on manufacturing respirators for pre-mature infants and newborns. Requirements of medicai devices in neonata! care are fundamentally different from those for adults; artificial respiration needs to be as gentle as possible and must take physiological differences into account. Recent development and integration of a module for automatic contro! of oxygen saturation in respirators, thus improving treatment of premature infants, is just one recent example how Stephan innovations result in advanced lifesaving technology.

GE Healthcare

Website: www.gehealthcare.comBooth N°. : 21/22

GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhan-ced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and techno-logies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biophar-maceutical manufacturing technologies and performance impro-vement solutions, GE Healthcare helps medical professionals deli-ver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.

138138

GINEVRI srl Address: Via Cancelliera 25/B – 00041 Albano Laziale (RM), ItalyWebsite: www.ginevri.comEmail: [email protected] Telephone number: +39 0693459330Booth N°. : 32

GINEVRI srl is a “State of the Art” leading Italian manufacturer of ad-vanced electromedical solutions regarding the neonatal/paediatric field since 1953.Being internationally recognized the Company strives for perfection in reliability, quality and innovation.A comprehensive range is available on the following website: www.ginevri.comEach step of the production process is entirely monitored with our pro-ducts being 100% MADE IN ITALY and fully customizable to meet the most demanding international medical standards.

Hamamatsu Photonics Deutschland GmbH

Address: Arzbergerstraße 10, D-82211, Herrsching, GermanyWebsite: www.hamamatsu.deEmail: [email protected] number: +49 8152-375-200

Hamamatsu Photonics is a world leader in the manufacture of op-toelectronic devices, including many for the medical market. The new NIRO-200NX Monitor enables the monitoring of the cerebral or systemic oxygenation. As it provides not only the oxygenation data but also can detect the haemodynamic functions in the tissue it is a perfect tool for monitoring and improvement of the patient manage-ment during cardiac surgery. Our NIRO monitors are routinely used in many hospitals.

139139

Injeq Oy (Ltd)

Address: Hermiankatu 22, FI-33720 Tampere, FinlandWebsite: www.injeq.comEmail: [email protected] number: +358 50 528 70 12Booth N°. : 15

Injeq Ltd is a medical device company based in Tampere, Finland. The company is devoted to developing real time bioimpedance guided tissue identification technologies. The technologies can be applied for multiple clinical applications, for example regional ane-sthesia, lumbar punctures, and more.Injeq IQ-Needle™ knows where its tip is during the lumbar puncture. Bioimpedance guidance functionality was developed to avoid too deep punctures and unnecessary tissue damage to improve the success rate of lumbar punctures. The Injeq IQ-Needle™ products are expected to benefit the patients by improving diagnosis, redu-cing complications and enabling new type of treatments.

Inspiration Healthcare Group plc Address: 2 Satellite Business Village, Fleming Way, Crawley, West Sussex, RH10 9NE, UKWebsite: www.inspiration-healthcare.comEmail: [email protected] number: +44 (0) 1455 840555Booth N°. : 34

Inspiration Healthcare Group plc is a global supplier of medical te-chnology for critical care, operating theatre and home healthcare applications. Our mission is to provide high quality innovative pro-ducts to patients and caregivers around the world that help to im-prove patient outcomes and efficiencies of healthcare organisa-tions with patient focused customer service and technical support.Our own brand of critical care solutions span non-invasive respi-ratory management, thermoregulation and patient warming for newborns through to adults in intensive care and the operating theatre, whilst our distribution business in the UK and Ireland sup-plies solutions to support specialised surgical procedures and infu-sion therapies.Inspiration Healthcare products are available in over 50 countries worldwide, our success has been built on continuous innovation, excellent customer service and an inherent commitment to impro-ving the quality of life of patients.

140140

Masimo Corporation

Website: www.masimo.co.ukBooth N°. : 2

Masimo Corporation is one of the world’s most admired medical te-chnology companies credited with revolutionizing pulse oximetry and noninvasive patient monitoring. A global medical technology innova-tor, Masimo has been on the forefront of patient safety and a beacon of innovation in healthcare for more than 25 years. As the inventor of Measure-Through Motion and Low Perfusion Masimo SET® pulse oxi-metry—the market-leading pulse oximetry technology solution—and Masimo rainbow® Pulse CO-Oximetry™—a breakthrough noninvasi-ve blood-constituent monitoring platform, Masimo has a portfolio of clinically proven products that lead the way in innovation, perfor-mance and patient safety by giving health care providers the infor-mation they need to optimize clinical decision-making. In addition, with technology license and OEM agreements with leading patient monitoring manufacturers spanning the globe, Masimo’s advanced oximetry technologies can be found inside of today’s top multipa-rameter brands, such as Atom, Datascope, GE Medical, Medtronic, Philips, Spacelabs and Zoll, among others.

Medela

Website: www.medela.comBooth N°. : 8

Founded in 1961 by Olle Larsson and headquartered in Switzerland, Medela today is led by his son Michael Larsson. Medela concentrates on two business units: “Human Milk”, which is leading in the develop-ment and production of breastfeeding products and solutions, and “Healthcare”, which engineers and manufactures highly innovative medical vacuum technology solutions. Medela conducts basic rese-arch in partnership with leading scientists, medical professionals and universities, and uses the research results in the development of its breastfeeding products and solutions. Medela has 19 subsidiaries in Europe, North America and Asia, and together with independent partners distributes its products in more than 100 countries. The com-pany employs over 1,600 staff worldwide, 400 of whom are located in the Canton of Zug, Switzerland.

141141

Medtronic

Website: www.medtronic.euEmail: [email protected] number: +420 739 249 515 Booth N°. : 13

As a global leader in medical technology, services and solutions, Medtronic improves the lives and health of millions of people each year. We use our deep clinical, therapeutic and economic experti-se to address the complex challenges faced by healthcare systemstoday. Let’s take healthcare Further, Together.

Monivent AB

Address: Arvid Wallgrens backe 20, 413 46 Gothenburg, SwedenWebsite: www.monivent.seEmail: [email protected] number: +46 73 800 43 55Booth N°. : 18

Monivent is dedicated to improving the care of newborn babies in need of respiratory support at birth. About 3-6 % of all newborns end up in this situation, and the caregiver needs to provide ma-nual ventilation to the baby. Insufficient or excessive volumes of air given may contribute to severe injury to the lungs and other or-gans. Healthcare personnel are lacking good tools to determine how effective the treatment really is. Monivent Neo is a user-friendly tool, measuring the airflow to the baby and providing continuous feedback on several parameters, helping the caregiver achieve a gentle and effective treatment.

142142

Natus Medical

Website: www.natus.comBooth N°. : 6

Natus Newborn Care products address the critical areas of asses-sment and treatment of newborns, and are designed for use by clinicians as they provide care in the critical minutes & hours after delivery and prior to discharge from the hospital. By allowing for ear-ly detection and treatment, we believe our products can improve clinical outcomes, help reduce costs, and minimize the duration of treatment, unnecessary retesting, or hospital readmission. The Natus Newborn Care product portfolio is offering a wide range of devices dedicated to Hearing Screening, Thermoregulation, Newborn Brain Injury and Jaundice Management just to name the major applica-tions.

Neotech Products

Address: 28430 Witherspoon Pkwy, Valencia, CA 91355 USAWebsite: www.neotechproducts.comEmail: [email protected] number: +1 661-775-7466Booth N°. : 14

Neotech Products, based in the USA, have been leaders in the field of neonatal care for 30 years. We create products that are developed by clinicians for clinicians. Our focus is on disposable, skin care frien-dly products that are gentle for neonatal and pediatric patients, and now home care. Some of our most popular products are the Neotech RAM Cannula, NeoShades Phototherapy Eye Shields, NeoBar ET Tube Holder, NeoPulse Pulse Oximeter Wrap and the EZ-Hold Tubing and Cannula Holder.

143143

Nestlé

Address: Avenue Nestlé 55, 1800 Vevey, SwitzerlandWebsite: www.nestle.comTelephone number: +41 219241111Booth N°. : 3/5

Nestlé Nutrition helps the next generation of children to develop their full potential and live healthier lives by providing high quality, innovative, science-proven nutrition solutions and education for mothers and infants in the crucial first 1000 Days’ of life. Together, nurturing a healthier generation.The Nestlé Nutrition Institute (NNI), shares leading science based information and education with health professionals, scientists, nu-trition communities and stakeholders in an interactive way. NNI is the world’s largest private publisher of nutritional information with more than 3000 publications. All our nutrition resources are avai-lable on the NNI website for free to registered members at http://www.nestlenutrition-institute.org

Peak Medical Ltd

Address: Giborey Israel !0, Netanya, IsraelWebsite: www.peakmedic.comEmail: [email protected] number: +972 522946755Booth N°.: 11

Peak Medical Ltd is a provider of unique airway management, emergency and critical care devices that do beyond what tradi-tional devices would normally supply.Our mission is to develop a steady stream of novel, patentable me-dical devices for Global Market.Among the products that Peak Medical has developed and is manufacturing are: - Video Laryngoscope for neonates, especial-ly for very low weight preemies, with range of disposable blades and special attachments for surfactant application and oxygen insufflation. - Range of disposable and reusable laryngoscope for neonates, especially for very low weight preemies, with range of disposable blades and special attachments for surfactant applica-tion and oxygen insufflation. -Disposable Neonatal Transilluminator -Portable Neonatal Resuscitator -Ventilator - Portable Mobile Moni-tor of resuscitation process (under development) All the products based on 7 company’s patents and patents applications

144144

PeerVoice

Address: 3rd Floor, 75 Davies Street, London W1K 5JNWebsite: www.peervoice.com Email: [email protected] Telephone number: +44 (0)20 7665 9200

PeerVoice understands that today’s healthcare professionals are expected to stay up to date with the latest medical information and to demonstrate continual improvements in patient care, but are often challenged to find the time. We facilitate excellence in clinical practice through live and online education designed to positively im-pact patient care. You can trust us to provide:• Education designed to eliminate specific knowledge and/or practi-ce gaps• Objective discussion of the best-available evidence and treatment guidelines• Practical clinical perspectives from internationally-renowned facul-ty• An easy-to-use online educational platform that allows you to con-trol how, when and where you learn

Prolacta Bioscience Inc. Address: 1800 Highland Avenue Duarte, CA 91010, USAWebsite: www.prolacta.com Email: [email protected] number: +1 626-599-9260Booth N°. : 16

Prolacta Bioscience, Inc. is a privately-held life sciences company dedicated to Advancing the Science of Human Milk®. The com-pany pioneered the development of human milk-based nutritional products to meet the needs of critically ill, premature infants in the NICU and leads the industry in the quality and safety of nutritional products made from breast milk. Prolacta operates the first and only pharmaceutical-grade manufacturing facility for the processing of human breast milk.

145145

SenTec AG Address: Ringstrasse 39, 4106 Therwil, SwitzerlandWebsite: www.sentec.comEmail: [email protected] number: +41 61 726 97 60Booth N°. : 17

SenTec is leading the way to a new standard of care for nonin-vasive, continuous monitoring of neonates’ ventilation and oxyge-nation. Doctors and nurses receive the information they need to safely adjust neonate’s respiration therapies and to reduce com-plications in neonatal care. SenTec OxiVenT™ Sensors feature inno-vative technologies overcoming the limitations of current sensors, such as drift of tcPO2 and risk of burns. The SenTec Digital Monito-ring System is safe, accurate and easy to use. SenTec is already the standard of care in many leading Children Hospitals world-wide.

SIMCharacters GmbH Address: Rüdigergasse 10, 1050 Vienna, AustriaWebsite: www.simcharacters.comEmail: [email protected] number: +43 1-5812094Booth N°. : 33

SIMCharacters develops paediatric simulators to improve the me-dical care of critically ill children. His work as a NICU specialist has taught founder Jens Schwindt that a highly professional interdisci-plinary team is an indispensable prerequisite for effective medical care. SIMCharacters´ High Emotion Preterm Simulator Paul enables medical teams to train how to handle critical neonatal emergen-cies under highly realistic conditions.

146146

SLE Ltd. Address: Twin Bridges Business Park, 232 Selsdon Road, Croydon, CR2 6PL, UKWebsite: www.sle.co.ukEmail: [email protected] cc: [email protected] number: +44 (0)208 681 1414Booth N° : 19

SLE Ltd is a leading developer and manufacturer of infant life support devices based in the UK. Our products provide respiratory support to infants in Neonatal Intensive Care Units globally, providing a range of invasive and noninvasive respiratory support modes. At this meeting we will be showing our new SLE6000 ventilator with its easy-to-use Lunar™ interface and additional non-invasive modes (Including nHFOV). The new SLE6000 uses SLE’s well-known technologies such as valveless ventilation and High Frequency Oscillation to give more controllable, responsive and powerful ventilation, and its compact design makes it ideal for the busy neonatal unit.

Vygon

Website: www.vygon.comBooth N°. : 24

Vygon is a world leader in the creation of high technology single-use medical devices, distributed throughout the world by our dedicated network of 27 subsidiaries and 331 integrated distribution partners.Vygon offers an extensive range of products suitable for use in the following clinical departments:• Neonatology, nutrition & obstetrics• Intensive care• Anaesthesia & Emergency • Intravascular Therapies• Cardiovascular & Surgery

Supporters

147147

Wisepress Medical Bookshop

Address: 25 High Path, Merton Abbey, London SW19 2JL, UKWebsite: www.wisepress.comEmail: [email protected] number: +44 20 8715 1812Booth N°. : 4

Wisepress.com, Europe’s leading conference bookseller, has a ran-ge of books and journals relevant to the themes of the meeting. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers. Follow us on Twitter for the latest news @WisepressBooks.

Supporters

148148

149149

GENERAL INFORMATIONCONGRESS SITEVENICE CONVENTION CENTER - veniceconvention.comAddress: Lungomare Guglielmo Marconi - Lido di Venezia, VE, Italy

Plenary room (Darsena) is located in Palazzo del CinemaParallel sessions and Exhibition/F&B area are located in Palazzo del Casinò

CONGRESS DATE31st October - 4th November 2017

PRE CONGRESS COURSES DATE

Abstract Book

All abstracts submitted within the deadline are published on Journal of Pediatrics and Neonatal Individualized Medicine (JPNIM). Late breaker abstracts (the ones submit-ted after the deadline) will only be published in the abstract book. Both documents will be available on the congress website www.jens2017.eu

30th October 2017

ESN COURSE 1 - Neonatal Infections

31st October 2017

ESN COURSE 2 - NeonatalHaemodynamics

PCC 1 - Ventilatory support-matching physiology?

PCC 2 - Multimodal neuro-imaging and neuro-monitoring in neonates

2nd November 2017

Neonatologist performed echocar-diography (NPE)

ESN COURSE

1

ESN COURSE

2

PCC 1

PCC 2

PCC 3

PCC 4

PCC 5

NPE

PCC 3 - Unmet needs: improving the quality of neonatal care - approaches and strategies

PCC 4 - Controversity in pharmacology

PCC 5 - Neonatal gastroenterology, surgery and nutrition

150150

INTERNATIONAL ACCREDITATION (UEMS)

The 2nd Congress of Joint European Neonatal Societies has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) – asfollowing:

n. LEE17-00673 with 31 European CME credits (ECMEC) for the entire Congress. EACCME credits are recognized Europe-wide and in North America.

They can be converted into their national equivalent by contacting your National CME authority. EACCME credits are recognized by the American Medical Associa-tion (AMA) by the Physicians Recognition Award (PRA).

ITALIAN ACCEDITATION (ECM - EDUCAZIONE CONTINUA IN MEDICINA)

Congresso - 2nd Congress of joint European Neonatal Societies N° evento: 202261 Crediti assegnati: 6 crediti

CORSO ESN COURSE - Infectious DiseasesN° evento: 202050 Crediti assegnati: 7 crediti

CORSO ESN - Circulation Course N° evento: 202072 Crediti assegnati: 5 crediti

CORSO - Neonatologist performed echocardiography (NPE) N° evento: 202232 Crediti assegnati: 2 crediti

Il congresso e i corsi sono stati accreditati per le seguenti categorie:

MEDICO CHIRURGO - discipline di:NeonatologiaPediatriaPediatria (pediatri di libera scelta)

Per acquisire i crediti ECM, i partecipanti dovranno:• aver partecipato al 90% dell’evento• aver compilato on line la scheda di partecipazione, la scheda di valutazione per il congresso e il questionario per i corsi.• aver risposto correttamente ad almeno l’80% delle domande incluse nel questio-nario ECM del congresso

FARMACISTA (farmacia ospedaliera/farmacia ospedaliera)Infermiere PediatricoInfermiere

151151

Certificate of AttendanceThe Certificate of Attendance will be available for download at the end of the congress from the congress website. Participants will be notified by email.

ORGANISING SECRETARIAT

All attendees have to finalise their registration at the registration desk starting from 31st October from 07:30.

FROM TO31st OCTOBER 07:30 19:301st NOVEMBER 07:30 19:30

2nd NOVEMBER 07:30 19:303rd NOVEMBER 07:30 19:30

4th NOVEMBER 07:30 13:00

OFFICIAL LANGUAGEEnglish is the official language of the Congress. No simultaneous translation will be provided.

COMMERCIAL EXHIBITSThe Trade Show Exhibition, located on the third floor of Palazzo del Casino will be held from 1st to 4th November 2017. It will feature pharmaceutical and biotech-nology companies, medical publishers and scientific societies. Please refer to the “exhibition area” map in order to check all the companies that are present in the exhibition area.

SOCIAL EVENTS

Welcome cocktailThe welcome cocktail will be held in the Exhibition area anex (located on the 3rd floor of Palazzo del Casinò) Tuesday, 31st October at 18:30.

Networking dinnerThe Networking dinner will be held on Friday, 3rd November 2017 close to the con-gress venue at Palazzo del Cinema Foyer.

Ticket cost: €50,00* (per person) Available for purchase at the new registrations desk.

*The price includes light dinner and welcome drinks.

This version of the programme has been printed on 20th October, 2017All the modifications sent after this date have not been taken into consideration

152152

UENPS


153153

UENPS


154154

155155

AAbduvalieva S.Abed Y.E.L.Abogunrin S.Abraham V.Abroug S.Abrudan G.Achille C.Achiron A.Achiron R.Acosta L.Adamczak A.Adam-Darque A.Adams M.Adamsson M.Aden U.Åden U.Afset J.Agbeko R.Ågren J.Ahearne C.Ahlqvist-Björkroth S.Ahlsson F.Ahmad S.AI Evensen K.Aikey C.Ai-Rhan Kim E.Aita M.Aiton N.Ajmi H.Akanbi S.Akira O.Akuma A.Al Masri D.A.Al Samnan M.Aladangady N.Alarcon A.Albachiara R.Aldecoa-Bilbao V.Alfani R.Algra S.O.Al-Hosni M.Ali A.Ali Mamuri G.Aliefendioglu D.Alisik M.Alkan Ozdemir S.Alkhoraidly A.Allegaert K.Allendorf A.Almeida A.Alonso-Clemente S.Alonso-Moya M.Alsina M.Alsweiler J.M.Altman M.Alvarelhão J.J.Alves Sá de AlmeidaAlyamac E.D.Alyamac Dizdar E.

85 112 102

37 77

115 94 76 76 17 37

118 58, 79, 93, 95, 103

56, 86, 94, 103 68, 77, 103, 104

67, 103, 109 103

68 111

53 90

111 50

78, 118 97 62

39, 82, 83 22

42, 77 40 76 85 90 96

42, 43, 64 101

21 83 66 53 99

50, 53, 112 20 43 83 79

32, 112 9, 15, 41

76 19, 116

112 112

20, 76 61

92, 95 94 6853

23, 85, 98

Amadei F.Ambjörnsson T.Ameliana E.Amess P.Amirouche A.Amodeo I.Amoedo Blanco R.Amunts L.Anastasovska V.Anblagan D.Andelius T.C.Andersen G.Anderson C.Anderson P.Andersson M.X.Andersson O.Andersson S.Andorka C.S.Andrada M.G.Andraka B.Andreicuţ D.Andresen J.Andreu A.Andriessen P.Angelico R.Angelini F.Annink K.Antari V.Anthony M.Antognoli L.Apsey C.Aquilano G.Aquino G.Aragon D.C.Arca G.Arifoglu I.Arısoy A.E.Arjona D.Arlettaz R.Arman D.Armengaud J.B.Arnold C.Arques L.Arriada Redondo M.Arruza L.Arslanoglu S.Arun Ozer E.Arunoday Asaro J.Asay G.Ashina M.Ashton J.Asner S.Aspevall O.Assaf Z.Ateş Beşirik S.Atikah S.Augurio M.R.Aunal R.Austin T.Avdic-Belltheus A.Avenarius S.

36 66 85 22 88

28, 49, 63 116 47 24 86 78

103 39

103 32, 45

29, 33, 94 118 63 94 65 25 69

114 31, 49, 88

75 116 72 44

115 61

111 117 36

61, 110, 20, 22, 25 76 83 98 78

76, 26 113

116, 121 37 83 41 36

108, 24 66, 78

81 97 99

110, 21 43

101 66 97 81 30 66

115 48, 91

54, 119 120

156156

B

Beaulieu J-F.Beauport L.Bech B.H.Bech Jensen J.-E.Beck I.Behrsin J.Beke A.Belfort M.Belik J.Bellalah M.Bellaleh M.Bellallah M.Beller E.Bellini C.Bellis S.Belteki G.Beltempo M.Belzer C.Bemgard C.Ben Ahmed A.Ben Ameur K.Ben Ammou S.Ben Amor S.Ben Hamida H.Ben Salah N.Ben Salem A.Ben Salem H.Ben Singor C.Ben Slamia L.Benavente-Fernández I.Benders M.J.N.L.

Bendix I.Bendor-Samuel O.M.Bennedsgaard K.Berber M.Bercovitz R.Berger A.Berglund S.K.Bergonzelli Degonda G.Bernet V.Bernhard J.Berretim-Felix G.Bertoldi M.Bettolli M.Betzelos N.Bezirganoglu H.Bezrukov L.Bhat N.Bhat P.Bhatia A.Bhatt J.Bhayat S.Bhisikar S.Bialas A.Bianco F.Bianconi T.Biban P.Bickes M.S.Bickle-Graz M.Bidho M.Binder C.

70 45 58

121 29 85 17 82

19, 42 25, 108, 116

108, 109 77, 107

79 79, 80

41, 107 48 95 43 44

112 24, 25, 42, 77, 112

7777

24, 25, 42, 112 77, 112

24, 25, 42 18, 19, 117

112 77

72, 93 12, 29, 39, 47, 53, 68, 72

73, 80, 87, 118 87, 119

96 64 75 76

36, 43, 44, 80, 81, 87, 103 93

118 29 19

113 20, 22, 25

70 82

53, 85, 96, 98 117 22

39, 70 33, 50

27 26, 61

30 83 36 98

110 67

79, 93, 103 121

43, 44, 61, 87

Avian A.Axelin A.Ayache H.Ayachi E.Aydemir O.Ayech H.Ayyagari R.

Babakissa C.Bach C.C.Bäckman M.Backman Johansson C.Bae J.G.Baerts W.Bagcı O.Bahonjic A.Baibarina E.Baik-Schneditz N.Bakalli I.Bakar F.Balaam M-C.Balasch M.Balashova E.Balcells C.Balink S.J.A.Ballantyne M.Ballard P.Ballard R.Baltane Z.Banerjee J.Bansal S.C.Baquedano I.Baraldi E.Barbaria W.Barbouch H.Barbouche H.Barczyk-Kahlert K.Bariamis S.E.Baritussio A.Baros A.Barrett M.Barrington K.Barro C.Barry J.Barta H.Bartnicka A.Bartocci M.Barton N.Bassi E.Bassler D.Basso O.Bastanie M.Bastin M.Batra D.Battersby C.Baud O.Baumann-Holzle R.Baydemir C.Bearer C.F.

64 30, 39, 90, 122

108, 116, 25 81 39

108, 109 31, 55

70 29, 94, 103

56, 94 44

111 47

44, 66 50 48

61, 62, 64 20 75

123 114

75 45, 83, 113

61 81 51

120 17

42, 43, 64, 71 23 36

120 18

109 25, 108, 116

66113

65 117

18 58 92 99 67

113 42 84

120 19, 42, 58, 76, 85, 95, 103

58 100

86 24, 98, 109

95 97 75, 76, 101

57 98

43, 44

157157

Binder J.Binder-Heschl C.Bjellmo S.Björklund L.J.Bjuland K.J.Blackwell S.J.Blackwood B.Blaga L.Blake K.Blake R.Blanco C.Blanco D.Blaz W.Blennow M.Blibech S.Blom H.Bloor I.Bluhme E.Boantă O.Boardman J.Bocu E.Bodeau-Livinec F.Boeri L.Bøgh N.Bogossian F.Bohlin K.Bohnhorst B.Boix H.Bol B.Boldrini R.Bolger T.Bolk J.Bölte S.Bomont R.Bonafiglia E.Bonefeld-Jørgensen E.C.Bonsante F.Borena W.Borges A.Boria A.Börjesson L.Borradori C.Borradori Tolsa C.Borrego R.Borrelli A.C.Borysiuk O.Böttger R.Bouaicha E.D.Boubred F.Boukadida J.Bourika V.Bouwmeester R.Bouza H.Bowden A.Boylan G.Boylan G.B.Boyle E.M.Boyle M.Bragatti J.A.Branagan A.Branco M.Brandstetter S.

61, 62 61

103 97 78 47 99

62, 115 71

18, 116 87

72, 93 65, 83

36, 62, 12018, 19, 117

100 119

57 25, 85

86 24 53

68, 80 78 79

20, 51, 59, 82, 97, 120, 122 120

36, 72, 93 99 75 18 77

67,104 22

110 58

110 115

25 62 39 67

79, 93, 103 78 21

37, 44 120

19 64

115 115

27 59 81 12

72, 80 53, 86 31, 65

47 108

116, 115, 19 36

Branvik-Ingelsson C.Brasseler M.Bravo M.C.Breatnach C.Breatnach C.R.Brégère C.Breindahl M.Brenda E.Brennan C.Bresesti I.Breur J.H.M.P.J.Breur J.M.P.Brightman L.Brignole D.Brini I.Brisigotti M.P.Brodin P.Brohet R.M.Brom M.K.Brookle M.E.L.Bröring T.Broström L.Brown A.Brown S.Brubakk A.Brubakk A.M.Brugman A.Brunet S.Bruno L.Brunton A.Bruschettini M.Brussé I.A.Bruzzese D.Bucci L.Buchan S.Bucher H.Bucher H.U.Buffat C.Buhrer C.Bujari D.Bujorescu D.Bullimore G.Buonocore G.Burger D.Burgess L.Burghardt K.M.Burgmann J.Burkhardt T.Bussmann N.Butticè S.Buxmann H.Buyukkayhan D.Buyuktiryaki M.

Byrne J.Byrne M.Bystrykh O.

83 49

19, 48, 64 14, 33, 64, 89 33, 41, 65, 89

93 16, 62

84 89 27 80

29, 109 48 72

115 72 59 84 24 79 78

109 62 30 78 78 78 81

109 27

30, 77 57 66 66

115 57 42 64

9, 59, 65 37 85

39, 70 79, 92

41, 49, 88 45, 111

69 66 26 19 84

120 24

23, 41, 53, 59, 82, 85 96, 98

53 81 75

158158

Caballero S.Caballero-Villarraso J.Cabañas F.Cacchioli A.Cadete A.Caiazzo M.A.Cainelli E.Cakır U.Calado E.Calderisi M.Calevo M.G.Calik Saglik A.Calixto C.Callaghan F.Callea F.Calthorpe R.Cama A.Camblos A.Campbell-Yeo M.Camporeale A.Campos A.C.Canabarro N.T.Candace R.Candotti F.Caner I.Cañete M.D.Canizci P.Cañizo D.Canpolat F.E.Cao B.Cao Y.Caoci S.Capasso L.Capdevila E.Capone E.Caram-Deelder C.Cardoso W.V.Carey W.A.Carfagna M.Carlsson S.Carmona F.Carnielli V.P.

Carolan S.Carpenter J.Carpenter M.Carr P.Carter B.Carvalho C.Casale M.Casale Aragon D.Cassidy M.Castoldi F.Castro Conde J.R.Catinella S.Catozzi C.Catroon K.Caudron S.Caulfield F.

122 110

72, 93, 101 36 94 21 48 59 94 79

30, 47, 72, 77, 80 39

20, 22, 25, 61, 107 111

75 84

26, 79, 82 99

13, 30 66

19, 76 96 79

116 40

110 108 113

23, 41, 53, 85, 96, 98 96 40 23

21, 66, 98, 120 123

66 31

120 99 50 43

107 33, 48, 50, 51, 55, 61, 62 65,

70, 102, 104, 12053 61

114 30 22

19, 116 44 22 81 27 47 36 36 90 78 97

C Cavallaro G.Cavanagh P.Cebeci B.Celaj E.Cenni S.Cernada M.Ceroni F.Cerritelli F.Céspedes M.C.Cetinkaya M.Ceyte H.Chaaya S.B.Chae S.A.Chaffanel M.Chakhunashvili A.Chakravarty M.Chang J.Chang M.Chang Y.S.Chang Y-S.Chao K.Y.Chappell F.Charlton M.Chartrand C.Chasapi S.A.Chatzidimitriou K.Chatzitoliou E.Chaudhry S.Chebsey A.Chen C.Y.Chen H.K.Chen M.Chen W.M.Chen Y.L.Chen Y-T.Cheong J.L.Y.Chernausek S.D.Chessell L.Chetcuti Ganado C.Chiang C.E.Chien Y.H.Chimenti-Camacho P.Chiofalo B.Chioukh F.Chioukh F.Z.Chisholm C.Chisholm P.Chitty H.Chmielarz B.Chmielewska A.Choi B.M.Choi Y.J.Chojnacka K.Chollopetz Da Cunha M.L.Chou H-C.Christopoulou I.Chu S.H.Chu S.M.Chuang C.Y.Chung S.H.Cilio M.-R.Ciralli F.

28, 49, 63 69 22 20 66

72, 93 77, 123

27 114 22 78

114 78

72, 93 83 45 65 65

28, 95 28

23, 37, 107 86 85 81

113 79 44

107 79 98

120 121 108

23, 37, 107 98 47

121 50

115 23, 37, 107 23, 37, 107

26, 82 84 77

24, 25, 42, 77, 112 99 64 68 65 32 42 62

109 83 98

113 21 59 77

110 32, 80

63

159159

Cirulli F.Civelli M.Claessens N.Claessens N.H.P.Clark R.Clarke G.Clarke P.Claure N.Clayton A.Clayton S.Cloet E.Cnattingius S.Cobas J.Cobas Pazos M.J.Cobo T.Codru M.Coffey D.Coffrey Z.Cogo P.Colby C.Collins J.Colnaghi M.Comito V.Concheiro-Guisan A.Conti G.Conti R.Conway J.Cools F.Cooper E.Corcoran D.Cordero-Llana O.Cornacchione S.Cornet M.-C.Correani A.Corrias M.Corsi C.Corsini I.Corso A.L.Cortes D.Coscia T.Cosmi E.Costeloe K.Coutts J.Coviello C.Cowan F.M.Cozinov A.Cragg L.Crasmöller M.Croon A.Crossley K.J.Crothers E.Crott G.C.Cseko A.Cucerea M.Cucerea M.C.Culliney L.Cuttini M.Cuzino I.Cuzzilla R.Cyr P.Cyranowicz B.

86 36 29

29, 53, 118 99 72 20 68 54 56 53

102 24

115 116

85 97 97

33, 48, 65, 120 99 33 63

109 112

38 44 80 97 86 19 54 79

32, 80 33, 50, 120

82 76 98 65

121 32 33 95

115 98 47 67 56 87 57 84

108 19 64

17, 107 108

97 53 67

24, 47, 66 47 64

D’Aló F.D’Aronco S.D’Haens E.D’Haens E.J.Däbritz J.Daley A.J.Damhuis G.Dammann O.Danhaive O.Dani C.Dargaville P.Darlow B.Darlow B.A.Darque A.D’Ascenzo R.Dassios T.Datta A.N.Davies A.Davis J.Davis J.W.Davis P.Davis P.G.De Angelis L.De Bisschop B.De Boer J.de Boode W.De Boode W.P.De Booij E.De Cássia Pinheiro Da Motta G.De Clifford-Faugère G.De Coppi P.De Dassel T.De Graaff J.C.De Grandis E.De Groot R.De Haan M.de Halleux V.De Jonge R.C.J.De Jongh F.H.C.De Klerk J.De Kort E.De la Torre M.J.De Luca D.

De Martino D.De Martino L.De Meulemeester J.De Mol A.C.De Rooy L.De Tersant M.De Villepin B.De Vries L.De Vries L.S.De Vries W.B.De Waal C.G.Dean F.Dear P.Degraeuwe P.Degtyarev D.

36 33 43 31 96 66

122 118 80 98

46, 68, 73 58 95

68, 118 67 55

118 27, 109

22 95

29, 37, 38, 46 30, 68, 84

65 97

40, 57 40, 48, 54, 89, 14

48, 108 57 83

39, 82 34 79

118 68, 80 49, 88

53 96

23, 61 36 41

100 110

11, 20, 38, 55, 63, 69, 70 98, 101, 102

66 102 97

100 111 38 88

67, 87, 101 29, 53

109 36 17 38 49

48, 75

D

160160

Degtyareva M.Del Campo R.Del Pozo S.Del Rey Hurtado De Mendoza B.Dell’Orto V.Demeulemeester V.Demirel N.Dempsey E.Dempsey E.M.Deneva S.Deoni S.Depoorter A.Derhaschnig U.Dermitzakis M.Derriks F.Descloux C.Deshpande G.Dewhurst C.Dewitt K.Dewitz R.Di Costanzo P.Di Cunto F.Di Fabio S.Di Guardo V.Di Lallo V.Díaz R.Díaz-Castro J.Diaz-Redondo A.Dima M.Dinerstein A.Dinsdale S.Dionne K.Doagi M.Doberschuetz N.Dobryanskyy D.Dobush O.Doerr A.Dogan P.Doglioni N.Doherty A.Doherty D.Doherty R.Doll H.Domellöf M.Donaldson B.Donnikov A.Doolan A.Doré-Bergeron M.-J.Dorling J.Doros G.Dorsi M.Douagi M.Downe L.Doyle L.Dozier M.Draper E.S.Drenchev N.Drevin G.Drews K.Dreyhaupt J.Drugan T.Dubois J.

98 114 114

26, 45, 113 38, 55, 69, 102

100 83, 113

15, 49, 88 23 20 33

92, 118 43 93 97

119 42

66, 92 18 76 66

100 109

98 36 78 66 82

117 44 30 30

19, 117 76

21, 37, 44 44

39, 94 44, 66

120 41

80, 55 75 84

32, 43, 45, 93, 111, 121 114

48 97 81

15, 18, 42, 69 108 114

18 42

46, 101 80 86 22 61 92

120 190

12

72 45

25, 85 40

114 119

4617 83

53, 109, 111, 121 78 59 59 57

23, 82, 95 41

39, 53 114 114

67, 104 75 75 50 82 47

116 48 43

14, 19, 33, 40, 41, 48, 54 65, 89

16 41, 57, 107

99 99 63

26, 33 109

39, 68 58 19

32, 45 98

112 49 43

113 83, 113

76 33

118 30 98

83, 113 17

23, 53 69, 114 24, 78

115

Dudink J.Duerden E.Dumitra R.Dunlop A.Durmush R.Dzietko M.

Ebbesen F.Ebela I.Edqvist I.Edstedt Bonamy A-K.Edwards D.M.Efstathiou A.Efstathiou P.Eggink A.Egyepong J.Ehman G.L.Eijsermans M.J.C.Ejder Apay S.Ejder Tekgündüz S.Eklöf E.El Doory S.El Halik M.El Helou S.Eldaw S.M.El-Dib M.Eleanor M.Eleuteri A.Elfvin A.El-Khuffash A.

Elliott M.Ellis E.Ellsworth K.Ellsworth M.El-Naggar W.Elorza M.D.Elsaadany L.Emery F.Emond A.Enes C.Engström E.Er I.Erçin S.Ercoli G.Erdem Dursun Z.E.Erdil A.Erel O.Ereno I.Erickson-Owens D.Eriksson J.G.Eriksson M.Erokhina A.Erol S.Eros F.R.Ertekin O.Esaiassen E.Escobar A.EscobarIzquierdo A.B.

E

161161

Escribano E.Eskola V.Espinosa M.G.Essers J.Evans D.Evans N.Evensen K.A.I.Evers K.S.Ewald U.Ewer A.

Faas D.Fairchild K.Falasco G.Falcão I.Fang A.Fang J.Fang L.C.Fantinato M.Farombi I.Farooqi A.Farré J.M.Farré-Sender B.Fasth A.Fauchère J.Fedorova N.Fedorova T.Feeley N.Fehlhaber B.Felderhoff-Müser U.Fellman V.Feng W.W.Fenton T.R.Ferkol T.Fernandes G.M.Fernandez P.Fernandez R.Fernández C.Fernandez Oviedo A.N.Fernández-Colomer B.Fernandez-Lorenzo J.R.Fernando I.Ferradal S.L.Ferrara T.Ferreira C.H.Ferreira E.Ferretti E.Festival J.Ficial B.Field D.Fields D.A.Fijnvandraat K.Filip V.Finer N.Firmino I.C.L.Fisch U.Fischer Fumeaux C.Fischer-Riepe L.Fischler B.Fitting C.

114 81

24, 111 38 58

54, 89 78, 118

92 29, 122

35

120 99

48, 65 19, 116

32 9921

120 81

32, 56, 58, 77, 86, 94, 103 123 123

33 57 75 75

82, 83 65, 66

87, 119 39, 88, 118

96 53 41

113 36

22, 80 36 82 93

93, 112 24 47 66

19, 42 36 69 82

110 86

12131 75 30 113

92, 93 45

6657

55, 102

F

Fitzgerald E.Fitzgerald M.P.Fitzpatrick C.Fitzsimons J.J.Fjalstad J.Flacking R.Fleiss B.Flemmer A.W.Flint R.Flint R.B.Flood E.Florez I.D.Flunt A.Folha T.Folkmanis V.Fonollá Joya J.Foong J.Förster K.M.Fowler S.Fox C.Frame A.Francalanci P.Frange P.Franklin O.Franta J.Franz A.R.Frauenfelder O.Fredriksson Kaul Y.Freitas A.Freitas L.Frick M.A.Friesenhagen J.Frøisland D.Fromonot J.Frusca T.Fuchs H.Fuentes T.Fuiko R.Fujioka K.Fukushima S.Fulcheri E.Fullarton J.Furness J.Fusch C.Fusch G.Fustolo-Gunnink S.F.

Gadzinowski J.Gafencu M.Gaia T.Gale C.Gałęcka M.Gáll Z.S.Gamulescu D.Gancheva S.Gangaram-Panday N.H.Gantseva-Patsoura S.Gao F.Gao W.

65 76 26

81, 82 114 39

54, 71, 119 19, 21, 111 34, 41, 49

88 84 40 36 94 17

116 45 21 99

115 70, 39

75 114

33, 41, 65, 89 81

109 122 78

116 118 114

664664

104 29, 37, 97, 120

75 36

21, 67, 110 21 72

115 18

32, 50, 53, 82, 112 50, 53, 82, 112

31

17, 37, 53, 92

108 94 90

113 108, 17

13 83 23

101 55

31, 55

G

162162

Gao X.García-Alix A.García-Fragoso L.García-García I.Garcia-Rodenas C.L.García-Sánchez A.Garg S.Garland C.Gatti M.G.Gatti S.Gavare I.Gebauer C.General F.Gennissen L.Gentilino V.Genzel-Boroviczeny O.Georgakopoulou I.Georgieva R.Geraci D.M.Gerbaulet L.Geurtzen R.Ghazal K.Ghith A.Giacalone M.Giampietri M.Giampietro S.Giannakopoulos I.Giannattasio A.Giannì M.L.Gibbins S.Gibbons D.Gil Fenoy A.M.Gil-Campos M.Gill A.W.Gilmore C.Ginet V.Giordano V.Giretti I.Giske C.G.Giuseppi A.Gizzi C.Gjeta I.Gladstone M.Glander S.Glass H.C.Gliga C.Glover A.Goel S.Goeral K.Gojnovci X.Gökalp A.S.Golosovsky E.Golovchenko O.Gomez-Solaetxe M.Gonçalves A.B.Gonçalves-Ferri W.A.Gonzalez J.J.Gonzalez R.Gonzalez S.González Barrios D.González Campo C.González Pacheco N.

90 76, 101

113, 116 113, 116

118 63, 102

77, 84 22, 39, 70

92 49 17 97 44 57 28

120 113

20 94

117 27 77

25, 108, 116 98 98 94

113 66

110 30 53 24 19 55 56

119 80, 87

120 66

81, 110 11 20 92 66 32

17, 107, 108 39 30

80 114

98 83 83 36

22, 25 20, 22, 25, 61, 107, 110

114 36

114 47 47

25, 26, 38, 41, 94, 112

GonzálezGonzález N.L.González-Valcárcel M.Goos T.G.Göpel W.Gorbunov A.Gordon E.Gorman T.Goudoever J.B.V.Gounaris A.Gouvea A.B.Gouveia R.Gouyon J.B.Govaert P.Gowda H.Gozen D.Gözen D.Gozzini E.Gragnaniello D.Gramignoli R.Grandvuillemin I.Grant P.E.Grathwohl D.Gratopp A.Gray J.Gray P.H.Grayson N.Green G.Greenough A.Gregersen N.Gregorio-Hernández R.Greisen G.Gressens P.Gribaa M.Griesmaier E.Griffin I.Griggio A.Grill A.Grimaldi C.Grinfelde I.Grira M.Groenendaal F.

Gromann J.Grönqvist H.Grouiller F.Grunt S.Grynspan D.Gudmundsdottir A.Guedich N.Guerrero A.Gui L.Guimarães H.Gulati N.Gulczyńska E.Gulden S.Günlemez A.Guo T.Gürol A.Gursoy T.Gustafsson A.Gutierrez E.Guzman R.

47 24, 75 23, 61

32, 73, 90 98

115 99 50

101 61 94

110 92

22, 25, 26, 61 112 81 98

120 57 64 47

121 40

117 78 30

118 55 64

26, 82 48, 50, 100, 103

34, 54, 72, 100, 119, 123 77 92 97 49 36 75 17 77

29, 47, 53, 67, 72, 80, 87, 118

26 32 78

118 79, 93, 103

69 83, 109

77 115 67

26, 85, 116 85 64

28, 49, 63 98 45

114 112 59

63, 102 93

163163

Guzoglu N.

H’mida D.H’mida-Ben Brahim D.Ha C.G.Hachem T.Haddaji Mastouri M.Hadj-Abdallah H.Haeberlin A.Hafström M.Hagberg H.Hägglöf B.Hagman C.Hagmann P.Haiden N.Haiek L.Hair A.Hakannson S.Hakeem M.A.Halamek L.Halil H.Hallab Y.Hallak A.C.Hallberg B.

Halleb Y.Halonen S.Hamazaki T.Hamdi S.Hamilton R.Hammami S.Hamolko K.Hamvas A.Hannachi N.Hansen B.M.Hansen G.Hansen Pupp I.Hansson V.Hantzi E.Hård A–L.Harding J.E.Harris D.L.Harris L.Härtel C.Hartley C.Haschke F.Hascoet J-M.Hăsmăsanu M.Haumont D.Ha-Vinh Leuchter R.Hawksley J.Hayakawa M.Hayde M.Haydon H.Hayes B.Hayes-Gill B.Haynes M.Hays N.P.Hazbahta G.He M.

43

77, 107 77, 112

47 114

77 107

99 77, 103 54, 119

56, 86, 94 97 45

36, 43, 44, 81, 87 83 82 95 62 27 59

112 22, 25

34, 45, 57, 72, 83, 87, 88 90, 94, 111

77, 107 81 76 42 86 77 36

41, 89 115 103 120

45, 84, 97, 112 100 115

45, 93 28, 114 28, 114

67, 80 65

118 121

78, 82 62, 109, 115

31 118

68 76 36 79 76 61 99

121 23

43, 44

HHeathcote A.Heckmann M.Hedin M.Heep A.Heijnen C.Heinemann A.S.Heinonen K.Heiring C.Helder O.K.Helenius K.Hellgren G.Helliwell E.Hellström A.Hellström W.Hellström-Westas L.Hemels M.Hemmatpour S.Hemse Nojd K.Henckel E.Hending M.Hendriks M.Hendriksen A.Henriksen T.B.

Henry C.Hentschel R.Héon M.Herber-Jonat S.Herdt A.Herlenius E.Hernandez-Chirlaque C.Herranz Barbero A.Herz J.Hetzer B.Hiatt C.Hidar S.Higginson J.Higman W.Hitendu D.Hjerde E.Hjortdal V.Hjortdal V.E.Höck M.Hoehn T.Hofer M.Hoffmann C.Hogeveen M.Högström J.Hokuto I.Holland M.Holland M.R.Höller N.Hollis C.Holsti A.Holsti L.Holt A.Hongjie G.Honore A.Hooper S.Hooper S.B.Horgan E.Horoshkeeva O.

20 120 100

79, 54 87

66 118 120 99 95

32, 45, 87, 112 68

32, 45, 60, 62, 87, 112 112

78, 118 43 81 44

57, 59 57

47, 57 47

29, 31, 46, 58, 64, 71, 78, 86 102, 103

61, 95 34, 61, 96, 120

82, 83 19, 21

97 61, 117

19 116

87, 119 115 18 77 84 71 29 69

29, 103 31, 78

77 17, 49

116 76 27 82 75 89 41 64

104 86 31 23 41

117 29 84 30 75

164164

Hosang N.Hovhannisyan C.Hovi P.Howarth C.Hristova E.Hristova M.Hsieh W.S.Hsieh W-S.Hsin A.Hsu J.F.Hsu S.Hu X.J.Huang C.C.Huang E.Huang R.Huber E.Huescar M.Huescar M.Huh J.Huhn E.A.Huhtala M.Hulzebos C.V.Humaun Kabir M.Hummler H.Hundscheid T.Hung C.C.Hunt T.Huotilainen M.Hüppi P.Hüppi P.S.Hurley M.Hurley T.Hurtado Suazo J.A.Hussain J.Hutten G.J.Huttner W.Hwang J.H.

Iacob D.Iacob E.R.Iacobelli S.Ibrahim C.P.H.Ibrahim H.Ichiba H.Iglesias I.Iglesias-Platas I.Iijima K.Ikuta T.Ilieva I.Imbulana D.Inarejos E.Indredavik M.S.Ingman A-S.Inomata K.Inoue T.Ionov O.Ioroi T.Isayama T.Išgum I.

84 114

56, 96, 118, 121 42 63

54, 119 98 98 77 59

108 40 95 80 90

44, 92 24, 111 24, 111

96 118

90 31

66 38, 120

40 77

22 39

12, 34, 68, 86, 10467 27 26

24, 66, 112, 116 84 36 91

24, 62, 79, 11

117 117

44, 69, 110 114

90 76

113 45, 83, 113

21, 110 21, 67

20 38 83 78 83

107 76, 107

48, 75 67 95 53

I

63, 102 82

112 19, 42

23 82 20 20 66 3750

113 45, 113, 116

27 24, 66

56, 58, 94 33, 89

76 29, 53, 80

97 107 19

118 17

114 84 37 81 39 31 46

121 6, 64, 67

99 121 96 50 40 43 68 96 86 59

86, 95, 104 111

15, 69, 110 56 30 79 20 55

111 39 66 63 57

55, 97, 99 38

Isidoro-García M.Isik S.Iskander R.Isler H.Ismaili H.Israelsson C.Ivanova J.Ivanova V.Iversen A.Ives K.Iyore E.O.Izquierdo M.Izquierdo-Renau M.

Jackson A.Jacobs S.E.Jaekel J.James A.T.James E.Jansen N.J.G.Jansen S.Jaraba M.P.Jarosz-Lesz A.Järvelin M.-R.Jarvis H.Jashari H.Jayasinghe D.Jazexhiu–Postoli E.Jebali S.Jenken F.Jenkinson A.Jensen C.F.Jensen E.Jermendy A.Jesacher B.Jeter J.M.Jiang M.Jiang P.Jiang S.Y.Jilma B.Jimenez-Espinoza C.Jin X.Joels M.Johansson E.Johansson S.Johnson K.Johnson M.Johnson S.Johnston C.Johnston L.Jones J.Jones J.G.Jones R.Jongmans M.J.Jonsson B.Jordanova A.Jorns C.Jost K.Jourdain G.

J

165165

Juhl S.M.Jung E.Juul S.Juvet L.Jynge Ö.

Kacem I.Kadioglu Simsek G.Kaila K.Kairamkonda V.Kajantie E.Kajtazi F.Kalaydzhieva M.Kallel F.Källén K.Kaltsogianni O.Kamath-Rayne B.Kampmann B.Kan Onturk Z.Kang S.J.KanijoMøller B.Kanmaz H.G.Kanmaz Kutman H.G.Kao Y.H.Kapadia V.Kapfhammer J.Kappeler J.Kara M.Karadag A.Karadagi A.Karageorgou K.Karagianni P.Karam M.Karen T.Karetnikova N.Kari J.Karkani A.Karpinski L.Kasdallah N.Kasprian G.Kasraoui I.Kasser S.Kassirer M.Y.Katayama Y.Kattwinkel J.Kavalloor N.Kawase A.Kayyali R.Kazeem O.Kbaier H.KC A.Keenan W.Kelly J.Kelly L.Kelly L.A.Kemp J.Kempley S.Kendall G.Kennedy G.

50 79, 112

87 114

57

25, 107, 109, 116 23, 41, 82, 96

63 32

118 23 20 77

58, 109 55 99

114 112 111 121

23, 41, 96 85 21 30

79, 93 21 40 78 57 23 44

100 19, 42

75 81 83 37

18, 19, 117 80

18, 19, 117 32, 118

57 67 99 23

107 65

116 1829 99

112 80, 101

101 41 64

27, 59 70

K

Kennedy S.Kenner C.Kent E.Keogh C.Kerinova E.Kermorvant E.Kernan R.Kerrn-Jespersen S.Keshavjee B.Keskin H.Kettle R.Khammari Nystroem F.Khan R.A.Khemis T.Khoo P.C.Kidszun A.Kiechl-Kohlendorfer U.Kiely M.Kierkegaard H.Kilchevski A.Kilic D.Killalea A.Kim A.R.Kim C.S.Kim C.Y.Kim E.J.Kim E.K.Kim H. Kim H.R.Kim H.S.Kim K.S.Kim K.-S.Kim S.Kim W.H.King M.Kioumi A.Kirkham J.J.Kirpalani H.Kirtbaya A.Kirupakaran K.Kistler K.Kjeldsen M.Kjellin T.Kjellson K.Klarer N.Klebermass-Schrehof K.Klein N.Klein S.Kleinlein B.Kleiser S.Klemme M.Kleshchenko E.Klevebro S.Klingenberg C.Klishch O.Klotz D.Kneyber M.K.Knibbe C.Knibbe C.A.J.Knirsch W.Knol J.Kobas M.

120 105, 122

41, 65 30 20

32, 50, 75 108 64

121 40 99 95

115 24, 25, 46, 112

23 37 92 45 64 36 22

112 62, 79, 112

111 62

110 7762 96 77

62, 112 79

62, 111 18, 62

76 44 49 46 75 27 94 64 57 44

118 36, 80, 87

54, 119 57

120 19, 42

21 102

45, 87, 111 29, 68, 84, 114

38 37, 62, 97

70 15, 41, 49, 88

88 29 43

101

166166

Koch B.Kocova M.Koehne P.Kokkori F.Koksal N.Kola E.Kolossvary M.Koltunov I.Komoriyama A.Kondo Y.König K.Königs M.Konstantinova V.Kontilska S.Koopman-Esseboom C.Korja R.Kornelisse R.Kornsteiner-Krenn M.Korstanje J.P.Kortsalioudaki C.Kositamongkol S.Kosova R.Köster C.Kostilainen K.Kostovski A.Kostukov K.Kotidis C.Kousholt B.S.Kouskouni E.Kovacs K.Kovacs S.Kozak L.R.Kramer B.Krasinski Z.Krasniqi F.Krasniqi I.Kreissl A.Kristiansen M.Kronström K.Kroon A.A.Kryuchko D.Ksia A.Kuehn T.Kuhle J.Kuhn P.Kujawa M.Kuligowski J.Kumar A.Kumar Bikkarolla S.Kunz N.Kurinczuk J.Kuroda J.Kurzawińska G.Kusuda S.Kvanta H.Kwan C.Kwinta P.Kwon J.Y.Kyng K.J.

114 24 40

101 44, 66

20 67 98 92

107 122

78 20 20 53

90 9

43 100

27, 59 96

120 87, 119

39 24 75 48 64 59

63, 64 25 67

54, 119 109

23, 114 114

44, 87 81 81

3148, 102, 107

25 82 92

51, 84 19

72, 93 65 66 68 56 21 92

58, 76, 98 68 82

45, 110 96

64, 71, 78, 86

Laarman A.R.C.Lager M.Lærum A.M.W.Lafeber H.Lafeber H.N.Laforgia N.Laganà A.S.Lagercrantz H.Lahiff M.Lakatos A.Lakshminrusimha S.Lalchev Z.Lamouchi M.T.Lamur K.D.Lamy E.Landau-Crangle E.Lange S.Lano A.Lapaire O.Lapillonne A.Laroche S.LaroneJuneau A.Larsen S.H.Lasheras G.Latal B.Latour J.Lattuada D.Lauenborg J.Lauridsen M.H.Lavallée A.Lavizzari A.Law S.Lawn C.Lawrenson J.Lazar C.Lazeyras F.Leach C.Lebouedec A.Lee B.S.Lee E.H.Lee H.J.Lee K.H.Lee K.J.Lee L.H.Lee M.Lee N.H.Lee N.M.Lee S.Lee S.J.Lee S.K.Lee S.L.Lee W.M.Lee Y.M.Lefebvre F.Lehtonen L.Lei W.T.Lemmers P.Lemmers P.M.A.Lenderking W.

45 92 78 78 45 37 84

67, 81, 88, 103, 104 84 67 71 63

18, 19, 117 80 64

32, 53 59, 105

118 32, 92

15, 45, 50, 69, 97, 114 100 83

29123

29, 76 13, 36, 57, 90

49 121 31

39, 82, 89 11, 36, 46

71 22, 39

48 75

67, 68, 118 39, 70

96 62, 79, 112

42, 96 78 96 47

96, 111 96

18 78

51, 58, 95 40 40

18, 84, 111 18

1881

13, 31, 58, 90, 95, 122 21

29, 47 109 95

L

167167

Leon M.Leonardi V.Leong V.Lequin M.Leucuta D.Leung T.Leva E.Levasseur K.Levy E.Levy P.Levy P.T.Lewis J.Ley D.Li C.Li N.Li Y.Liamlahi R.Lieftüchter V.Liegl R.Liem D.Lien R.Liew Z.Likeman M.Lilliesköld S.Lima B.B.Lin C-H.Lin Y.C.Lin Y.J.Linde M.A.Ling T.Y.Lingam I.Linklater A.K.Linnér A.Linsell L.Liotto N.Lista G.Lithoxopoulou M.Little G.Little R.Liu K.Liu S-Y.Liu Z-J.Löfqvist C.Loftus E.Logothetis M.Lombaard C.J.Longford N.Longini M.Loof T.G.Looney A.M.Lopes T.Lopez Lozano Y.López-de-Heredia J.Lopriore E.Lordier L.Loureiro B.Lourenço M.M.Lozar Krivec J.Lu K.Ludeña D.Lui K.Luka R.L.

76 98 47 72 62

42, 43 63 83 69 89

41, 65 94

45, 93, 112 55

121 50, 98, 120

29 19 87

49, 88 106

58 79 82

25, 110 28, 95

95 95

114 120

54, 119 24 38 56

110 20, 27, 120

44 99 39 53 98 87

32, 45, 87, 93, 112 53 59 48

87, 97 79 66 72

19, 116 115

36 31

68 36, 93

25, 107 19

30, 9563, 102

30, 58, 95 20

Lundgren P.Luu T.M.Lydersen S.Lynne K.

Macchini F.Machidani N.Mactier H.Mader S.Madero R.Maderuelo-Rodriguez E.Maeyama K.Magalhaes L.V.Magerl W.Magny J.F.Maguire F.Mahdhaoui N.Mahieu L.Mahoney L.Mai V.Maida C.M.Maier R.F.Maingay-de Groof F.Majcherczyk M.Malavolti A.M.Malchau Carlsen E.Maldonado J.Malic N.Mallardi D.Mallya P.Malniece I.Malone F.Malone F.D.Malova M.Målqvist M.Mancino I.Mandò C.Manerkar S.Mangili A.Manktelow B.N.Manley B.Mannheimer C.Manolidou Z.Manou A.Mansvelt P.Marchini G.Marchionni P.Marciano Alves Mousinho R.Mardare R.Margeli A.Marginean O.Marian R.Mario M.Markasz L.Marlow N.Marrin M.L.Marroun H.E.L.Maršál K.Marshall A.

43, 87, 93 81

78, 103 116

28 36 86

16, 51, 70, 90, 105, 122 26 26 67 47

118 97, 114

53 25, 77, 107, 108, 109, 116

100 22 65 94 53

100 19 76

121 112 113 110 84 17

33, 41 41

47, 68, 72, 79, 80, 92 2932

104 30

31, 55, 84, 95 86

37, 38, 46 87 59 81 99 44

50, 61, 62 97 82

115 108

17, 107, 108 94 21

53, 56, 86, 103, 104, 105 53

118 58, 93

115

M

168168

Marsinyach-Ross I.Marsubrin P.M.T.Mårtensson G.Martin A.Martin D.Martin T.Martín C.M.Martin-Alvarez E.Martin-Ancel A.Martin-Celini F.Martinello K.Martinez A.Martinez F.E.Martinez V.Martinez Gimeno A.Martinez-Biarge M.Martini S.Martín-Peregrina F.Martins C.Martins-Celini F.P.Maruniak-Chudek I.Masaki H.Masilungan C.Maslarska R.Mastouri Haddeji M.Mateos M.Mathlouthi J.Matic A.Matinolli H-M.Matterberger C.H.Matthew A.Matthiesen N.B.Matusiak G.Matyas M.Maurina A.Mayer B.Mazaev A.Mazela J.Mazur-Magoła M.Mbuagbaw L.Mc Coy R.McCallion N.McCarthy E.McCarthy L.McCartney D.McCormack M.McCurmin D.McDermott H.McDonald K.Mc Eneaney V.McFadden V.Mc Garvey C.McGillick E.V.McGregor C.McGuire J.McMillan D.McNair C.McNamara D.McNamara P.McNulty A.McPherson B.McSweeney L.

26, 3885 67 26 16 65 24

24, 66, 112, 116 76

10754, 119

19, 24, 75 19 36

115 101

47 66

101 20, 22, 107, 110

19 113 115

20 112

63, 102 112, 107, 109

77 118

62 64

29, 31, 58, 103 17

62, 109, 115 17

37, 38 98

37, 109, 113 83 40 32

33, 41, 6845 65 61 82 87

24, 39 22

80, 101 18 7684 72 80 63 30 61

14, 54, 89 70 54 41

Meder U.Meehan C.Meesters N.Meeus M.Megaw K.Mellinger L.Melorz A.Mendoza N.Menis C.Menshykova A.Mercer J.Merchant N.Merglen A.Méritet J.F.Mestiri K.Methlouthi J.Michalec M.Miechowicz I.Mielgo V.Mielnik K.Migliaro F.Mikhalenka E.Mikkola K.Mildenberger E.Mileder L.P.Miletin J.Miller P.Miller S.Mills M.Milov V.Minoo P.Mirada Vives A.Mirahamdi S.Miranda A.M.Miranda L.Miranda Romera P.Mitra S.Mitsiakos G.Mittal S.Miyazawa T.Mizobuchi M.Moczko J.Modi N.Moeskops P.Mohammadzadeh A.Mohammed L.Mohanraj N.Mohlkert L.A.Moiron M.Moja L.Mok D.Mól N.Moldovan E.Moles L.Moll J.Mollamahmutoglu L.Molloy E.J.Moloney G.Moltu S.Monastiri K.Mondello I.Mondkar J.

63 54, 119

31 100 113 66

116 114 110 21 33

77, 100, 123 118

88, 114 77

25, 108, 116 19 37 36

17, 113 98, 120

36 39 37

61, 62, 64 26, 42, 108, 109, 112

108 29, 45, 100

67, 80 63 55 84 61

113 94 24

40, 63 44

85, 107 110 67 37

31, 58, 90, 95, 97, 121 53 20 82 81

121 44 30

108 45, 110

107 114 64 83

18, 30, 43, 53, 80, 101 72

32, 44, 50, 69, 110 24, 25, 42, 77, 112

109 30

169169

Monk D.Monnelly V.Monteagudo-Sánchez A.Monteith C.Montirosso R.Moore C.M.Morales A.Morales De Mata P.Moral-Pumarega M.T.Morana G.Morcelli-Tovar C.Moreno A.Moreno Hernando J.Moretti C.Morgan C.Mori R.Mori T.Morioka I.Morisaki N.Morisawa T.Morley C.J.Morris C.Morris J.Morsing E.Mosca F.Moshous D.Mosig D.Mougou S.Moungsuwan K.Mowitz M.Msalbi K.Mu S.C.Muche R.Mukai T.Mukherjee A.Mukherjee D.Mulder A.Mulder E.E.M.Müller V.Mungan Akin IMupanemunda R.H.Muppidi P.Muraca M.C.Muresan D.Murillo C.Mürner-Lavanchy I.Murphy M.Murphy R.Murray D.M.Mussi M.M.Mustafa S.Mustafa Kamal A.M.Muster M.Mynarek M.

Naberezhnev Y.Nabetani M.Nabialek T.Nadeem N.

20 86 20 41

122 81, 82 24, 84

84 72, 93

47, 68, 72, 80, 92 22 111

116 20, 26

68, 123 32, 45, 50, 110, 111

76 75

21, 67, 110 95 67

30, 68 115

42, 56, 64 93

28, 49, 63, 110 114 121

77, 108 96

31, 55 112

23, 37, 107 120

76 117 117 100

84 66

24, 108 27 32 92

109 116

79 65, 120

53 53, 71, 72, 80

110 23, 87

84 83

103

83 76 97 17

Nader P.J.H.Nader S.S.Naef N.Nagamura-Inoue T.Naghib S.Nagy Z.Naicker K.Nair H.Najm S.Nakato A.M.Nakstad B.Nallagonda S.Narayanan S.Nardi V.Nardou K.Nassel D.Nasseri N.Natalucci G.Nath P.Navarro N.Navarro Patiño N.Navér L.Negro S.Negrón J.Nelle M.Nelson S.E.Nemeth A.Neovius M.Neşelioglu S.Nestaas E.Neumann R.New K.Newell S.Nguyen A.Nguyen T.D.Nichols T.Nicloux M.Nicolau Manzano M.Niedbalski P.Niederhauser T.Niermeyer S.Nieto R.Nijboer C.Nikitina I.Niklas V.Nilas L.Nilsson A.K.Nilsson J.Nishimura N.Nixon P.Nobile S.Noguchi A.Nogueira M.Nohr E.A.Nolan O.Nolbrant S.Noori S.Noorizadeh S.Noorlag L.Nordberg V.Nørgaard K.Norman E.

17, 96 17, 96

29 76 57 12 65 76

32, 45, 112 20

69, 116 82

77, 100, 123 109 116 81 42

76, 79, 85, 93, 103 18, 23, 39, 100, 114

8525, 41, 85

66 92

113 82

121 57

102 83, 113

14, 33, 40, 54 92

105, 122 38 50 85 58

114 84 37 99 99 44 87 48

91, 96 121

32, 45 82 67

121 50, 61, 62

95 85, 116

58 108 94

14, 54 20 29 66

121 88, 122

N

170170

Norman G.Norman M.

Nosarti C.Noureldein M.Nouri A.Nouri S.Nouri Merchaoui S.Noventa M.Nowak G.Núñez-Ramiro A.

Ó Catháin N.O’Connor D.O’Connor N.O’Dea M.O’Dowd M.O’Leary J.J.O’Riordan M.O’Sullivan M.P.O’Brien O.Ochoa J.J.O’Connor N.Odd D.Oddie S.O’Dea M.O’Donnell C.O’Donnell C.P.F.Oei J.Ofoegbu B.Ognean M.L.Oguz S.S.

Ohlund I.Ohyama S.Okafor I.O’Kelly R.Okubo S.Okur N.

Olariu A.Olariu E.Olariu G.Olariu L.Olariu S.Olbertz D.Olin A.Olischar M.Olsen J.Olsen R.K.Olsson K.W.Olsson Mägi C-A.Olteanu R.G.Omann C.Omer M.Oncel M.Y.Onland W.Oosterlaan J.Oostrom K.

76 58, 66, 82, 93, 109, 111

121 56

23, 82, 95 77

77, 107, 109, 112 25, 108, 115, 116

84 57

72, 93

112 82 53

101, 116 39

101 97 72 53

66, 112 53

58, 79, 94 59, 65

101, 116 65, 120

30 30

82, 90 25, 85

23, 41, 53, 59, 82, 85 96, 98

32 21 18

112 21

23, 41, 53 59, 82, 85, 96, 98

23, 82, 95 25

20, 27, 85 20

20, 27 96 59 80 58 64 43 81 67 78

116 59, 82 31, 98

78 78

O

Oral B.Ordoñez M.D.O’Regan S.O’Reilly H.Orlikowsky T.Örtenstrand A.Osborne L.Oshalim M.Østergaard J.R.Østerholt H.C.D.Ostojic D.Ouwehand T.L.Ovali F.Owen L.Owsiańska Z.Özcan B.Ozdemir N.Ozer Bekmez B.Ozkan H.

Padalino M.Padbury J.Padilla N.Pagel J.Paiva P.Paiva P.P.Paize F.Pakarinen S.Pal R.Palmkvist Kaijser K.Panickar A.Panjwani D.Pansy J.Pantoja A.Panza R.Papadopoulou M.Papamichael E.Papassotiriou I.Park J.H.Park S.H.Park W.S.Parker A.Parmar M.Parodi A.Paro-Panjan D.Parra A.Parraga M.J.Parrella C.Parri N.Partanen E.Parthasarathy P.Patel B.Patel M.Patel M.D.Pavel A.M.Paviglianiti E.Pavlyshyn H.Pavon A.Pavord S.

66 107 30 56 35

100 23, 40

59 29, 31, 103

116 19, 42

53 24

37, 38, 46 17 83 78 85

44, 66

48, 65 33

67, 68 65

22, 25 61 92 39 22 44 77

107 64 24 37

83, 101 40

115 18, 111

18 34 33

77, 123 47, 68, 72, 79, 80, 92

19, 79 72, 93

107 21 98 39

100 27 89 41 97

109 38

72, 93 81

P

171171

Paynter J.Pedersen L.H.Pedersen M.Pedersen M.V.Pedersen T.Peinado H.Pejovic N.J.Pelligra G.Pelling V.Peña-Caballero M.Peng X.Peralta J.Pereira Martins-Celini F.Peretti A.Perez E.Pérez I.Perez-Navero J.L.Perez-Perez A.Perk Y.Perrone M.Perrone S.Pertile M.Pescador Chamorro I.Peters J.Petersen O.B.Peterson M.Petersson G.Petrela E.Petroni G.Petropoulou C.H.Petrova D.Petrukhina N.Petty J.Peyter A.C.Pfeifer S.Pfeiffer H.Pfister M.Pfister R.E.Philpott A.Pianesi A.Pichler G.Pieltain C.Piemontese P.Pietrobelli A.Pillow J.J.Piñeiro-Ramos J.D.Pinho L.Pioselli B.Pirr S.Pissarra S.Pittet M.P.Poets C.F.Poggi C.Poggi G.Pogka M.M.Poindexter B.Pokrzywinski R.Polat I.Polat S.Polentarutti S.Polglase G.R.Pollien P.

79 71, 86

78 78 69 26 61 82

67, 80 66, 112

90 115

22 67 76 24

110 26 81

110 79, 92

36 25, 38, 94, 95

120 31

102 92, 102

37 99 59 63

102 105

64 66

3232 79 18 67

61, 62, 64 96

110 110

55, 62 72 19 36

65, 66 26 79

68, 101, 109 98

120 113

82 95 40

114 29 84

118

Polonara G.Polycarpou E.Ponce J.Ponchia E.Ponnusamy V.Popoiu A.Poppe J.Porcarelli F.Porta R.Porter R.Posod A.Prager S.Prasad R.Prayle A.Pre-Curto F.Preusche A.Pritchard M.Procianoy R.S.Proença E.Proietti F.Provitera L.Pryds O.Psyllidou S.Puccini P.Pugni L.Puigarnau Vallhonrat R.Pulzer F.Pupp Hansen I.Putter H.Puyal J.

Quero J.Quigley A.Quigley J.Quintana Rio E.Quintero Fuentes I.

Raaymakers M.J.A.Raba G.Rabe H.

Rabi Y.Raffa S.Raffaeli G.Ragab S.Rahim R.Rai D.Räikkönen K.Raimondi F.Raiskila S.Rajadurai V.Ramanathan R.Ramaswamy R.C.Ramenghi L.A.

Ramos N.

67 40

116 33 75

108 88 62

123 85

77, 92 119

75, 108 27

116 109

78, 79, 105, 122 47, 65

19, 116 79

28, 49 121 117 36 63 84

120 112 31

119

101 86 44 84 47

108 83

22, 27, 33, 48, 49, 67, 80, 91, 109

30 47

28, 49, 63 54, 119

114 86

118 21, 66, 98, 120

122 23

55, 90 24

12, 27, 47, 67, 68, 72, 79 80, 92, 104

24

Q

R

172172

Ramos-Navarro C.Rana N.Rapisarda A.M.C.Rapushi E.Rascher W.Raschetti R.Rasiah S.Rasiah S.V.Rasiah V.Ratiu A.Ravanetti F.Ravegnani M.Ravn M.J.Raynero R.C.Razai A.Re M.Rechtman D.Ree I.M.Regnicolo L.Reicherzer T.Reichman B.Reinboth B.S.Reis e Melo A.Reiss I.K.M.

Reister F.Reitan S.K.Relton C.L.Remesal A.Renes I.Repa A.Resnick S.Rettedal S.Reulecke B.Reuner F.Reyes Millán B.Reynolds A.Reynolds P.Rey-Santano C.Rheinländer C.Ricci F.Rich W.Richter A.Richter M.Rickenbacher H.Rigby M.Rigo J.Rigourd V.Rimensberger P.Rimol L.M.Rite S.Rivera-Sánchez S.Roberts C.Roberts E.Robertson N.J.Roch G.Rocha G.Rocha N.A.C.F.Rochow N.Rodgers-Gray B.Rodrigues M.Rodriguez A.

18, 25, 26, 38, 41, 85 2984 37

120 55 24

18, 24, 75, 108 117

85 36 79 81 24

117 72 96 3167

111 58 95

119 26 85

9, 23, 31, 35, 49, 57, 88 100

38 78

71, 86 63, 102

43 43, 44, 81, 87

95 69

22, 80 66 47 76 37 36 40 36 30 61 65

118 65 96

81, 88, 97, 110, 114 70 78 36

116 37, 46

49 54, 87, 119

83 26 76

32, 50, 53, 82, 96, 112 115 116

95

Rodriguez M.V.Rodríguez J.M.Rodríguez J.R.Rodriguez Fanjul J.Rodriguez Guerineau L.Rodriguez Sánchez De la Blanca A.Rodriguez-Benitez M.V.Roehr C.C.

Roesch L.F.Rogerson S.Roggero P.Rogido M.Rohde O.Rohsiswatmo R.Roldán R.Rolle U.Romantsik O.Rombo K.Romero J.Romeu Garbí J.Rook D.Rosander K.Rosário M.Rosario Filho N.Rosenbaum J.Rossetti D.Rossi A.Rossi R.Roth J.Rousson V.Roviglione B.Rovira Zurriaga C.Roy R.Rudas G.Rueda C.Rueda R.L.Ruiz M.D.Ruiz-Gonzalez M.D.Rumba-Rozenfelde I.Rusconi F.Rusneac M.Russo L.Russo S.Ryan E.

Saad A.Saccani F.Sacramento E.Sadarangani M.Sadasivam I.Sadeghirad B.Saeidi R.Saenz De Pipaon M.Saffioti M.C.Saghrouni F.Saglam O.Sala D.

107 114114

26, 98 20

18, 25, 38, 41, 82, 94, 95

19 18, 20, 23, 31, 37, 46, 62,

81 91, 96, 115, 123 65 47

110 97

120 85 24 76 77 13 87 84 30 78

26, 85 20 78 84

47, 68, 72, 80, 92, 109 120

65, 66 29 27 20

21, 116 67

116 107 107 19 17

58 95 17, 107, 108

101 79 18

77, 107, 112 36

20, 22, 25, 61, 107 115 81 40 20

114 75

116 22 20

S

173173

Salabay Z.Salas S.Saleh M.T.Saleh S.Salguero E.Saliba A.Sallabanda S.Sallemi M.Sallmon H.Salomone F.Salvagno M.Samuelsson M.San Feliciano L.Sanches E.F.Sanchez A.Sanchez A.A.Sanchez T.Sánchez-de-Toledo J.Sánchez-Gómez De Orgaz M.Sánchez-Illana ÁSánchez-Luna M.

Sánchez-Martínez M.B.Sánchez-Redondo M.D.Sanchez-Torres A.M.Sandegren L.Sangalli A.Sangaralingham L.Sangild P.T.Sannia A.Sanpietro G.Sansone C.Sánta R.Santhalingam T.Santos A.L.Santos M.M.Santos Silva J.Sanz-Lopez E.Sapia F.Saporito L.Sapun O.Sarapuk I.Sarda S.Sari F.N.Sari R.Sarmiento-Carrera N.Sarosa G.Sarri G.Sartori S.Sartz L.Saso A.Sato Y.Satodia P.Saugstad O.D.Saunders M.Sauser J.Savani R.C.Sävman K.Saysanasongkham B.Sboui H.Scacioli L.Scalise L.

37, 44 113

75 75

24, 111 90 20 18

18, 40 36

48, 65 86

63, 102 87 36

41, 89 111

26 26

72, 93 16, 18, 26, 38, 41, 60, 68

82, 85, 94, 95 66, 112

24, 78, 115 26 66 17 99 50

47, 68, 72, 79, 80 84

120 17, 108

95 116

76 85

26, 82 84 94

102 38

31, 55, 84, 94, 95, 102 85, 98

85 112 114 102

48 94

114 76

17, 18, 23, 40, 114 30, 31, 61, 62, 71, 92, 118

116 118

21 32, 45, 112, 118

17 77, 107, 115

22, 25 61

Schaefer C.Schappin R.Schelonka R.Schenk D.Schenk W.Schiefele L.Schimmel M.S.Schloesser R.Schlösser R.Schmid A.Schmid M.Schmidt L.Schmidt S.Schmolzer G.Schmölzer G.M.Schneider H.Schneider J.Scholkmann F.Schöning J.Schreek S.Schultze J.L.Schulze A.Schulzke S.M.Schumann S.Schütze G.Schwaberger B.Schwartz E.Schwarz C.E.Scopesi F.Scott J.G.Scott M.Scrivens A.Sdobnikovs M.Seboui H.Sedin G.See L.C.Segerer H.Seidenberg J.Sekarski T.Sekarski T.J.Sekili Z.Sekretar L.Sellami M.Sellwood M.Semberova J.Semple S.Senterre T.Senyuk T.Seppänen A-V.Seraissol P.Serdar M.Seremak-Mrozikiewicz A.Serenius F.Seribeli G.H.Seribelli G.H.Serkant U.Serrano I.Serrano López L.Serreau R.Severino M.Sevuk Ozumut S.Sgarbi E.

29 53 99 19

120 38 57 76

120 77

38, 120 80 17 99 62

37, 97 45, 47, 101

19, 42 66 66 66

21, 111 99 37

111 61, 62, 64

84 109 27 79

114 37 17

25, 77, 108, 116 21

108 120 120 89 41 39 37

117 27, 59

26, 42, 108, 109, 112 86 96

102 53 88 87 92

58, 77, 86, 103 20

25, 107 59 36

24, 66, 112, 116 88

47, 68, 72, 80, 92 24, 108

36

174174

Shah P.Shah Farhat A.Shanahan I.Shankar-Aguilera S.Shankle N.Sharafutdinova D.Sharkey D.Sharp G.Sharp G.C.Sharp H.Shetty N.Shibata A.Shimotake J.Shin J.Shin J.S.Shin S.H.Shin S.Y.Shing H.Shintaku H.Shipley L.Shires P.Shishkina O.Shishko G.Shoji H.Shore H.Shuttleworth B.Shyur S.D.Siahanidou T.Siddiqui F.Sierra A.Siffel C.Siljehav V.Silva A.Silva G.Silva R.P.G.V.C.Silveira R.C.Silverman A.Simard J.M.Simeoni U.Simmen P.Simms V.Simon M.Simonato M.Simons E.A.Simons S.H.P.

Sindelar R.Singer B.B.Singh A.Singh B.Singh G.Singh G.K.Singh K.Singh M.Singh N.Singh Y.Singhal N.Sinha A.Sinha S.Sipola-Leppänen M.Sizonenko S.Sizonenko S.V.

58, 95 20 65

55, 63, 102 18 75

61, 95, 119 71 86 27 59 67 80 42 77 77

18, 111 25 76

61, 119 109 102

36 110 111

59 21

115 85

100 55, 94, 102

117 87

85, 116 20

47, 65 27 43

53, 64, 96, 116, 121 99 56

17, 107, 108 33, 48, 65, 102, 120

100 9, 15, 27, 31, 41, 49, 57,

59 88, 100 21, 43

119 24, 85

63 89 41 32

108 85

41, 89, 107 99 64 68

118 51 87

Sizun J.Sjörs G.Sjöström A.Skenderi Mustafa B.Skiöld B.Skjaerven R.Skranes J.Slater R.Sminato M.Smith A.Smith J.Smith L.E.H.Smyth J.Snoek L.So H.Y.Sodano A.Söderström M.Sol J.Solana C.Sola A.Sola-Visner M.C.Soler P.Solevåg A.L.Soliz A.Soliz J.Soltirovska Salamon A.Song I.G.Songstad N.T.Sørensen A.S.Soubasi V.Souza T.S.Spaans E.Späth C.Spaull R.Spencer S.Spittle A.J.Spong R.Spyroulias G.A.Staffler A.Stanescu A.Stanulla M.Stanzelova A.Starnberg J.Stas H.G.Staunstrup N.H.Staves J.Stefanovic S.Stefanovic V.Stegeman R.Steinhorn R.Stellari F.F.Stellin G.Stendahl T.Stephansson O.Stevens B.Stewart M.Stiles S.Stjernqvist K.Stocken D.Stoecklin B.Stoelhorst G.M.S.J.Støen R.

51, 57 95 94 23

38, 92, 109 102 18

118 55

39, 41, 65, 89 48, 67

45, 87, 93 30 98 53 98 57 57 44

35, 6087

114 116 21 21 79 77 84 4644 22 41

111 54 27 47 56

113 21 97 66

112 93

100 86 81

115 115 80

11, 55, 71 36 48 39

92, 95 30 37

111 103 68

55, 62 100 69

175175

Stoiber H.Stoimenova E.Stokes S.Stoltz Sjöström E.Storring N.Stoyanova V.Stranak Z.Strand M.Strand Brodd K.Streuli J.Stringer S.Stroescu R.Strom S.Stucchi I.Studzinski F.Su Y.N.Suarez-Albo M.Subhedar N.Subhedar N.V.Suchojad A.Suciu L.Suciu L.M.Sukharava A.Sun A.Sun K.M.Sun Y.Sun Song W.Sundberg B.Suppiej A.Sutcliffe M.Suter L.Suzuki K.Svedenkrans J.Svensson J.Sweetman D.Syrimi E.Szabo M.Szadkowska A.Szakmar E.Szczapa T.Szczapa-Krenz H.Szepetowski P.Szpecht D.Szymankiewicz M.

Tabasso C.Taber M.Tachtsidis I.Taddio A.Taguchi A.Taher N.A.Takatera A.Taki A.Takyi A.Talar T.Talbot L.Talias M.Talman M.Tamayo M.E.

115 63 66

45, 111, 121 75 63

42, 109 99 78 57 95

108 57

120 96 77

112 14 99 19

17, 107 108

36 96 22 87 62 38 48 18 99

43, 113 55

103 31, 43, 44, 80

23 63, 64, 67

65 63, 64 17, 37

37 100

92 92

110 42

54, 119 30 76

80, 116 67 76 27 64 83 40

121 40

Tammela O.Tamura M.Tan J.Tan K.Tandberg B.Tang N.Taniguchi S.Tann C.Tann C.J.Tarko A.Tarnow-Mordi W.Tataranno M.L.Tayman C.Tchirikov M.Tedroff K.Teh W.Y.Tei M.Teig N.Tekgündüz K.ŞTekgündüz S.E.Tekin N.Teles Silva C.ter Heine R.Terki Hassaine R.Testoni D.Tetruashvili N.Thanhaeuser M.Theodoraki M.Thibault M-P.Thiele N.Thielen M.Thio Lluch M.Tho A.Thomas S.Thomson G.Thomson L.Thorolfson F.Thwaites R.Tibboel D.Tidrenczel Z.S.Tikanmäki M.Timme K.Tin W.Tocoian A.Todorov T.Toet M.Tofani L.Tofé I.Toivonen M.Toma A.I.Tomasik P.Tomasini E.P.Toome L.Topf H-G.Tormey P.Torres Torres M.Tortora D.Totsu S.Touati A.Touqui L.Towers H.M.Trabelsi S.

81 76

22, 64 38

122 43, 44

107 54, 119

59 19

30, 88 109, 118

59, 85 83

102 76 92

120 40, 114

114 39

85, 116 41 81 25 75

43, 44, 81, 87 83, 101

69 57, 105

9962 95 99

39, 123 50 82

115 48, 49, 57, 88, 118

17 118 120 68 84 20

29, 118 98

19, 72, 93, 107, 110 90 67

45, 110 61

53, 122 120 44 95

47, 68, 72, 80, 92 110

77, 107, 112 55, 102

57 77

T

176176

Traggiai C.Tran P-A.Trancassini M.Tremblay E.Tremlett C.Treston B.Trevisanuto D.Triantafyllidou P.Trickett J.Troiano D.C.Truttmann A.Truttmann A.C.Tsai L.Y.Tsai M.H.Tsai Y-S.Tsakalidis C.Tsanova A.Tsao P.-N.Tsilika S.Tsou K.I.Tsou K-I.Tsuji M.Tubman R.Tufvesson E.Tully E.C.Tunescu M.Turner A.Turner M.Turner M.A.Twomey D.M.Tzialla C.

Uccella S.Uclés G.Uclés López G.Ueda M.Ulas T.Uldbjerg N.Ulrich T.H.Ulubas Isik D.Umphrey L.Unal S.Uney J.Ungureanu M.Uras N.Urbanek M.Urilli D.Urlesberger B.Uygun M.

Vääräsmäki M.Vaiman D.Valenti G.Valentsiukevich I.Valstar M.Valverde E.

80 99 94 69

116 108, 112

23, 62, 120 101 104

22 45, 119

101 23, 37, 107

59 28 44 63

77, 98, 120 24, 98 95, 98

98 76 39 97 41

27, 85 71

9, 31, 45, 47, 84, 105 47 53 94

68, 80 24, 75, 78

115 67 66 31

120 83, 113

62 83, 113

54 107

23, 41, 82, 85, 96, 98 77 92

92 61, 62, 64, 80, 82

24

118 81 84 36 95

72, 93

U

Van Beek F.van Beek R.H.T.van Bel F.Van De Heuvel M.Van De Ville D.van Den Akker C.H.P.van Den Anker J.van Den Anker J.N.van Den Bosch G.E.van Den Hoogen A.van Der Aa N.van Der Bom J.G.van der Horst B.van Der Lugt A.van Der Net J.van Dijk M.van Dijk-Lokkart E.van Drongelen J.van Essen T.van Eyck J.van Gasselt B.van Gennip A.van Haastert I.C.van Heijst A.van Kaam A.H.L.C.van Kampen F.S.Van Laere D.van Lingen R.van Lingen R.A.van Marter L.van Meurs-Asseler L.van Rosmalen J.van Straaten I.van Tuyl M.van Weissenbruch M.van Weissenbruch M.M.van Weteringen W.Van Wyk L.van Zanten H.van Zoeren-Grobben D.van’t Verlaat E.P.G.Vanniyasingam T.Vanpée M.Vanya M.Varal I.Varvarigou A.Varxalama E.Vecchio D.Vedovelli L.Vedovili L.Vejnoska B.Veldhuis M.S.Velilla-Aparicio M.Veneselli E.Vento Torres M.

Verdoliva L.Vereshchak S.Vergely C.Verhage C.Verhage C.H.Verhagen E.

49 61

47, 87 12

118 43

114 32

110, 118 9, 16, 38, 39, 70, 80, 105

67 3188

118 39

31, 40, 57, 118 78

108 23 84 67 84

53, 109 27

36, 70, 73, 98, 101 100 10043 84 99

100 31

101 98

100 45

23, 88 48, 107

99 43

100 40

45, 117 84

44, 66 113 101 94

33, 48, 65, 102 55 92

109 38

68, 8030, 31, 35, 58, 60, 71, 72,

73, 93, 95120 37

121 67 39 55

V

177177

Verlato G.Vermeulen R.Verstyuft C.Vervenioti A.Vestergaard E.M.Viberg M.Vidra C.Vieira A.A.Viemann D.Vieten D.Vijlbrief D.Vijlbrief D.C.Vik T.Villamor E.Villar-Castro S.Villarino R.Villetti G.Vinaixa Vergés A-A.Virella D.Virupachi S.F.Visentin S.Vishna Rasiah S.Visick M.Vitagliano A.Vitale S.G.Vitsa L.Viuff A-C.Vlasova O.Voeten M.Vogeser M.Vogl T.Voigt M.Völler S.Völlger L.Volpe J.J.von Hofsten C.von Kaisenberg C.S.von Köckritz-Blickwede M.von Krusenstiern L.Von Laer D.Vora S.Vormoor J.Vu K.P.T.Vucinovic A.Vucinovic M.Vyas R.

Wackernagel D.Wada K.Wagenaar N.Wagh D.Wagner M.Waheed G.Walker A.Walker K.Walker S.Wallace L.Wallendorff M.Walsh B.Walsh B.H.

120 100

88 51 31

83, 100 115

22, 111 65, 66

18 72

31, 109 103

28, 49, 102 25 75 36 84 94

115 33 85 99 84 84

113 58, 71, 86, 94

69, 117 100 111

65, 66 96 88 66 92 78 66 66 31

115 23 68 45 80 80 47

62 110

67, 87 22 80 86

109 105, 122

118 71 41 47 80

Wang D.H.Wang H.S.Wang J.Wang J.Y.Wang L.X.Wang M.Wang S.M.Ward C.Ward R.Warner B.Warren J.Warwick H.Washburn L.Watabe S.Watchko J.F.Watkins R.Watts L.Wauer R.R.Webbe J.W.H.Weber S.C.Wechselberger K.Weeke L.Weider S.Weindling M.Weiss M.D.Wellmann S.Wells J.Wen Y.H.Wertheim D.Wesolowska A.Westerlund F.Westin V.Weston P.J.Westrup B.Wheeler K.I.White T.Whybra-Trümpler C.Wickström R.Wielenga J.Wigdel J.B.Wiingreen R.Wilbaux M.Wilde ÅWillassen N.P.William J.Williams K.Williams L.Z.J.Williams M.Williams T.Wilson E.Wilson P.Winckler M.I.Winderbank-Scott D.Winter J.Witoslaw B.Wittekindt B.Wittwer-Backofen U.Wolf M.Wolfs T.Wolke D.Wood C.Wood H.

96 96 31 21 96 33 96

61, 95 84 41 99 23

121 76

43, 44 22

39, 7018 90 40 77

12, 29 78 48 79

26, 32, 79, 92, 93, 118 123 98 65 82 66

45, 111 28, 114

38, 93, 122 68

118 37 92 99 81

103 32 93 69 17

111 61 57

17, 76, 102 83 59 47 39

37, 99 37 76 96

19, 42, 109 54, 119

56, 58, 94, 103, 104, 118 76

108 117

W

178178

Woodgate L.Woods P.Wösten-van Asperen R.M.Wright B.Wright I.Wrigley C.Wróblewska-Seniuk K.

Xiao J.

Yacoubi M.T.Yagmur Bas A.Yahya L.Yajamanyam P.Yalnızoğlu Çaka S.Yamada J.Yamada N.Yamana K.Yamane M.Yan J.Yang H-I.Yao L.M.Yap T.L.Yaprak Sul D.Yaremchuk S.Yasin F.Ye X.Yen T.A.Yi F.Yılmaz Semerci S.Yoon H.R.Yoon Y.M.Yoshimoto S.Yousef N.Yurdakul E.Yzydorczyk C.

Zaharie G.Zaharie G.C.Zamir I.Zanetti B.Zanin A.Zappettini S.Zardi S.Zareen Z.Zasada M.Zdraveska N.Zea A.M.Zeballos Sarrato G.Zeballos-Sarrato S.Zeitlin J.Zenker S.Zernickel M.

115 62 98

116 30 53

109

42

25 83, 113

90 43 81 30 27 21 67

79, 93 98 96 23

113 37

115 50

84, 98 47 22 77 77 67

63, 98 113

64, 116, 121

62, 115 109 121

21 75 30 77

80, 101 45, 110

24 40 26 25 53 66

120

X

Y

Zgârcea C.Zhang L.Zhang R.Zhang Y.Zhao J.Zhou P.Zhou Q.Zhu L.Zhu X.Ziegler E.E.Zile I.Zimmermann A.Zimmermann L.Zivanovic S.Zoutkamp G.I.Zuanetti G.Zubkov V.Zwittink R.Zych B.

25 50 90

40, 96 31, 55

50 40 90

79, 93 121 17

120 16, 53, 62, 91

20, 37, 96 43

28, 49, 63 75 43

65, 83

Z

© 2017 Masimo. All rights reserved.1 de-Wahl Granelli A et al. BMJ. 2009 Jan 8;338:a3037. 2 de-Wahl Granelli A et al. Acta Paediatr.2007 Oct;96(10):1455-9. 3 Ewer AK et al. Lancet. 2011 Aug 27;378(9793):785-94. 4 Zhao QM et al. Lancet. 2014 Aug 30;384(9945):747-54. 5 Meberg A et al. Acta Paediatr.2009 Apt;98(4):682-6. 6 Kemper AR et al. Pediatrics. 2011 Nov;128(5):e1259-67. * Referred to as “CCHD Mode” in Radical-7 Operator’s Manual.

For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions. Masimo devices with Eve has obtained CE Marking. Not available in the U.S. PL

CO-0

0115

0/PL

LT-1

0032

C-0

717

CCHD Screening with Masimo SET®

Measure-through Motion and Low Perfusion™™ Pulse Oximetry

Studies found that Masimo SET® contributed to increased sensitivity and specificity of critical congenital heart disease screening compared to physical exam alone1-5

> In the largest CCHD screening study to date, with over 122,738 subjects, screening sensitivity increased from 77% using clinical assessment alone to 93% when clinical assessment was combined with Masimo SET® pulse oximetry.4

> Masimo SET® pulse oximeters and sensors were exclusively used in the two studies (59,876 subjects) that were the basis for the CCHD workgroup recommendation for CCHD screening protocols.1, 3, 6

Eve™ Newborn Screening Software Application*

> Automates each of the screening steps with animated instruction, including sensor application, measurement selection, and screening result determination.

www.masimo.co.uk/eve

Please visit us at Masimo

Stand #2

CCHD/EVE, JENS 2017, 15x21cm, EN.indd 1 20.10.17 11:25

share your experience by using the - mca scientific events€¦ · share your experience by using...

Documents